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Abstract 
Wound healing is a vital process, ensuring re-establishment of homeostasis and 
protection from pathogens. A few regions exhibit privileged healing, such as 
buccal mucosa, repairing very rapidly. In contrast, wound healing can be 
impaired, creating chronic wounds. Connexins (Cx) are a group of proteins that 
form gap junctions, enabling direct communication between the cytoplasm of 
connected cells. They play a pivotal role in normal skin wound healing. Cx43 is 
involved in cell proliferation and migration, but the roles of Cx26 and Cx30 are 
less well understood.  
 
Connexin expression changes in the privileged healing of buccal mucosa have 
not previously been determined. Cx26, Cx30 and Cx43 were highly expressed 
throughout the mucosa epithelium, but became rapidly down-regulated at the 
wound edge. This is in contrast to skin, where Cx26 and Cx30 are expressed at 
low levels, but increase at the wound edge, showing that the connexin 
dynamics differ between the tissues.  
 
Cx26, Cx30 and Cx43 expression also differs in chronic wounds compared to 
normal skin. They are expressed at abnormally high levels throughout the 
epidermis, and Cx43 is highly expressed in the dermis. It is thought that 
bacterial infection is involved in chronic wound development and healing 
impairment. Staphylococcus aureus is found in 90% of chronic wounds, where it 
forms a biofilm. I found that in vitro S.aureus biofilm exotoxins caused 
senescence in fibroblasts, impaired migration, and reduced Cx43 expression. 
The bacteria themselves reduced Cx43 expression, which increased their 
internalisation into fibroblasts. Furthermore, loss of Cx43 expression resulted in 
increased toxicity of S.aureus infection. In vivo S.aureus infection impaired 
healing, and resulted in epidermal hyperplasia and connexin up-regulation, 
mimicking the aetiology of chronic wounds.   
 
Connexin expression differs in buccal mucosa and S.aureus infected wounds 
compared to normal skin during healing, but their role in the healing status of 
these tissues is still poorly understood. 
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1.1. Overview 
The capacity to heal is of paramount importance for multicellular organisms. 
However, there are regions of the body that exhibit rapid, privileged healing. 
Alternatively, healing can be impaired by bacterial infection, such as in chronic 
wounds, where pathogenic species like Staphylococcus aureus are frequently 
found. Gap junctions are increasingly acknowledged to play a crucial role in 
cutaneous wound repair, and the changes in connexin expression during both 
privileged and S.aureus impaired healing are examined in this thesis. The 
relationship between S.aureus infection and connexin expression is explored, 
as are the implications of this relationship for cellular function and for healing.  
 
1.2. Overview of wound healing 
1.2.1. Architecture of the skin and mucosa 
Skin is a complex organ that covers the entire surface of the body (Kanitakis 
2002; Young et al. 2000). It is continuous with the mucous membranes that line 
the internal orifices of the body, such as the mouth, creating a continuous 
protective barrier from the external environment. Skin is comprised of three 
major layers: the epidermis, the dermis and the hypodermis.  
 
The epidermis is the outermost layer (Kanitakis 2002; Young et al. 2000). It is a 
stratified epithelium, consisting primarily of keratinocytes but also including a 
small number of melanocytes, Merkel cells and Langerhans cells. The 
epidermis also contains several skin appendages, such as pilosebaceous 
follicles and sweat glands. These terminate in the epidermis, but are 
predominantly located in the underlying dermis. The epidermis is divided into 
four layers, the lowest layer being the proliferative stratum basale, or basal 
layer (figure 1.1.A). The stratum spinosum (prickle cell layer) is next, followed 
by the stratum granulosum (granular layer), and the most superficial stratum 
corneum (cornified layer). Cells divide basally, differentiating and changing 
morphologically as they pass through the layers. They become more flattened, 
losing their nuclei and many organelles as they become increasingly superficial, 
until they are anucleate and flattened in the cornified layer, where the most 
superficial are shed.  
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Figure 1.1. Diagrams of the skin and oral mucosa. The epithelial and underlying connective 
tissue layer of (A) skin, and (B) oral mucosa are shown. The layers of the epithelium are 
labelled on the left of each diagram, and demarked by differing colours and morphologies (the 
information used in the creation of these images was taken from the following references 
(Diegelmann & Evans 2004; Martin 1997; Shaw & Martin 2009; Abiko & Selimovic 2010; Squier 
& Brogden 2011; Squier & Kremer 2001; Young et al. 2000)). 	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Underlying the epidermis, and only separated by a basement membrane, is the 
dermis (Kanitakis 2002; Young et al. 2000). This is a connective tissue, and is 
largely comprised of collagen type I bundles, arranged in a loose basket weave 
structure, and interlaced by elastic fibres. The dermis is richly supplied by nerve 
fibres and lymphatic vessels, as well as having a dense vascular network. 
Additionally, epidermal structures such as pilosebaceous follicles and sweat 
glands are also located in the dermis. The main resident cells within the dermis 
are fibroblasts. They both synthesise and degrade the connective tissue fibres 
that are continuously being turned over in the dermis, but the majority are 
quiescent in healthy undamaged skin. In addition to fibroblasts, the dermis is 
sparsely populated by mast cells, immune cells that are quickly activated upon 
wounding.  
 
The hypodermis (Kanitakis 2002; Young et al. 2000) is the deepest layer of the 
skin. It is often referred to as subcutaneous fat as it comprised almost entirely of 
adipocytes. It provides protection from mechanical injury, and is involved in 
insulation and thermoregulation, as well as acting as a nutritional store.  
 
Mucous membranes have the same protective role as skin, as well as other 
additional functions such as secretion or absorption, depending on the 
anatomical location (Squier & Kremer 2001; Markiewicz et al. 2007; Squier & 
Brogden 2011; Young et al. 2000). Oral mucosa is continuous with skin, and 
can be either keratinised or non-keratinised. Keratinised epithelium closely 
resembles skin and is found on the gingiva, hard palate and dorsum of the 
tongue, surfaces that are subject to mechanical force as they come into contact 
with food during chewing. The majority of the remaining oral mucosa though is 
non-keratinised. This includes labial mucosa (inside the lips) and buccal 
mucosa (inside the cheeks). In many ways, oral mucosa largely resembles skin. 
It is also made up of three layers; a stratified squamous epithelium overlying 
connective tissue, which is referred to as the lamina propria, with an underlying 
fatty submucosa.  
 
The epithelium of keratinised mucosa closely mimics the epidermis of skin, 
containing the same four layers (Squier & Kremer 2001; Markiewicz et al. 2007; 
Squier & Brogden 2011; Young et al. 2000). The epithelium of non-keratinised 
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lining mucosa, though, is a little different (figure 1.1.B). It is substantially thicker, 
and is comprised of only the two lower layers, the basal layer and an 
intermediate layer similar to the stratum spinosum, plus an uppermost layer 
referred to as the superficial layer (Squier & Kremer 2001). Cells in the basal 
layer proliferate, and differentiate as they pass through to the upper layer, but 
the upper most cells show less morphological differences than the cells in skin. 
They do become enlarged and flattened and develop cross-linked protein 
envelopes, but they retain their nuclei and organelles. This makes non-
keratinised epithelium more permeable than keratinised epithelia (Squier & 
Kremer 2001).    
 
The lamina propria is thin, but still closely reflects the dermis (Squier & Kremer 
2001; Markiewicz et al. 2007; Squier & Brogden 2011; Young et al. 2000). It is 
made of loose bundles of collagen type I fibres and is innervated by nerves and 
vasculature. Non-keratinised mucosa also contains elastin, and the extracellular 
matrix (ECM) is looser than in skin and keratinised mucosa. The predominant 
cell type is fibroblasts, but macrophages and mast cells are also present. Like 
skin there are also appendages in the form of sebaceous follicles, but unlike 
skin there are no pilosebaceous (hair) follicles. The submucosa also closely 
resembles the hypodermis, containing mostly adipocytes, but is only present in 
regions of non-keratinised mucosa (Glim et al. 2013).  
 
1.2.2. Acute wound healing in the skin 
1.2.2.1. Introduction to acute wound healing 
The ability of skin to heal is of enormous importance in maintaining 
homeostasis within the body and preventing infection, as skin is the body’s 
main protective barrier from the external environment. Full thickness injuries 
through the skin result in damage to several different cellular layers. Healing 
requires a plethora of coordinated signals and events, but is often described as 
proceeding through four key phases, which overlap: haemostasis, inflammation, 
proliferation and re-modelling (figure 1.2). This process is discussed in greater 
depth in the following reviews (Martin 1997; Shaw & Martin 2009), but each 
phase is reviewed briefly below. 
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Figure 1.2. Diagrams showing the stages of wound healing in skin. (A) Intact skin prior to 
injury. (B) Wounded skin immediately after injury, showing a clot (yellow) and broken blood 
vessel (red). (C) The initial stages of healing, showing inflammation and the start of re-
epithelialisation. Leukocytes (blue) infiltrate the wound, blood vessels begin to grow into the 
wound bed, and keratinocytes from the epidermis (pink) begin to migrate over the granulation 
tissue (dark red). (D) Re-epithelialisation is complete, restoring barrier function. Keratinocytes 
continue to proliferate at the wounded site. (E) The dermis and epidermis, which is hyper-
thickened, begins to remodel. (F) Skin is repaired and full barrier function restored (the 
information used in the creation of these images was taken from the following references 
(Diegelmann & Evans 2004; Martin 1997; Shaw & Martin 2009; Young et al. 2000)).  
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1.2.2.2. Haemostasis 
During injury to the skin blood vessels are invariably damaged (figure 1.2.B). 
Platelets in the blood are activated upon contact with the ECM at the wound site. 
They aggregate and form a clot of insoluble cross-linked fibrin fibres that block 
blood vessels and prevent further bleeding. Furthermore, platelets release 
cytokines and growth factors as they degranulate, which are sequestered at the 
site of injury by the network of fibrin fibres.  	  
1.2.2.3. Inflammation 
The inflammatory response is initiated immediately upon wounding by the 
leakage of circulating leukocytes from damaged blood vessels (figure 1.2.C). 
Mast cells present in connective tissue around the wound site are also rapidly 
activated by the innate immune system, releasing granules of pro-inflammatory 
molecules. These increase vasopermeability, vasodilation, and leukocyte 
recruitment (Artuc et al. 1999; Diegelmann & Evans 2004). Increased blood 
vessel leakiness means an increase in exudate production. The exudate dilutes 
any irritants, and the fibrin clot traps any foreign material. The mast cells also 
release hyaluronic acid and proteoglycans, which interact with the exudate to 
form a gel, which further prevents movement of foreign material. 
 
Neutrophils, macrophages and fibroblasts are recruited by pro-inflammatory 
cytokines released by mast cells, platelets and endothelial cells. They are also 
recruited by the presence of epitopes recognised as foreign by cells, such as 
pathogen associated molecular patterns (PAMPs) found on bacteria. 
Neutrophils are the first to arrive, as they circulate within the bloodstream, and 
extravasate at the site of injury within minutes. Neutrophils phagocytose 
contaminants such as bacteria, resulting in the production of bactericidal 
reactive oxygen species (ROS). Additionally they undergo degranulation, 
releasing DNA and bactericidal enzymes. Neutrophil infiltration is normally 
resolved within 1-2 days in uninfected wounds (Martin & Leibovich 2005). 
 
Macrophages are recruited at the same time as neutrophils and by many of the 
same pro-inflammatory cytokines, though they take longer to respond, typically 
accumulating in the wound 48-96 hours after wounding. Monocytes, precursors 
to macrophages, circulate within the blood and are recruited to damaged 
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tissues. They extravasate into the inflamed tissue and differentiate into 
macrophages, which phagocytose opsonized bacteria and necrotic tissue. 
Macrophages also remove remaining neutrophils, but unlike neutrophils, 
macrophage recruitment will typically continue to increase until 5 days after 
wounding, even in the absence of infection. Their presence decreases slowly 
and persists during granulation tissue formation. Macrophages are very 
sensitive to their environment and can release a range of molecules including 
cytokines, complement, coagulation factors, ECM proteins, ROS and growth 
factors. Macrophages also recruit lymphocytes of the adaptive immune system 
(Diegelmann & Evans 2004; Martin & Leibovich 2005).  
 
1.2.2.4. Proliferation 
As the presence of neutrophils declines the proliferative phase begins (figure 
1.2.C-E). Macrophages release growth factors, such as platelet derived growth 
factor (PDGF) and transforming growth factor (TGF) –β, that attract fibroblasts 
to the wound site, primarily from the surrounding healthy dermis. These 
proliferate and migrate into the wound bed, depositing ECM, predominantly type 
III collagen. At the same time as fibroblasts are migrating into the wound bed, 
angiogenesis of new blood vessels into the wound bed also occurs. The 
combination of ECM, fibroblasts and new blood vessels is called granulation 
tissue, and it provides a bed for epithelial cells to migrate over. Wound closure 
can also be aided by wound contraction. This is mediated by myofibroblasts, 
differentiated fibroblasts that attach to fibronectin and other ECM components 
within the granulation tissue and contract, though how this occurs and its 
importance is still contentious (Martin 1997; Diegelmann & Evans 2004)). 
Simultaneously, epidermal growth factor (EGF) and TGF-α stimulate 
proliferation of basal keratinocytes in the epidermis. Keratinocytes at the wound 
edge, in front of the site of proliferation, become migratory and a tongue of 
collectively moving cells proceeds over the granulation tissue (figure 1.2.C). 
This process is termed re-epithelialisation, and continues until migrating 
keratinocytes at the wound edges come into contact, enabling the closure of the 
wound (figure 1.2.D). The cells will continue proliferating and differentiating until 
a fully stratified epithelium is reinstated and the barrier function of the skin is 
restored (figure 1.2.E) (Shaw & Martin 2009).  
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1.2.2.5. Tissue remodelling 
After re-epithelialisation is complete, tissue remodelling begins (figure 1.2.E). In 
the dermis, excess blood vessels are retracted and new vasculature is matured 
to reform a functional network (Martin 1997; Diegelmann & Evans 2004; Shaw 
& Martin 2009). ECM laid down hastily during granulation tissue formation is 
also remodelled, and type III collagen is gradually exchanged for type I, the 
normal collagen found in healthy skin. Moreover, inflammatory cells disperse or 
apoptose, and myofibroblasts undergo apoptosis. 
 
1.3. Privileged healing in oral mucosa 
1.3.1. Introduction to privileged healing 
Oral mucosa is described as “proceeding through the same stages of healing 
as other parts of the body” (Enoch & Stephens 2009). However, clinical 
observations by periodontists suggest that this anatomical location within the 
adult body exhibits rapid healing with reduced scar formation (Häkkinen et al. 
2000; Ferguson & O’Kane 2004). Evidence for rapid and scarless healing has 
also been obtained using animal models (Szpaderska et al. 2003; Wong et al. 
2009; Mak et al. 2009). Although differing in a number of ways, oral mucosa 
healing is frequently compared to the rapid and scarless healing seen in 
foetuses, and so has been called ‘privileged healing’ (Sciubba et al. 1978; 
Szpaderska et al. 2003). Some of the potential reasons for this privileged 
healing status are discussed here and are reviewed in more detail by (Glim et al. 
2013).  
 
1.3.2. Features and differences in privileged healing 
1.3.2.1. Reduced inflammatory response in privileged healing 
An important difference between skin and oral mucosa during healing is the 
inflammatory response. Foetuses heal without scarring; embryonic wounds 
exhibit little or no inflammatory response, and this is thought to be part of the 
reason for the fast and scarless healing (Degen & Gourdie 2012). Inflammation 
in adult skin is clearly vitally important for control of infections as it is exposed to 
the environment and pathogens. It was thought that inflammation is necessary 
for adult skin healing, as inflammatory cells provide growth factors and 
cytokines that are necessary for repair. However, removal of neutrophils and 
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macrophages in a transgenic mouse found no delay in healing (Martin et al. 
2003), and so the role of inflammation in either improving or delaying healing in 
adults is uncertain. It is acknowledged though that inflammation can be 
detrimental to wound healing, and inflammation has also been comprehensively 
linked to fibrosis (Shaw et al. 2010; Grose & Werner 2004). Like embryonic 
healing, a reduced inflammatory response has been observed in oral mucosa 
wounds compared to dermal wounds (Chen et al. 2010; Szpaderska et al. 2003; 
Mak et al. 2009; Schrementi et al. 2008). In tongue mucosa compared to skin it 
was found that there was significantly less infiltration by neutrophils, 
macrophages and T cells, with earlier resolution of inflammation (Szpaderska et 
al. 2003). Fewer macrophages and mast cells were similarly found to infiltrate a 
pig gingival wound compared to the skin (Mak et al. 2009). The authors suggest 
that the reduced inflammatory response in oral mucosa wounds may underlie or 
support rapid healing and reduced scar formation.  
 
In conjunction with a reduced infiltration of leukocytes, a reduction in pro-
inflammatory cytokines has also been shown in oral mucosa wounds. Whole 
transcriptome analysis of oral mucosa and skin during wound healing in mice 
found considerably more inflammatory response genes were expressed in the 
skin than mucosa (Chen et al. 2010). Particularly, differences in TGF-β 
expression have been highlighted (Schrementi et al. 2008; Szpaderska et al. 
2003; Mah et al. 2014; Mak et al. 2009; Eslami et al. 2009). TGF-β is a cytokine 
with both pro- and anti-inflammatory roles (Han et al. 2012). It has three 
isoforms: TGF-β1, TGF-β2 and TGF-β3, with TGF-β1 being the most abundant. 
Following wounding, significantly less TGF-β1 was produced in both porcine 
and murine oral mucosa than skin (Schrementi et al. 2008; Szpaderska et al. 
2003). Similarly human gingival fibroblasts produced less TGF-β than skin 
fibroblasts (Mah et al. 2014). Increased and more persistent TGF-β expression 
was also found in skin wounds compared to oral wounds in red Duroc pigs, 
although the β1 and β3 isoforms were not distinguished in this study (Mak et al. 
2009). Another study in red Duroc pigs though found increased TGF-β3 
expression significantly earlier in mucosa than in skin (Eslami et al. 2009). 
Interestingly, TGF-β3 expression was lower in unwounded murine oral mucosa 
compared to skin. Following wounding though, levels increased to be similar to 
those in skin, while expression in skin did not change. This means the ratio of 
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TGF-β1 to TGF-β3 was considerably lower in oral mucosa than skin 
(Schrementi et al. 2008). High levels of TGF-β1 have been closely associated 
with increased scar formation, and the ratio of TGF-β1 to TGF-β3 is thought to 
be particularly important; lower ratios are related to reduced scar formation, 
while higher ratios are related to increased scarring, so the ratio observed here 
may be contributing to the improved scar outcome (Beanes et al. 2004). Other 
cytokines have also been shown to differ between skin and oral mucosa 
(Szpaderska et al. 2003; Liechty et al. 2000; Graves et al. 2001; Chen et al. 
2010). Szpaderska et al reported lower expression and a more rapid reduction 
in the pro-inflammatory cytokines interleukin-6 (IL-6) and cytokine-induced 
neutrophil-attracting chemokine (KC, a murine homolog of human IL-8) in 
mouse tongue wounds compared to back skin wounds. Interestingly they didn’t 
find an increase in IL-10, the anti-inflammatory cytokine that suppresses 
expression of IL-6 and IL-8 (Szpaderska et al. 2003). Using knockout mice, IL-
10 has previously been shown to be important for both foetal and hard palate 
mucosal healing, but not skin healing (Liechty et al. 2000; Graves et al. 2001). 
Wounds in IL-10 knock out foetal skin and adult mucosa had delayed closure 
and exhibited excessive inflammation. However, healing of the mucosal wounds 
was rescued by administration of antibiotics, suggesting that IL-10 is involved in 
protection from bacteria within oral mucosa (Graves et al. 2001). It was also 
found that stimulation of murine skin keratinocytes with IL-1β stimulation, a pro-
inflammatory cytokine, produced significantly greater amounts of the pro-
inflammatory cytokines tumour necrosis factor-α (TNF-α) and IL-6 than 
stimulation of oral keratinocytes (Chen et al. 2010). This shows that not only is 
the inflammatory response reduced, but oral mucosa cells also respond 
differently to pro-inflammatory stimuli compared to their cutaneous counterparts.  
 
It is evident that oral mucosa wounds have a reduced inflammatory response 
compared to skin. However, oral mucosa is nonetheless exposed to 
environmental pathogens, and oral epithelia have a rich microbiota, found both 
extracellularly (Mancl et al. 2013)) and intracellularly (Rudney et al. 2001). 
Interestingly, it has also been reported that mild inflammation of rat oral mucosa, 
induced by injection of turpentine, increased proliferation of keratinocytes 
peripheral to the site of inflammation, both basally and suprabasally (Willoughby 
et al. 1986). This suggests that while a reduction in the inflammatory response 
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may be contributing to the privileged healing status of oral mucosa, 
inflammation may still play an important role in this tissue. 
 
1.3.2.2. Keratinocytes and the epithelium in privileged healing 
Keratinocytes are the major cell type found in the epidermis and mucosal 
epithelium. They play a central role in wound healing, as they must proliferate 
and migrate in order to close the wound. Wound closure is clinically reported to 
be faster in oral mucosa wounds that in skin, and re-epithelialisation in 
particular was found to occur more rapidly in murine mucosa than skin 
(Schrementi et al. 2008; Szpaderska et al. 2003). Earlier onset of re-
epithelialisation was also observed in the healing of parakeratinised rat tongue, 
commencing at 4 hours in the mucosa compared to 12 hours in the dorsal skin. 
The mucosal keratinocytes at the migrating edge were also observed to retain 
their cuboidal morphology, whereas the epidermal keratinocytes became 
elongated (Sciubba et al. 1978).  
 
Proliferation in intact oral mucosa epithelium is also faster than in skin, with an 
accordingly higher turnover rate, as shown in mouse buccal mucosa (Susi 
1968). Similarly, staining of human soft palate (a non-keratinised mucosa) with 
Ki67, a proliferation marker, showed more proliferating keratinocytes in the oral 
mucosa, which were also present suprabasally, compared to only in the basal 
layer of the epidermis (Glim et al. 2014). The more extensive proliferation of 
keratinocytes in oral mucosa might in part be due to the presence of saliva 
(Gröschl et al. 2005). Application of salivary leptin is able to improve wound 
healing in mice and enhances proliferation of human dermal keratinocytes in 
vitro (Frank et al. 2000). Applying leptin to oral keratinocytes similarly increased 
proliferation (Gröschl et al. 2005). It also resulted in a significant increase in 
epidermal growth factor (EGF) and keratinocyte growth factor (KGF) production 
and secretion. Both EGF and KGF are involved in proliferation of keratinocytes.  
Furthermore, murine oral keratinocytes were found to produce decreased levels 
of vascular endothelial growth factor (VEGF) compared to cutaneous 
keratinocytes (Szpaderska et al. 2005). VEGF stimulates angiogenesis, and it 
has been suggested that excessive angiogenesis can contribute towards 
scarring ((Szpaderska et al. 2005; Bloch et al. 2000), reviewed by (Johnson & 
DiPietro 2013)).  
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1.3.2.3. Fibroblasts and granulation tissue in privileged healing 
Fibroblasts play a vital role in wound healing. They deposit granulation tissue, 
stimulate re-epithelialisation, remodel granulation tissue after the wound has 
closed, and differentiated fibroblasts induce wound contraction. Fibrosis and 
scarring is, however, associated with excessive formation of ECM proteins and 
increased myofibroblast transformation, factors associated with fibroblasts 
(Kendall & Feghali-Bostwick 2014). Oral mucosa wounds, in addition to closing 
more rapidly, heal with minimal scar formation compared to dermal wounds 
(Mak et al. 2009; Wong et al. 2009; Schrementi et al. 2008; Eslami et al. 2009). 
Unsurprisingly, differences compared to skin have been observed in the 
composition of intact lamina propria, the repair of connective tissue, and the 
activity and gene expression of oral fibroblasts.  
 
The unwounded lamina propria of human palate non-keratinised oral mucosa 
was reported to differ somewhat from the dermis of skin in its composition (Glim 
et al. 2014). Several ECM components including fibronectin, chondroitin 
sulphate and elastin were differentially expressed between the tissues, with the 
oral mucosa more closely resembling foetal skin. Collagen bundles in the 
lamina propria of pigs and mice were also found to be smaller and looser than 
in dermis (Mak et al. 2009; Schrementi et al. 2008). An increased number of 
blood vessels in the oral mucosa compared to skin has also been reported, in 
humans, mice and pigs (Glim et al. 2014; Szpaderska et al. 2005; Mak et al. 
2009). However, the increase in blood vessels normally observed following 
injury was not as pronounced in oral mucosa as it was in the skin (Szpaderska 
et al. 2005; Mak et al. 2009). This is interesting, as a vigorous angiogenic 
response often precedes fibrosis in in vivo models of scarring, and might be 
related to it (Johnson & DiPietro 2013). Consequently a less robust response 
could contribute to the minimal fibrosis seen in oral mucosa wounds.     
 
Differences have also been observed in the formation of granulation tissue. In 
porcine wounds fewer cells were immuno-positive for pro-collagen type I in the 
lamina propria granulation tissue than in the dermis, and there was reduced 
fibronectin content (Wong et al. 2009). In culture, human oral fibroblasts also 
produced less collagen I and III, osteopontin and elastin than dermal fibroblasts 
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(Mah et al. 2014). Expression of many matrix proteins including collagen type I, 
fibronectin and osteopontin are associated with and actively contribute to 
scarring (Mori et al. 2008; Bhattacharyya et al. 2014; McKleroy et al. 2013), and 
so it is likely that reduced production of these matrix proteins may be 
contributing to the reduced fibrosis seen in oral mucosa wounds. Additionally, in 
cutaneous wounds collagen fibrils normally appear immature; they have a 
reduced diameter compared to those in unwounded dermis, with a more 
random organisation. However, in porcine and murine oral mucosa wounds the 
thickness of collagen bundles and their orientation was instead similar to that 
seen in unwounded mucosa (Mak et al. 2009; Schrementi et al. 2008). Mak et 
al also observed that at days 28 and 60, in porcine oral mucosa wound beds 
there were fewer but better aligned fibroblasts compared to skin wounds (Mak 
et al. 2009); lower cell density is associated with improved maturation of 
granulation tissue. These results indicate that granulation tissue remodelling is 
superior in oral mucosa compared to in the dermis. Granulation tissue 
remodelling is partially achieved through the actions of matrix 
metalloproteinases (MMPs), which degrade ECM, and unsurprisingly 
differences too have also been reported in their expression. Oral fibroblasts 
were found to express significantly elevated levels of active MMP-2, MMP-3 
and MMP-10 compared to dermal fibroblasts, but reduced levels of MMP-7 and 
MMP-11. MMP-3 activity in particular was also shown to be important for the 
contractile ability of oral fibroblasts, but not skin fibroblasts (Mah et al. 2014; 
McKeown et al. 2007; Stephens et al. 2001). The exact role of each MMP in 
wound healing and granulation tissue remodelling is still uncertain, but the 
balance of different MMPs and their inhibitors, (tissue inhibitors of 
metalloproteinases-TIMPs) is thought to be important in determining the healing 
outcome, and may well be contributing to the privileged status of oral mucosa 
(McCarty et al. 2012).  
 
Increased transformation of fibroblasts into contractile myofibroblasts, alongside 
increased matrix production, is also associated with fibrosis (Kendall & Feghali-
Bostwick 2014). Interestingly, no differences in the number of myofibroblasts 
(as assessed by α-SMA staining) were found in porcine oral mucosa when 
small incisional wounds were made, but there was a significant increase in 
myofibroblasts in both intact and wounded oral mucosa when larger wounds 
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were made. In these the myofibroblasts also persisted in the region for longer, 
although the oral mucosa wounds exhibited less contraction than the skin 
wounds (Mak et al. 2009; Wong et al. 2009). This is in spite of the finding that 
both human and murine oral fibroblasts were found to have greater contractile 
ability compared to dermal fibroblasts (P Stephens 1996; Lygoe et al. 2007; 
Shannon et al. 2006; Lee & Eun 1999; McKeown et al. 2007). Furthermore, 
increased basal levels of α-SMA expression has been shown in oral fibroblasts 
(Lygoe et al. 2007), although the opposite has also been shown (Shannon et al. 
2006; Mah et al. 2014; McKeown et al. 2007). Additionally, oral fibroblasts were 
found to be more sensitive to TGF-β, which stimulates their differentiation into 
contractile myofibroblasts (Lygoe et al. 2007; Lee & Eun 1999), although less 
TGF-β production has also been reported in oral mucosa (Schrementi et al. 
2008; Szpaderska et al. 2003). As such, for the moment the role of 
myofibroblasts in oral mucosa wounds, and their contribution to the minimal 
scar formation remains uncertain.   
 
Like keratinocytes, oral fibroblasts also differ in their production of growth 
factors compared to dermal fibroblasts. Human buccal oral fibroblasts were 
found to produce more keratinocyte growth factor (KGF) and hepatocyte growth 
factor (HGF) (Shannon et al. 2006), while gingival produced more VEGF-α 
(Mah et al. 2014) and insulin like growth factor 2 (IGF-2) (Ebisawa et al. 2011), 
promoting epithelial and endothelial proliferation. Furthermore, human oral 
fibroblasts were found to proliferate significantly faster than dermal fibroblasts 
derived from breast skin (Mah et al. 2014). They were also found to have a 
longer replicative lifespan than dermal fibroblasts; they had longer telomeres 
than skin fibroblasts, which enables a greater number of cell divisions, and 
delayed senescence (Enoch et al. 2009).  
 
1.3.3. Summary of privileged healing 
Although oral mucosa shares many similarities with skin, examining its 
privileged healing status has also revealed many differences. Oral fibroblasts 
and keratinocytes are phenotypically distinct from their cutaneous counterparts, 
displaying differences in their contractile and proliferative capabilities, as well as 
in their growth factor and cytokine production. The inflammatory response is 
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also markedly dampened compared to skin, and this is all thought to contribute 
to the improved healing observed in these exceptional tissues.  
 
1.4. Staphylococcus aureus impairment of wound 
healing 
1.4.1. Introduction to S.aureus impairment of healing 
Staphylococcus aureus is able to transiently but harmlessly populate the human 
skin and mucous membranes, but it is frequently a pathogenic species, and is 
the most common cause of skin infections. Infection results in an acute 
inflammatory response (discussed in detail by (Fournier & Philpott 2005)), which 
S.aureus has derived numerous mechanisms to avoid or overcome (discussed 
in detail by (Kraus & Peschel 2008)). Infection with S.aureus can cause serious 
health problems, including wound infection, osteomyelitis and sepsis; chronic 
wounds (wounds that remain open for longer than 3 months) are attributed, at 
least in part, to persistent infections, with S.aureus seen as a major player 
(Davies et al. 2004; Gjødsbøl & Christensen 2006). In chronic wounds S.aureus 
is predominantly found within a biofilm, an antibiotic resistant community of 
sessile bacteria encased in a self-produced matrix (James et al. 2007). 
Increasingly, evidence suggests that the formation of biofilms is an important 
part of the ability of S.aureus to prevent healing in chronic wounds (Mustoe et al. 
2006). Research has shown that S.aureus can produce 300-400 virulence 
factors, some of which are toxic to cells and others which affect cell function 
(specific toxins are not discussed here in detail. For more information see the 
review by (Kraus & Peschel 2008)). The toxins secreted vary between strains, 
but moreover, they can change depending on whether the bacteria are 
planktonic or within a biofilm (Resch & Rosenstein 2005; Secor et al. 2011). 
Thus, the consequences of an infection for the host will differ depending on the 
location or state (planktonic or biofilm) of the contaminating S.aureus (Secor et 
al. 2011; Kirker & James 2012). Moreover, biofilms are notoriously difficult to 
destroy, and persistent infection by them is also thought to be responsible for 
the prolonged inflammation found in chronic wounds, which is highly damaging 
(Fazli et al. 2011).  
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As well as the formation of biofilms, S.aureus internalisation into host cells is 
increasingly thought to play a role in the virulence of this pathogen (Kubica et al. 
2008; Menzies et al. 2002; Hamza et al. 2013; Edwards et al. 2010). S.aureus 
is a facultative intracellular pathogen, and internalisation into host cells is 
thought to be an immune evasive mechanism. There is even evidence that it 
may also aid the dispersal of S.aureus throughout a host, and so be involved in 
bacterial dissemination (Kubica et al. 2008). Intracellular S.aureus are now 
implicated in the recurrence of a growing number of diseases, including cystic 
fibrosis, bovine chronic mastitis and chronic rhinosinusitis (Jarry & Cheung 
2006; Hébert et al. 2000; Clement et al. 2005). Thus there is growing evidence 
that invasion of host cells may be an important part of S.aureus virulence. 
However, the role of intracellular S.aureus in impairing skin wound healing has 
not been well studied and so is poorly understood. 
 
1.4.2. Biofilm S.aureus in impaired wound healing 
1.4.2.1. Brief introduction to chronic wounds 
S.aureus is commonly found colonising the skin, and can easily contaminate 
cutaneous wounds. Despite the array of 300-400 virulence factors that S.aureus 
possesses, the immune system of a healthy individual is usually capable of 
controlling the contamination before it becomes an infection (Fournier & Philpott 
2005). However, in individuals with compromised health there is a greater risk 
of contamination developing into infection, and this is particularly true in 
individuals with poor healing (Falanga 1993; Mustoe et al. 2006). Thus, 
unsurprisingly, S.aureus is one of the most commonly reported species found in 
chronic wounds (Davies et al. 2004; Gjødsbøl & Christensen 2006). It is also 
associated with a non-healing phenotype, as it was found in 60% of non-healing 
chronic wounds, compared to only 25% of healing wounds (Davies et al. 2004). 
Consequently, S.aureus infection has most commonly been researched in 
relation to chronic wounds, where bacterial infection is increasingly considered 
to be a major contributing factor in their chronicity (Mustoe et al. 2006; 
Bjarnsholt et al. 2008). 
 
Chronic wounds are wounds that fail to heal in a timely fashion (Stadelmann et 
al. 1998). They fail to proceed through the normal stages of acute wound 
healing. Instead they become locked in the inflammatory phase, and a 
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sustained low grade inflammation is one of the hallmarks of chronic wounds; 
sustained inflammation though impedes the healing process (Menke et al. 
2007). Chronic wound keratinocytes are often hyperproliferative, and divide 
suprabasally, rather than in just the basal levels, forming a hyper-thickened 
epidermis around the wound. They have been reported to display 
hyperkeratosis (thickened cornified layer) and parakeratosis (nuclei present in 
the cornified layer), and to be negative for markers of differentiation and 
migration (Stojadinovic et al. 2005; Usui et al. 2008; Brem et al. 2007; 
Stojadinovic et al. 2008). Keratinocytes isolated from chronic wound can also 
display a reduced ability to respond to growth factors (Stojadinovic et al. 2005; 
Waikel et al. 2001). Chronic wounds also characteristically exhibit dermal 
fibrosis, defective granulation tissue formation and poor ECM remodelling 
(Herrick et al. 1992). Differences observed in fibroblasts from chronic wounds 
compared to those from acute wounds include an induction of senescence 
(Ågren & Steenfos 1999; M. V Mendez et al. 1998; A. C. Stanley et al. 1997; 
Vande Berg et al. 1998), reduced proliferation (Brem et al. 2007), reduced 
migration (Brem et al. 2007), and changed responses to growth factors (Ågren 
& Steenfos 1999; Hasan et al. 1997). Research into chronic wounds has shown 
that ischaemic reperfusion, hypoxia, intrinsic host disease and bacterial 
infection are all major factors contributing towards impaired healing (Mustoe et 
al. 2006).  
 
1.4.2.2. Formation and persistence of S.aureus biofilms 
S.aureus have been studied extensively over the years, predominantly as freely 
moving planktonic bacteria in single species, nutrient rich, liquid cultures. 
However, this is not how these bacteria are found naturally. Instead they exist 
preferentially within biofilms (Figure 1.3), complex adherent matrices of self-
synthesised extracellular polymeric substances (EPS), often alongside multiple 
species (Donlan & Costerton 2002). This is how S.aureus are predominantly 
found within wounds, and it is becoming increasingly apparent that biofilm 
formation is involved in bacterial impairment of healing (Bjarnsholt et al. 2013).  
 
Biofilm formation is initiated when planktonic bacteria become reversibly 
adhered to a surface, priming the surface for irreversible attachment (figure 
1.3.A). Irreversibly adherent bacteria then proliferate clonally and produce EPS,
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Figure 1.3. Diagrams of biofilm formation and dispersal. (A) The stages of planktonic 
Staphylococcus aureus forming a biofilm are shown from left to right. Planktonic S.aureus 
adhere to a surface, first reversibly, then irreversibly. They form a micro-colony, producing 
extracellular polymeric substances that encase them. Mature biofilms appear as ‘mushrooms’ or 
‘towers’. (B) Two methods of S.aureus dispersal from a biofilm are shown. On the left, 
planktonic S.aureus are shed from the biofilm. On the right, part of the mature biofilm breaks 
away (the information used in the creation of these images was taken from the following 
references (Donlan & Costerton 2002; Costerton et al. 1999; Mancl et al. 2013; Bjarnsholt et al. 
2013)).  
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a process referred to as biofilm maturation. EPS is comprised of 
polysaccharides, proteins, and extracellular DNA (Donlan & Costerton 2002). It 
encases the increasingly sessile bacteria, forming “mushrooms” or “towers” 
(Figure 1.3.A) (Mancl et al. 2013). Bacteria within biofilms are phenotypically 
distinct from planktonic bacteria, displaying reduced growth rates, altered gene 
expression, and producing different virulence factors (Donlan & Costerton 2002). 
A mature biofilm is normally polymicrobial. It will be comprised of 
heterogeneous populations with species-specific niches, linked by channels 
(Costerton et al. 1999). These channels enable the passage of nutrients and 
waste products. They also enable the transportation of signalling molecules 
used in quorum sensing (a system used to coordinate gene expression of the 
bacteria based on nutrient availability and population density, amongst other 
things) and of genetic material. Furthermore, biofilms are not static, but develop 
temporally as the population density, nutrient availability and combination of 
species changes.  
 
Biofilms often display a marked resistance to the host immune system and to 
antibiotic treatment. This resistance is a common feature of biofilms. It is 
thought to be due to multiple factors, although it is still not fully understood. 
These factors include, but are not limited to, increased resistance to antibiotics, 
reduced penetration of antimicrobial agents, and physiological changes in the 
bacteria due to them being found within the biofilm (Van Acker et al. 2014). 
These mechanisms appear to be highly conserved, and are often very similar 
between only distantly related species.   
 
In order to be effective, antimicrobial agents must penetrate the biofilm to reach 
the bacteria within. Biofilms have been shown to reduce penetrance of 
antibiotics, although this appears to be very specific to both the bacterial 
species and strain, and the antibiotic. It was shown that Pseudomonas 
aeruginosa biofilms significantly impeded the movement of the antibiotic 
ciprofloxacin (Suci et al. 1994), whereas S.aureus biofilms did not, but they 
instead impeded the penetration of oxacillin, cefotaxamine and vancomycin, 
(Singh et al. 2010). Another study showed though, that the antibiotic 
vancomycin did penetrate an S.aureus biofilm, but took over 1 hour to penetrate 
to the centre (Jefferson et al. 2005). It was also shown that S.aureus at the 
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centre of a biofilm remained intact when challenged with cefuroxime (an 
antibiotic that significantly affected the biofilms viability), while the cell walls of 
peripheral bacteria were destroyed (Amorena & Gracia 1999), demonstrating 
the reduced penetration of the antibiotic to the centre of the biofilm. Slower 
penetration of antibiotics means bacteria would be exposed to initially low but 
gradually increasing doses of antibiotics. It has been suggested that this might 
provide a window in which the bacteria are able to mount a defence (Jefferson 
et al. 2005). Furthermore, microenvironments within the biofilms might directly 
influence the efficacy of antibiotics; there are anaerobic niches in biofilms (de 
Beer et al. 1994), and aminoglycosidase antibiotics are less effective against 
many aerobic bacterial species, including S.aureus, in anaerobic conditions 
(Tack & Sabath 1985). 
 
Biofilms have been shown to reduce the penetrance of some antibiotics, but the 
actual bacteria within the biofilm have also been shown to be more resistant 
than in planktonic cultures (Van Acker et al. 2014). This is thought to be 
because of phenotypic changes and differences in gene expression. Biofilm 
bacteria grow significantly slower than planktonic cultures, with distinct zones 
observed within biofilms where bacteria proliferate at different rates (Xu et al. 
2000). Slower growing bacteria have been found to be less susceptible to 
antimicrobials (Evans et al. 1990); It was reported that the sensitivity of E.coli to 
the antiseptic centrimide was dependent on the growth rate of the bacteria, with 
the fastest growing bacteria the most sensitive (Evans et al. 1990). It was also 
found that faster growing young S.aureus biofilms (6 hours) were more sensitive 
to antibiotics than older biofilms (24 hours) (Amorena & Gracia 1999). This was 
similarly shown using P.aeruginosa biofilms. Treatment of young biofilms (2 
days old) with tobramycin or pipercillin eradicated the bacteria, but this could 
not be achieved when 10 day old biofilms underwent the same treatment 
(Anwar et al. 1992). In addition to changes in growth rate, it is well established 
that biofilm gene expression differs from planktonic gene expression (Sauer 
2003). Although not widely studied yet, some of the differently expressed genes 
have been associated with antibiotic resistance. For example P.aeruginosa 
biofilm cells express the ndvB gene, which encodes for a cyclic glucan that is 
thought to sequester antibiotic molecules (Beaudoin et al. 2012). Similarly, 
expression of the agr quorum sensing gene by S.aureus in biofilms was found 
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to influence their susceptibility to the antibiotic rifampin (Yarwood et al. 2004). 
Additionally, it has recently been shown the frequency of mutations giving rise 
to antibiotic resistance in S.aureus biofilms was increased 60 fold compared to 
planktonic cultures, as a result of oxidative stress (Ryder et al. 2012). 
Furthermore, the rate of horizontal transfer of antibiotic resistance genes was 
higher in S.aureus biofilms compared to planktonic cultures (Savage et al. 
2013). Increased frequency of both antibiotic resistance mutations and transfer 
have similarly been shown in Pseudomonas ssp (Ehlers & Bouwer 1999; 
Driffield et al. 2008).  
 
In addition to being antibioticsresistant, biofilms are often described as resistant 
to host defences. Although there is extensive research into how planktonic 
bacteria evade host responses, research into the relationship between the 
immune system and biofilm bacteria is limited, and so is poorly understood. For 
a long time it was thought that biofilms reduced the penetrance of host immune 
cells. However, evidence is emerging showing that this is not always the case. It 
has been demonstrated that leukocytes are attracted to S.aureus biofilms and 
are able to attach to them (Leid & Shirtliff 2002; Günther et al. 2009; Thurlow et 
al. 2012). One group found that human leukocytes (mostly monocytes and T 
and B cells) were unable to penetrate a 2 day old S.aureus biofilm, but were 
readily able to penetrate 7 day old biofilms, although they failed to phagocytose 
the bacteria within (Leid & Shirtliff 2002). Similarly, using a mouse model, it was 
observed that there was only limited invasion of macrophages into S.aureus 
biofilms, and that successfully invading macrophages had minimal phagocytic 
activity or were killed (Thurlow et al. 2012). In contrast, human 
polymorphonuclear neutrophils (PMNs) were found to readily enter S.aureus 
biofilms and phagocytose the bacteria, but they too were found to be less 
effective against 15 day old biofilms than against 2 or 6 day old biofilms 
(Günther et al. 2009). Additionally, S.aureus biofilms in mice were found to 
cause a significant reduction in cytokines and chemokines normally increased 
during infection, including TNF-α and IL-1β (Thurlow et al. 2012).  
 
Within biofilms there are small populations of dormant bacteria that are very 
tolerant to antibiotics, called ‘persister cells’, which are thought to repopulate 
the biofilm following antibiotic treatment (Lewis 2010). However, repeated 
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cycles of antibiotics results in the selection of strains with higher levels of 
persister cells, a mechanism which has been shown to result in persistent lung 
infection by Pseudomonas in cystic fibrosis (Mulcahy et al. 2010). Thus, 
persister cells contribute to the persistence of biofilm infections.  
 
Furthermore, mature biofilms can shed planktonic bacteria or entire parts of the 
biofilm in a process called dispersion (figure 1.3.B) (Donlan & Costerton 2002). 
This means that when bacteria are present as biofilms within a host, the biofilm 
infection and release of planktonic bacteria is persistent, and therefore difficult 
to treat. Bacteria, and biofilms specifically, are increasingly being recognised as 
an important part of the poor healing seen in chronic wounds (Bjarnsholt 2013).  
 
1.4.2.3. S.aureus and biofilms during wound healing 
S.aureus form biofilms in physiological conditions (Davis et al. 2008; Han et al. 
2011), and an SEM study of human chronic wounds showed that 60% of the 
chronic wounds tested contained biofilms, compared to only 6% of acute 
wounds (James & Swogger 2008), suggesting that in chronic wounds S.aureus 
is predominantly found within biofilms. In fact, it is now commonly accepted that 
bacteria in chronic wounds exist predominantly in the form of biofilms, although 
mature biofilms also continuously shed planktonic bacteria (Bjarnsholt et al. 
2013). Several animal models have been made that attempt to mimic this in 
vivo, enabling investigation of the effects of S.aureus infection and the role of 
biofilm formation within wounds. Using these infected wound models, the 
presence of mature S.aureus biofilms has been confirmed at 24 hours in rabbits 
and mice, and at 48 hours in pigs (Akiyama et al. 1996; Davis et al. 2008; 
Gurjala et al. 2011). In mouse, pig and rabbit wound models, it was shown that 
infection with S.aureus delayed wound healing, particularly by reducing re-
epithelialisation (Schierle et al. 2009; Gurjala et al. 2011; Akhil K. Seth et al. 
2012; A. Seth et al. 2012; Pastar et al. 2013). In a rabbit wound model a 
predominantly biofilm phenotype was established by topical application of the 
antibiotic mupirocin, which eliminated planktonic S.aureus. This was compared 
to an ‘active’ infection which hadn’t been treated, where both biofilm and 
planktonic S.aureus were present; both forms of infection delayed re-
epithelialisation and reduced the granulation tissue area, indicating that 
S.aureus within a biofilm was important for the delay in healing (Gurjala et al. 
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2011). Furthermore, in a mouse model it was demonstrated that disruption of 
biofilms with RNAIII inhibiting peptide (RIP), which disrupt biofilms but has no 
effect on S.aureus viability, restored normal healing (Schierle et al. 2009). 
Similarly, infection with an S.aureus TRAP-null mutant, which has retarded 
ability to form a biofilm, improved the rate of healing compared to wild type 
S.aureus (Schierle et al. 2009). This demonstrated the importance of biofilm 
formation for S.aureus impairment of healing. Similar results were obtained with 
P.aeruginosa biofilms in diabetic mouse wounds (Zhao et al. 2010), confirming 
biofilm-induced prevention of healing is not specific to S.aureus infections.  
 
In addition to comparing the rate of healing, the effect of S.aureus biofilms on 
the immune response has also been observed. Using the S.aureus wound 
infected rabbit model previously described, Gurjala et al found that the ‘active’ 
infection created a greater inflammatory response than the predominantly 
biofilm wounds; they reported significantly higher levels of TNF-α and IL-1β in 
the ‘active’ infection wounds compared to the predominantly biofilm wounds at 
day 6, despite similar bacterial loads (Gurjala et al. 2011). These inflammatory 
markers remained elevated between 6 and 12 days in the predominantly biofilm 
wounds, showing a sustained low-grade infection. In contrast, no differences 
were observed in the mouse immune response when implanting tissue cages 
coated with either wild type S.aureus or ica-null S.aureus, which are unable to 
form biofilms. The immune response was assessed by the production of TNF-α, 
IL-8, MIP-2, and the presence of leukocytes (Kristian et al. 2004). Cutaneous 
wound healing involves multiple cell types, including keratinocytes and 
fibroblasts, as well as leukocytes, and it has been shown in cell culture that 
secreted biofilm products affect the cytokine production of different cell types in 
different ways (Secor et al. 2011; Kirker & James 2012; Sadowska et al. 2013; 
Tankersley et al. 2014). It is therefore possible that the differences in host 
responses might be a product of the in vivo model used.  
 
As well as investigating S.aureus infection in animal models, it has also been 
investigated in vitro, again in relation to chronic wounds and biofilm formation. 
Biofilm and planktonic bacteria have distinctly different gene expression (Sauer 
2003). Analysis of S.aureus gene expression showed that the biofilm bacteria 
expressed lower levels of toxins and proteases compared to planktonic 
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S.aureus (Resch & Rosenstein 2005). Differences were similarly observed in a 
proteomic analysis of secretions by biofilm and planktonic S.aureus, where a 
different strain was used (Secor et al. 2011). However, a comparison of several 
soluble products secreted by four different S.aureus strains found no 
differences in the levels of peptidoglycan, lipoteichoic acid, α-haemolysin and 
staphylokinase between planktonic and biofilm cultures (Sadowska et al. 2013). 
These conflicting results suggest that differences in secretions by biofilm and 
planktonic S.aureus are not in all products and may also be strain specific, but it 
is clear that there are differences in the secretions from some strains of 
S.aureus in the two states. While the effects of some individual toxins produced 
by planktonic S.aureus have been explored in some detail (see review by 
(Bronner et al. 2004) for more detail), there have been few studies that have 
compared the effect on cells of all the products secreted by either planktonic or 
biofilm S.aureus. Those that have, used cell culture media that had been 
conditioned with the exotoxins produced either by planktonic S.aureus (PCM), 
or biofilm S.aureus (BCM) (Kirker et al. 2009; Kirker & James 2012; Secor et al. 
2011; Tankersley et al. 2014). Kirker et al showed that exposing human 
keratinocytes to BCM, but not PCM, created using a clinical isolate of S.aureus, 
caused morphological changes in the keratinocytes, including dendritic 
extensions and disorganisation of the actin cytoskeleton (Kirker et al. 2009). 
They also reported that exposure to both PCM and BCM impaired scratch 
wound closure, but that exposure to BCM significantly reduced viability and 
increased apoptosis within 3 hours compared to PCM incubated cell (Kirker et 
al. 2009). In line with these findings, it was shown that BCM caused an up-
regulation of genes involved in apoptosis in keratinocytes (Secor et al. 2011). It 
was also reported that after 4 hours of incubation BCM caused an increase in 
cytokine production (IL-1β, IL-6, TNF-α, etc.) but by 24 hours this was reduced, 
resulting in a low grade sustained production of cytokines. In contrast, 
incubating keratinocytes with PCM resulted in continuously increasing 
production of cytokines, so at 24 hours all cytokines assessed were produced at 
significantly higher levels by keratinocytes exposed to PCM than BCM (Secor et 
al. 2011). Similarly, analysis of the effect of BCM created using a different strain 
of S.aureus (ATCC 6538) on human keratinocytes found an increase in 
numerous inflammatory genes compared to PCM exposed cells after 2 hours of 
exposure (Tankersley et al. 2014). The effect of incubating human fibroblasts 
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with either BCM or PCM, derived from the S.aureus clinical isolate, was also 
compared. However, while the viability, apoptotic rate and scratch wound 
closure in fibroblasts exposed to BCM or PCM differed from controls, it was 
found not to differ between BCM and PCM exposed fibroblasts (Kirker & James 
2012). Differences were, however, observed in cytokine production, with 
fibroblasts exposed to BCM producing less pro-inflammatory IL-6 and IL-8 than 
those exposed to PCM at all time points assessed over 72 hours, but more 
TNF-α (Kirker & James 2012). Interestingly, no differences were observed in 
the production of TNF-α over 24 hours by murine leukocytes when stimulated 
with either PCM or BCM created from four different S.aureus strains. BCM from 
two of the strains, however, stimulated increased production of IL-6, IL-10 
compared to PCM (Sadowska et al. 2013). These experiments suggest that the 
effects of planktonic and biofilm soluble products on host cell function and 
inflammatory response do differ, but that it is dependent on both the strain of 
S.aureus and the cell type investigated.  
 
Most in vitro and in vivo experiments investigating the inflammatory response to 
S.aureus biofilms observed differences to those seen in response to planktonic 
S.aureus. Interestingly, the inflammatory response in chronic wounds is also 
abnormal, compared to acute wounds. In acute wounds neutrophil infiltration is 
normally resolved within 72 hours; in chronic wounds neutrophils are present 
throughout, and there is sustained low grade inflammation (Diegelmann 2003). 
This is reminiscent of the inflammatory response observed in the in vivo 
S.aureus biofilm wound model, which was found to exhibit a sustained low 
grade inflammatory response (Gurjala et al. 2011). Similarly, there is an unusual 
cytokine and growth factor profile in chronic wounds. Analysis of a range of 
cytokines in diabetic foot ulcers found an increase in factors associated with 
keratinocyte migration and proliferation, as well as monocyte recruitment. In 
contrast there was a reduction in angiogenesis promoting factors (Galkowska et 
al. 2006). There is mounting evidence indicating that biofilm bacteria, and 
S.aureus in particular, within the wound are involved in sustaining the 
inflammation (Fazli et al. 2011). However, sustained inflammation, instead of 
removing the biofilm, results in damage to the host’s own tissues, a feature 
commonly observed in chronic wounds (Menke et al. 2007). Neutrophils secrete 
proteases such as MMPs and neutrophil elastase, which degrade tissue; 
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neutrophil infiltration in chronic wounds is excessive and sustained, and MMPs 
are also expressed at persistently high levels (Tarnuzzer & Schultz 1996; 
Diegelmann 2003). Neutrophil activity results in a large production of ROS. 
Neutrophils recruit more neutrophils, resulting in sustained inflammation and 
consistently high levels of pro-inflammatory cytokines, such as TNF-α and IL-1β 
(Tarnuzzer & Schultz 1996). TNF-α can further stimulate the production of 
MMPs, altering the delicate balance between MMPs and TIMPs. Furthermore it 
has been shown that S.aureus can induce the expression of multiple MMPs in 
human dermal fibroblasts, as well producing proteases themselves (Kanangat 
et al. 2006; Vollmer et al. 1996). This imbalance shifts the wound towards a 
predominantly degrading environment, where ECM deposited by fibroblasts is 
destroyed at a more rapid rate than it is produced. As keratinocytes in the 
epidermis migrate over granulation tissue, this can prevent keratinocyte 
migration, and thus prevent re-epithelialisation and closure of the wound. As 
well as destroying bacteria, neutrophils and macrophages secrete chemokines 
and cytokines involved in angiogenesis (e.g. VEGF), and the proliferation of 
keratinocytes and fibroblasts (e.g. IL-8, IL-1β) (Taichman et al. 1997; Gillitzer & 
Goebeler 2001). The persistent presence of these leukocytes can therefore 
alter the balance of cytokines and thus the cellular function of the target cells 
(Zhao et al. 2013). Furthermore, excessive proteases can degrade important 
growth factors and cytokines, leading to reduced levels of basic fibroblasts 
growth factor (bFGF), EGF and PDGF, amongst others (Galkowska 2006), 
subsequently reducing the mitogenic activity of cells. Thus a delicate balance is 
needed in wounds to enable healing, and when persistent infection causes 
sustained inflammation, the wound environment is tipped towards a degrading 
phenotype.  
 
1.4.3. Intracellular S.aureus in infections and wounds 
1.4.3.1. S.aureus internalisation into host cells 
For many years S.aureus was considered a purely extracellular pathogen. 
However, it is now well established that S.aureus can invade a variety of non-
professional phagocytic cell types and persist for varying lengths of time in vitro. 
These cell types include endothelial cells, fibroblasts, keratinocytes and 
osteoblasts (Fraunholz & Sinha 2012). Intracellular survival has even been 
reported in professional phagocytes, such as macrophages and neutrophils 
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(Kubica et al. 2008; Gresham et al. 2000). Importantly, there is mounting 
evidence that this too occurs in vivo, where invasion by S.aureus is thought to 
be responsible for the persistent recurrent infection in several diseases, 
including rhinosinusitis, chronic osteomyelitis and chronic mastitis (Garzoni & 
Kelley 2009). Internalisation and intracellular persistence has been suggested 
to be a mechanism enabling S.aureus to evade the immune response and 
antibiotics, and thus contributing to persistent and repeated infection.  
 
S.aureus are able to invade cells via an inactive process on their part, mediated 
by fibronectin and integrin α5β1 (Sinha et al. 1999; Dziewanowska et al. 1999). 
Integrin α5β1 is found in numerous cell types, including fibroblasts and 
keratinocytes, and is a component of focal adhesions, which form the 
attachment between cells and the ECM (Watson et al. 2009; Xu & Clark 1996; 
Collo & Pepper 1999). It binds to fibronectin, a major component of the wound 
blood clot. S.aureus express fibronectin-binding protein (FnBP) A and FnBP-B 
on their surface, which too bind to multiple fibronectin molecules. Fibronectin 
then acts as a bridge between the FnBPs on S.aureus, and integrin α5β1 on the 
host cell. The interaction between FnBPs and fibronectin leads to a 
sequestering of α5β1, resulting in a signal relay that causes actin 
rearrangement at focal adhesions, and eventually in endocytosis of the 
bacterium (Agerer et al. 2005; Schröder & Schröder 2006). Binding of FnBPs is 
sufficient to induce the uptake of S.aureus via zipper-type mechanism (Sinha et 
al. 2000), and so both heat killed and formalin fixed S.aureus are also taken up 
by host cells (Sinha et al. 1999; Kahl et al. 2000; Krut et al. 2003). An 
alternative FnBP-independent mechanism has been reported in primary human 
keratinocytes involving the S.aureus Eap protein, although the mechanism by 
which this occurs remains to be elucidated (Bur et al. 2013; Kintarak et al. 2004).  
 
The fate of intracellular S.aureus and its host appears to be dependent on both 
the cell type and the particular S.aureus strain. The bacteria can persist within 
the cell, or induce cell death through apoptosis or necrosis pathways. Krut et al 
determined the intracellular fate of 23 different S.aureus strains when 
internalised into fibroblasts and keratinocytes, and found that the majority, 16, 
were killed within the cell, probably via the phagolysosomal pathway (Krut et al. 
2003). Survival of the bacteria within non-professional phagocytes appears to 
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be dependent on the ability of the bacteria to escape from the phagosome into 
the cytoplasm or vacuoles (Krut et al. 2003; Klein et al. 2006). Prolonged 
persistence of S.aureus, of 2 weeks or more, has been reported in human 
epithelial cells, both in vitro and in vivo (Clement et al. 2005; Garzoni et al. 
2007). In vitro it was shown that the persistent intracellular S.aureus changed 
their own gene expression, reducing metabolic activity and cell division as well 
as down-regulating the expression of several toxins (Garzoni et al. 2007); no 
morphological changes were observed in the host cell though, which remained 
viable. However, not all strains of S.aureus that escape phagolysosomal 
degradation will persist intracellularly. Most are toxic and will induce either 
apoptosis or necrosis of the host cell. The toxicity and mechanism of cell death 
is difficult to predict, but it is largely dependent on the particular S.aureus strain 
(Krut et al. 2003). It has been suggested that this is a result of the secretion of 
different virulence factors; it is also influenced by the type of host cell infected, 
as the sensitivity of a cell to a particular toxin can depend on its origin 
(Fraunholz & Sinha 2012). For example, apoptosis in human endothelial cells 
was dependent on both invasion and the expression of haemolysis toxins; non-
haemolytic strains were unable to induce apoptosis but expression of α-
haemolysin partially restored apoptosis induction (Haslinger-Löffler et al. 2005). 
Similarly, in human keratinocytes a correlation was found between the 
production of haemolysins and the toxicity of invading S.aureus strains, where 
more haemolytic strain caused cytotoxicity and less haemolytic strains induced 
apoptosis (Mempel et al. 2002). Evidence is also mounting that induction of 
apoptosis, but not necrosis, by S.aureus is dependent on internalisation of the 
bacteria (Mempel et al. 2002; Krut et al. 2003; Haslinger-Löffler et al. 2005; 
Kubica et al. 2008).  
 
1.4.3.2. S.aureus internalisation in infection and wounds 
It is now well established that S.aureus is internalised by a number of cell types 
in vitro, including fibroblasts, keratinocytes and endothelial cells, as well as 
professional phagocytes such as macrophages and neutrophils (Kubica et al. 
2008; Gresham et al. 2000; Sinha et al. 1999; Kintarak et al. 2004). The 
evidence for a physiological role for intracellular S.aureus specifically in 
cutaneous wounds is very limited, but there is growing evidence of in vivo 
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intracellular S.aureus in other infections and diseases, where it is thought to be 
an important mechanism for S.aureus immune evasion and dissemination. 
 
Internalised S.aureus in vivo have been identified in several diseases where 
recurrent infections are common. Intracellular reservoirs of S.aureus were 
identified in the nasal mucosa cells of people experiencing recurrent 
rhinosinusitis, caused by patient specific strains of S.aureus (Clement et al. 
2005; Plouin-Gaudon et al. 2006). Similarly viable internalised S.aureus were 
found inside bovine macrophages and alveolar cells in milk produced by cows 
with chronic bovine mastitis (Hébert et al. 2000). Furthermore intracellular 
S.aureus have been identified in buccal and gingival epithelial cells in people 
suffering with periodontal disease (Colombo et al. 2013), and the invasion of 
airway epithelial cells by S.aureus has been linked to recurrent infection in 
cystic fibrosis (Jarry & Cheung 2006).  
 
Experimental infections in vivo have also provided evidence purporting an 
important role for S.aureus invasion in the persistence and spread of infection. 
Chronic osteomyelitis is often hard to treat and recurrent, and S.aureus has 
been identified as the causative pathogen in over 80% of cases. S.aureus are 
able to invade osteoblasts both in vitro and in vivo (Reilly et al. 2000; Ellington 
et al. 1999), and it was found that the death of intracellularly infected 
osteoblasts released viable S.aureus, which were then able to infect other 
osteoblasts, suggesting a mechanism for reinfection (Ellington et al. 2003). 
Transplant of osteoblasts containing intracellular S.aureus into a bone fracture 
was then sufficient to cause bone infection in rats (Hamza et al. 2013). 
Additionally, internalised S.aureus have been associated with an in vivo model 
of biofilm related implant infection (Murillo et al. 2009). A tissue cage was 
inserted subcutaneously in a rat and infected with S.aureus, which formed a 
biofilm, mimicking chronic prosthetic infection. Collection of fluid from the tissue 
cage revealed that the majority of S.aureus present were intracellular, 
presumably within leukocytes (Murillo et al. 2009). Invasion of cells by S.aureus 
is predominantly through the binding of S.aureus to fibronectin by FnBPs. 
Fibronectin interacts with α5β1 integrin on the host cell and facilitates the 
pathogen’s uptake (Sinha et al. 1999). It was found that the addition of 
recombinant fragments of FnBP prevented invasion of S.aureus into cells in 
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culture, and furthermore, significantly impaired the establishment of S.aureus 
infection in a guinea pig model of intramuscular wound infection (Menzies et al. 
2002). The authors speculated that by blocking internalisation of S.aureus by 
host cells the bacteria might have been more easily killed by host defences, 
thus reducing the infection. Similarly, S.aureus mutants lacking the non-
identical repeated FnBP binding domains were unable to invade mouse 
endothelial cells (Edwards et al. 2010). S.aureus with either full length FnBP or 
FnBP lacking the binding domains were injected intravenously into mice. Full 
length FnBP S.aureus caused significantly greater weight loss and mortality 
(60% versus 20%) in the mice. The authors concluded that invasion of host 
cells by S.aureus was necessary for S.aureus virulence and ability to cause 
sepsis. Of interest, it was also recently found that internalisation of S.aureus by 
human epithelial cells can affect proliferation of the host cell by delaying the 
G2/M phase transition, a phenomena which the authors suggested was used by 
S.aureus to aid their intracellular proliferation within the host (Alekseeva et al. 
2013).  
 
As well as invading non-phagocytic cells, S.aureus has been shown to invade 
and persist within professional phagocytes, such as macrophages, neutrophils 
and mast cells (Kubica et al. 2008; Gresham et al. 2000; Abel et al. 2011). This 
was described as “an infection reservoir” that contributed to reinfection and 
chronicity (Abel et al. 2011). S.aureus phagocytosed by monocytes were shown 
to survive intracellularly within the vacuole for 3-4 days. They then escaped into 
the cytoplasm and induced cell lysis, but prior to lysis the monocytes appeared 
healthy (Kubica et al. 2008). Koziel et al further showed that the infected 
macrophages had increased expression of anti-apoptotic genes (Koziel et al. 
2009), and the authors suggested that this might be an additional mechanism 
by which S.aureus persist and spread infection. Similarly, reservoirs of S.aureus 
were found in the macrophages of infected zebra fish, and found to disseminate 
the pathogen (Prajsnar et al. 2012). Gresham et al found viable S.aureus inside 
vacuoles in polymorphonuclear neutrophils (PMNs) isolated from the site of an 
infection (Gresham et al. 2000). When transferred to another healthy mouse the 
infected neutrophils were sufficient to cause infection, as well as induce an 
influx of endogenous neutrophils. However, using transgenic mice with limited 
capacity for neutrophil migration (IAP-deficient mice), they found that limiting 
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neutrophil influx to the site of infection enhanced survival rates. They proposed 
that S.aureus invasion of neutrophils is a virulence mechanism which 
contributes to the infection (Gresham et al. 2000). 
 
S.aureus is well established as a pathogen in many diseases. The physiological 
importance of its ability to invade host cells, both professional phagocytes and 
non-phagocytic cells, is becoming increasingly apparent, and research into this 
area is enhancing our understanding of the persistence and recurrence of 
S.aureus infections.  
 
1.5. Connexins 
1.5.1. Overview of connexins 
Connexins are a groups of proteins found in almost all vertebrate tissues. They 
combine to form channels in the plasma membrane called connexons. These 
dock to connexons on adjacent cells, forming channels that allow the direct 
passage of small molecules between the cytoplasms of the connected cells, in 
a process called gap junction intercellular communication (GJIC). GJIC is vitally 
important for the coordination of individual cells within a tissue, and so gap 
junction activity is tightly regulated. However, connexins do not just exert their 
influence through gap junctions. Undocked hemichannels can also allow 
molecules to pass through, enabling intracellular to extracellular communication. 
This is particularly important in the stress response. Moreover, evidence is 
accumulating showing non-junctional roles for some connexins in several 
cellular processes, including cell migration, proliferation and apoptosis. These 
processes are all important during wound repair, and several connexins are 
expressed in skin. In particular connexin43 (Cx43), connexin26 (Cx26) and 
connexin30 (Cx30) are expressed, and their expression changes dynamically 
during healing. There is mounting evidence that they are involved in cutaneous 
healing and can influence the outcome of wound repair. Throughout this thesis, 
particular attention is therefore paid to these three connexins.  
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1.5.2. Connexin structure and function 
1.5.2.1. Connexin structure 
Connexins are comprised of four α helical transmembrane domains (figure 
1.4.A-B). These are linked by two highly conserved extracellular loops, and a 
variable intracellular loop. They also have a variable C-terminus ‘cytoplasmic 
tail’ (Yeager et al. 1998). There are 20 connexins in mice and 21 in humans. 
Many of these show high sequence homology between murine and human 
orthologs, including Cx26, Cx30 and Cx43 (Willecke et al. 2002; Sohl & 
Willecke 2003). Cx26 and Cx30 have relatively short cytoplasmic ‘tails’, at 18 
and 55 amino acids respectively. The tails of the highly homologous Cx26 and 
Cx30 are not thought to be subject to phosphorylation (Dahl et al. 1996). Cx43 
on the other hand has a fairly long C-terminus, comprised of 155 amino acids, 
which can be phosphorylated at multiple sites (Evans & Martin 2002; Solan & 
Lampe 2009).  
 
Six connexins combine to form a connexon which amass in the plasma 
membrane (figure 1.4.C). Connexons can be made of only one type of connexin 
(homomeric) or several (heteromeric), although not all connexins are 
compatible (Stauffer 1995; Sosinsky 1995; Jiang & Goodenough 1996; Diez et 
al. 1999). Each adjacent cell provides a connexon, and these dock to one 
another, creating a gap junction (figure 1.4.D). Gap junctions allow a direct 
connection between the cell’s cytoplasms, enabling direct communication. 
Many gap junctions will accumulate together to form a gap junction plaque 
(figure 1.4.E). Like connexons, gap junctions can be homotypic (formed from 
hemichannels of the same connexin type), or heterotypic (formed from 
hemichannels of different connexins) (Werner et al. 1989; Swenson et al. 1989), 
though this is dependent on the compatibility of the connexins. For example 
Cx26 and Cx43 can’t form functional gap junctions, while Cx26 and Cx30 can 
(Tomasetto et al. 1993; Elfgang et al. 1995; Yum et al. 2007). Alternatively, 
connexons can remain undocked, accumulating in non-junctional regions of the 
plasma membrane. These undocked connexons are referred to as 
hemichannels. They are receiving increasing attention as it is becoming evident 
that they are also able to act as transmembrane channels. Instead of enabling 
intercellular communication, they provide a route for intracellular-extracellular 
communication (Evans et al. 2006). 
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Figure 1.4. Diagrams of connexin and gap junction structure. (A) Diagram of the connexin 
protein structure, showing each structural region. (B) Representation of a single connexin, as 
the protein regions fold. (C) Six connexins combined to show an individual connexon or 
hemichannel. (D) Two connexons, one provided from cell 1 and one from cell 2, docked to form 
a gap junction channel between the two cells. (D) Many gap junctions come together to form a 
plaque between the two cells. (NT= amino terminal, CT= carboxyl terminal/cytoplasmic loop, 
TM= transmembrane domain, EL= extracellular loop, IL= intracellular loop) (the information 
used in the creation of these images was taken from the following references (Evans & Martin 
2002; Hervé et al. 2012; Vinken et al. 2006)). 
 	    
Chapter 1 
	   49	  
1.5.2.2. Connexin selectivity and permeability 
Gap junctions enable the passive diffusion of metabolites smaller than 1.2 KDa 
across them, including Ca2+, inositol triphosphate (IP3), adenosine triphosphate 
(ATP) and cyclic adenosine monophosphate (cAMP) (Romanello & D’Andrea 
2001; Kang et al. 2008; Cotrina et al. 2000; Isakson et al. 2001; Sáez et al. 
1989; Niessen et al. 2000; Lawrence et al. 1978; Bevans et al. 1998; Kanaporis 
et al. 2008). Hemichannels are thought to allow the passage of similar 
molecules to gap junctions, though this remains to be extensively investigated 
(Trexler et al. 1996; Verselis et al. 2000; Li et al. 2001; Gomes et al. 2005; Kang 
et al. 2008; Romanello & D’Andrea 2001). They have been shown to mediate 
intercellular calcium signal propagation by releasing ATP, which activates 
purinergic receptors on nearby cells (Isakson et al. 2001; Kang et al. 2008). 
Classically gap junctions were thought to be non-selective, but interestingly, not 
all gap junctions have the same permeability to metabolites. Selectivity is based 
on both the size and charge of the molecules, and appears to be largely 
dependent on which connexins gap junctions are comprised of (Elfgang et al. 
1995). However, the permeability of gap junctions can also be modified by a 
number of factors including transjunctional voltage (the voltage difference 
between coupled cells), calcium concentrations, pH and post translational 
modifications like phosphorylation (Turin & Warner 1977; Rose & Loewenstein 
1975; Rook et al. 1988; Somogyi et al. 1989; Reynhout et al. 1992). Similarly, 
hemichannels are influenced by intracellular signals including intracellular pH, 
redox status and phosphorylation (Retamal et al. 2007; Bao et al. 2007; Liu et al. 
2011). Many external stresses, such as mechanical and ischaemic stress, 
induce hemichannel opening, indicating a role in the stress response (Contreras 
et al. 2002; Cherian et al. 2005; Thompson et al. 2006; Batra et al. 2012; 
Gomes et al. 2005). Consequently the specificity of gap junctions and 
hemichannels is highly selective and their permeability can be rapidly modified. 
Likewise, their turnover is fast and tightly regulated; in vivo hepatic murine 
connexins have a half-life of 5 hours (Fallon & Goodenough 1981), while in vitro 
the half life of connexins, including Cx26 and Cx43, is reported to be 1-3 hours 
(Traub et al. 1989; Laird et al. 1991; Darrow et al. 1995). This enables rapid gap 
junction remodelling to suit physiological requirement.  
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1.5.2.3. Connexin roles and function 
Connexons are found as part of multiprotein complexes located at the 
membrane, targeting proteins to particular regions in the membrane. A number 
of different connexins are able to bind cytoskeletal proteins, junctional proteins, 
scaffold proteins and receptors (see (Hervé et al. 2012) for a comprehensive 
list), though the precise functional role of many of these interactions has not yet 
been elucidated. However, it is known that these complexes anchor proteins 
that can modify connexins, such as protein kinases, enabling swift modification 
of gap junctions and facilitating a rapid response to physiological requirements 
(Hervé et al. 2012). Multiprotein complexes also enable connexins to indirectly 
influence other binding proteins via their interactions, such as cytoskeletal and 
signalling proteins. Furthermore, changes in Cx43 expression have been shown 
to result in significant gene transcription alterations in genes with diverse 
functions, and it has been suggested that Cx43 forms the centre of a protein 
‘nexus’ that enables it to influence the expression of multiple genes (Iacobas et 
al. 2004). Consequently it is becoming increasingly clear that, in addition to their 
role in intercellular and intracellular-extracellular communication, connexins are 
involved in modulating cellular functions through non-junctional means. These 
functions include cell migration, differentiation, proliferation and apoptosis (Xu 
et al. 2006; Man et al. 2007; Wright et al. 2009; Mendoza-Naranjo, Cormie, A. 
Serrano, et al. 2012; Brissette et al. 1994; Churko et al. 2012; Zhang et al. 
2001; Zhang et al. 2003; Djalilian et al. 2006; Huang et al. 2001; Klee et al. 
2011).  
 
Connexins are involved in determining cell morphology and polarity. They also 
affect the adhesions between cells, and can regulate the rearrangement of the 
cytoskeleton. Thus they have a function in cell motility and migration. This is 
complex though, and the role appears to be cell type specific (Matsuuchi & 
Naus 2013). For example, knockout of Cx43 expression causes cell migration 
defects in cardiac neural crest cells, as well as in neurons (Huang et al. 1998; 
Fushiki et al. 2003). Conversely, increased migration from Cx43 knockdown or 
attenuation of GJIC has been observed in epithelial cells and fibroblasts (Mori 
et al. 2006; Simpson et al. 2008; Wright et al. 2009; Mendoza-Naranjo, Cormie, 
A. Serrano, et al. 2012). Cx26 expression was found to inhibit migration in a 
gap junction independent manner in a breast tumour cell line (Kalra et al. 2006), 
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whereas overexpression in keratinocytes increased migration (Man et al. 2007). 
Cx30 over-expression in keratinocytes also increased migration (Man et al. 
2007).  
 
Connexins can propagate proliferative signals between adjacent cells through 
gap junctions and hemichannels in opposing membranes. They have been 
shown to interact either directly or indirectly with a number of important 
proliferation molecules, and can even influence their production or activity. 
Extensive research in cancer cells has shown connexins are involved in 
regulating the cell cycle, and addition of connexin genes to gap junction 
deficient tumour cells can restore normal growth (Vinken, Decrock, Leybaert, et 
al. 2012). Consequently, many members of the connexin family are considered 
to have tumour-suppressing roles, including Cx43 and Cx26. However, 
research in non-tumorigenic cells has shown some contrasting results. For 
example constitutive knockdown of Cx43 reduced proliferation in fibroblasts 
(Mendoza-Naranjo, Cormie, A. Serrano, et al. 2012), as did conditional 
knockout in astrocytes (Liebmann et al. 2013). Inducing expression of Cx26 has 
been associated with increased proliferation in keratinocytes (Lucke et al. 1999; 
Djalilian et al. 2006; Man et al. 2007). Cx30 expression in head and neck 
cancer cells, and in keratinocytes, also increased proliferation (Ozawa et al. 
2009; Man et al. 2007), but knockout of Cx30 in mice also increased the 
number of BrdU positive cells in the hippocampus (Liebmann et al. 2013). 
 
In addition to regulating proliferation through the cell cycle, connexins are 
involved in controlling apoptosis (Vinken et al. 2006). Just as with proliferation, 
apoptotic signals (calcium in particular) can be passed between cells through 
gap junctions and hemichannels, inducing a wave of apoptosis (Kameritsch et 
al. 2013; Decrock et al. 2009). Conversely, ‘rescue signals’ can also be passed 
from healthy cells to their afflicted neighbours (Blanc et al. 1998). Moreover, 
Cx43 is able to control the expression of a number of both pro- and anti-
apoptotic genes (Vinken, Decrock, Vanhaecke, et al. 2012). This all suggests 
that connexins can influence apoptosis but the ultimate outcome depends on 
the balance of several interconnected factors.   
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Finally, connexins are thought to be important for the differentiation of cells, 
particularly in the epidermis of the skin. Several connexins are expressed in the 
epidermis, confined to particular layers (Di et al. 2001). Mutations in connexins, 
including Cx26 and Cx43, result in skin diseases associated with poor 
differentiation of keratinocytes (Lucke et al. 1999; Djalilian et al. 2006; Churko 
et al. 2012). However, the roles connexins play in epidermal differentiation are 
still poorly understood.  
 
1.5.3. Connexins in skin 
Connexins are expressed in almost all tissues in vertebrates, and are thought to 
play a vital role in maintaining tissue homeostasis through their role in gap 
junction intercellular communication. Some are expressed in numerous tissues, 
such as the near ubiquitous Cx43, but expression of others is confined to 
particular tissues, suggesting that they may have more specific roles within 
these tissues. Ten different connexins with overlapping distributions are 
expressed in the human epidermis, and 8 in the mouse epidermis (see table 
1.1) (Di et al. 2001; Risek et al. 1992; Goliger & Paul 1994; Kretz et al. 2003). A 
number of diseases have been attributed to mutations in connexins, and most 
of these cause skin abnormalities (Kelsell et al. 2001; Laird 2014). Briefly, a 
specific mutation in Cx26 causes Vohwinkel syndrome, a disorder characterised 
by hyperkeratosis (thickening of the stratum corneum) at regions of flexion with 
diffuse palmoplantar keratoderma (hyperkeratosis specifically on the palms and 
soles) (Maestrini et al. 1999; Kelsell et al. 2000). Several Cx26 mutations also 
cause palmoplantar keratoderma, (Richard, White, et al. 1998; Kelsell et al. 
2000), as do mutations in Cx31 (Kelsell et al. 2000). Other Cx31 mutations 
cause erythrokeratodermia variablis (EKV), another skin disease that is 
characterised by hyperkeratosis amongst other features (Richard, Smith, et al. 
1998; Wilgoss et al. 1999; Gottfried et al. 2002). Mutations in Cx30 cause 
hidrotic ectodermal dysplasia, which similarly exhibits palmoplantar 
hyperkeratosis (Lamartine et al. 2000). Interestingly, although Cx43 is the most 
ubiquitously expressed connexin only one diseases has been attributed to 
mutations in the Cx43 gene (GJB1), Oculodentodigital dysplasia (ODDD) 
(Paznekas et al. 2003). ODDD is not primarily a skin disease, but some patients 
do develop palmoplantar hyperkeratosis. These mutations highlight the 
importance of these connexins for the normal function and structure of skin.  
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The connexins in the epidermis have specific distributions. The distribution 
differs somewhat between humans and mice, and the murine distribution has 
been focused on here. In intact adult skin Cx43 is normally expressed at 
moderate levels in the lower spinous and basal layers of the epidermis. Cx26 
and Cx30 are both expressed at very low levels within the granular layer with a 
highly overlapping distribution (Goliger & Paul 1994; Coutinho et al. 2003; Risek 
et al. 1992; Kretz et al. 2003). Cx43 is also expressed throughout the dermis, in 
hair follicles, fibroblasts, sebaceous glands and endothelial cells (Liu et al. 
1997; Risek et al. 1992; Little et al. 1995).  
 
Table 1.1. Connexin expression in skin and the related diseases. The connexins expressed 
in the epidermis of humans and mice are listed. The human skin diseases related to mutations 
in each connexin gene are also shown. Information reviewed in (Kelsell et al. 2001) and 
(Richard 2000). 
 
1.6. Connexins in wound healing 
Upon wounding of skin, connexin expression changes dynamically throughout 
the healing process (Goliger & Paul 1995). The changes in three connexins, 
Cx26, Cx30 and Cx43, are focused on here (figure 1.5).  
 
1.6.1. Connexin 43 in wound healing 
Experiments using incisional wounds in 10 day old rat tail, and in neonatal mice 
showed that Cx43 became down-regulated within 6 hours in the epidermal 
wound edge and for some distance from the wound (Figure 1.5.A), remaining 
low peripherally until returning to normal expression levels following complete 
Human Mouse Mutations linked to human skin diseases 
Cx26 Cx26 Vohwinkel syndrome Palmoplantar hyperkeratosis 
Cx30 Cx30 Hidrotic ectodermal dysplasia 
Cx30.3 Cx30.3 Erythrokeratodermia variablis 
Cx31 Cx31 Erythrokeratodermia variablis 
Cx31.1 Cx31.1  
Cx32   
Cx37 Cx37  
Cx40 Cx40  
Cx43 Cx43 Oculodentodigital dysplasia 
Cx45   
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Figure 1.5. Connexin43, Connexin26 and Connexin30 expression in skin and during 
wound healing. Connexin expression is shown in intact epidermis and dermis (left), and 24 
hours after wounding (right). Darker colours indicate higher expression levels (the information 
used in the creation of these images was taken from the following references (Goliger & Paul 
1995; Coutinho et al. 2003; Mendoza-Naranjo, Cormie, A. E. Serrano, et al. 2012; Mendoza-
Naranjo, Cormie, A. Serrano, et al. 2012)). 
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re-epithelialisation (Goliger & Paul 1995; Coutinho et al. 2003). Once re-
epithelialisation was complete, though, Cx43 increased in the hyperproliferative 
epidermis at the wound site (Goliger & Paul 1995; Coutinho et al. 2003). An 
additional study in 8 week old ICR mice found that, while most of the connexin 
distribution was the same as in the neonatal rodents, instead of decreasing 
expression peripherally from the wound edge, in adult mice Cx43 was elevated 
at 6 hours in hyperproliferative epidermis behind the wound edge (Mori et al. 
2006). It is known that connexin expression in the skin changes through 
development, and that expression and distribution of some connexins differ 
between neonatal and adult rodents (Goliger & Paul 1994); this is likely the 
reason for the differences observed. Cx43 is also expressed in the dermis, and 
was down-regulated both in human and mouse dermis near the wound edge 
within 4 hours of wounding (Mendoza-Naranjo, Cormie, A. Serrano, et al. 2012). 
In contrast Cx43 was up-regulated in the endothelial cells of the vasculature 
around the wound edge in mice within 6 hours of injury, and expression 
remained elevated during healing (Coutinho et al. 2003).  
 
In vivo observations of connexin dynamics during healing have led to the 
assertion that Cx43 needs to be down-regulated in the cells at the wound edge 
in order for their migration to occur (Qiu et al. 2003; Kretz et al. 2003; Mori et al. 
2006). This is supported by observations of the levels of connexin expression in 
a variety of human chronic wounds, which exhibit severely delayed healing. 
Brandner et al observed that Cx43 down-regulation at the wound edge did not 
occur in a mixed selection of chronic wound biopsies, and that expression was 
retained at the epidermal wound edge (Brandner et al. 2004). Another study 
found Cx43 expression was actually elevated throughout the dermis of venous 
leg ulcer biopsies compared to patient matched unwounded tissue, and there 
was a failure to reduce expression at the wound edge in these non-healing 
wounds (Mendoza-Naranjo, Cormie, A. Serrano, et al. 2012). Examination of 
Cx43 specifically in diabetic foot ulcers, venous leg ulcers and pressure ulcers 
found a significant increase in expression up to 4 mm from the wound edge in 
both the epidermis and dermis ((Mendoza-Naranjo, Cormie, A. E. Serrano, et al. 
2012), Sutcliffe et al, data from the Becker group, manuscript submitted). The 
abnormal expression and dynamics seen in chronic wounds are proposed to 
contribute to the wound healing delay, and this is corroborated by a number of 
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experiments where Cx43 expression in wounds has been purposely down-
regulated.  
 
Cx43 knockout mice die at birth due to heart defects (Reaume et al. 1995), but 
inducible knockout of Cx43 in mice was used to assess cutaneous healing in 
the absence of Cx43 (Kretz et al. 2003). Healing rates were enhanced in the 
Cx43 knockout mice, with wounds typically closing a day earlier than in 
littermate controls. Similarly, healing was sped up in mice where Cx43 
expression was targeted by application of Cx43 antisense 
oligodeoxynucleotides (Cx43 asODNs) (Qiu et al. 2003; Coutinho et al. 2005; 
Mori et al. 2006). Transient knockdown of Cx43 increased the re-
epithelialisation rate, alongside increasing the proliferation of keratinocytes in 
the migrating epithelial tongue (Mori et al. 2006). Cx43 knockdown also resulted 
in many factors that suggested more rapid granulation tissue formation and 
maturation: an increase in fibroblasts at the wound edge at day 2; earlier blood 
vessel formation; increased collagen type I and hydroxyproline; earlier presence 
and resolution of myofibroblasts, and a reduction in the amount of granulation 
tissue present at days 7 and 12 after wounding (Qiu et al. 2003; Mori et al. 
2006). Furthermore, Cx43 asODN also improved healing in diabetic rats (Wang 
et al. 2007). Induction of diabetes with streptozotocin (STZ) resulted in a 
thickened bulb of non-migratory keratinocytes reminiscent of chronic wounds, 
with an abnormally increased Cx43 expression at the wound edge, and delayed 
re-epithelialisation compared to controls rats. Preventing the abnormal increase 
in Cx43 expression, by applying Cx43 antisense, rescued re-epithelialisation, 
and even enhanced it compared to untreated controls (Wang et al. 2007).  
 
In order to investigate the mechanism of improved healing in vitro Cx43 
expression was knocked down in NIH3T3 fibroblasts, both transiently with Cx43 
asODN and permanently with Cx43 shRNA. A reduction in Cx43 expression 
increased the rate of migration, as well as polarisation of the Golgi body 
towards the wound edge. This was lost when wild type Cx43 was 
overexpressed in the cells. Cx43 knockdown also decreased cell-adhesion and, 
interestingly, proliferation (Mendoza-Naranjo, Cormie, A. Serrano, et al. 2012; 
Mori et al. 2006). This indicated a positive correlation between Cx43 expression 
and cell proliferation in skin. This correlation was similarly observed in 
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keratinocytes during wound healing in mice, where Cx43 expressing cells were 
found to be also Ki67 positive (Coutinho et al. 2003).  
 
Similar results to those found using Cx43 asODN in vivo were described when 
murine and porcine wounds were treated with ACT1 (Ghatnekar et al. 2009). 
ACT1 consists of the terminal 9 peptides of the Cx43 cytoplasmic tail, which are 
linked to the internalisation protein, antennapedia. In cell culture, ACT1 was 
found to interact with Cx43 binding partners (particularly Zonular Occludin 1 
(ZO1)), thus competing with the endogenous cytoplasmic Cx43. Its use in cells 
resulted in larger Cx43 gap junction plaques; the enlarged plaques were a 
result of an increased accumulation of gap junctions from non-junctional pools 
of Cx43, not of changes in the protein expression or turnover (Hunter et al. 
2005). When ACT1 was applied directly to the wounds of mice and pigs, the 
authors too reported improved wound closure rates, reduced inflammation, less 
granulation tissue, and faster maturation of the healed skin. However, as overall 
Cx43 expression was not altered by ACT1 the authors suggest that the 
beneficial effects of ACT1 is likely through a separate mode of action to Cx43 
asODN.   
 
In addition to the ACT1 peptide, healing rates have also been investigated after 
treatment with mimetic Cx43 peptides, particularly Gap27 (Kandyba et al. 2008; 
Wright et al. 2009; Pollok et al. 2011). This peptide binds to one of the highly 
conserved extracellular loops of connexins. Instead of preventing binding to 
cytoplasmic proteins, it prevents two connexons docking, ostensibly inhibiting 
gap junction formation and therefore communication, without altering Cx43 
expression or inhibiting protein interactions. There is also growing evidence that 
Gap27 can inhibit hemichannel function. Experiments have shown that Gap27 
increases cell migration rates in mouse epidermal keratinocytes (Kandyba et al. 
2008), human keratinocytes and dermal fibroblasts (Wright et al. 2009). They 
also increased migration in human organotypic skin models and an ex vivo 
porcine skin model (Pollok et al. 2011). Interestingly, Gap27 also increased 
proliferation of both adult human primary keratinocytes and fibroblasts at the 
leading edge of scratch wounds, and increased the number of ki67 positive 
keratinocytes in the migrating epithelial tongue in the ex vivo porcine wound 
model (Pollok et al. 2011). This is in opposition to findings where Cx43 
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expression was reduced in fibroblasts; loss of expression resulted in reduced 
proliferation (Mendoza-Naranjo, Cormie, A. Serrano, et al. 2012). The authors 
suggest that the differences observed may reflect a non-junctional role for Cx43 
protein in proliferation.  
 
In contrast with other data described above, an increase in Cx43 expression 
was reported to enhance granulation tissue formation in rat skin (Moyer et al. 
2002), as assessed by an increase in blood vessel formation and decrease in 
cellular density. However, Cx43 expression was increased by application of 
lithium chloride (LiCl). LiCl is non-specific; it enhances Cx43 expression through 
activation of canonical Wnt signalling. Wnt signalling also activates the 
expression of numerous other genes through β-catenin, which has also been 
shown to mediate wound healing (Cheon et al. 2006), making the specific role 
of Cx43 in this experiment difficult to determine.  
 
More recent studies have also investigated the functional consequences of two 
Cx43 mutations related to Oculodentodigital dysplasia (ODDD), a human 
disease discovered in 2003 to be caused by Cx43 mutations, and which can 
cause skin abnormalities (Churko et al. 2012; Churko et al. 2011; Paznekas et 
al. 2003). Primary fibroblasts from one ODDD patient with a missense D3N 
mutation were able to form gap junction plaques, while fibroblasts from another 
patient carrying a V216L mutation were not. However, gap junction intercellular 
communication was reduced by both mutations. The fibroblasts from both 
patients migrated and proliferated slower than fibroblasts derived from closely 
related but healthy donors, showing the importance of normal Cx43 expression 
(Churko et al. 2011). Additionally, a mouse with a Cx43 missense mutation in 
the first extracellular loop (G60S) also showed delayed healing of cutaneous 
injury, apparently due to reduced contraction of the wounds (Churko et al. 2011). 
Investigations into this revealed an inability for the patient derived fibroblasts to 
differentiate into myofibroblasts in response to stimulation with TGF-β1 (Churko 
et al. 2011). The authors also report abnormal Cx43 dynamics in the healing 
epidermis of the G60S mutant mice; they report higher expression at the wound 
edge in G60S mice compared to controls at 24 hours, a characteristic also seen 
in STZ diabetic rats (Wang et al. 2007). Interestingly, primary keratinocytes 
derived from these mice were found to proliferate faster but migrated and 
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differentiated normally (Churko et al. 2012). Unfortunately, the authors did not 
comment on whether a thickened bulb of keratinocytes also developed at the 
wound edge in the mice, as is seen in diabetic mice and in human chronic 
wounds where Cx43 is also elevated at the wound edge (Wang et al. 2007; 
Herrick et al. 1992; Brandner et al. 2004; Mendoza-Naranjo, Cormie, A. E. 
Serrano, et al. 2012).   
 
These experiments demonstrate the important role Cx43 plays in the wound 
healing process, in both the dermis and epidermis. Nevertheless the role Cx43 
plays in wound healing is complex, and is still poorly understood. Moreover, 
Cx43 is not the only connexin expressed in the skin, or to dynamically change 
expression during the healing process. Two other connexins, Cx26 and Cx30, 
are also thought to be involved in wound healing.  
 
1.6.2. Connexin 26 and Connexin 30 in wound healing 
Like Cx43, in both rat tail and mouse back epidermis Cx26 and Cx30 were 
down-regulated at the wound edge within 6 hours of wounding. However, they 
both became highly up-regulated directly behind the wound edge through 
several epidermal layers and for up to 500 µm from the wound (figure 1.5.B-C). 
Following wound closure expression levels remained high in the 
hyperproliferative epidermis during differentiation, but returned to normal 
following completion of full barrier restoration (Coutinho et al. 2003; Goliger & 
Paul 1995). 
 
Both Cx26 and Cx30 have been implicated in the pathology of chronic wounds, 
which are characterised by hyperproliferative epidermis peripheral to the wound 
and by a bulb of non-migratory keratinocytes at the wound edge (Herrick et al. 
1992). Brander et al reported that Cx26 and Cx30 were both expressed at the 
wound edge of a mixed selection of chronic wounds, and for some distance 
peripherally, whereas in healing wounds both were down-regulated at the 
wound edge (Brandner et al. 2004). Additionally Cx26 and Cx30 were found to 
be significantly up-regulated at the wound edge and up to 4 mm peripherally in 
both diabetic foot ulcers and venous leg ulcers, and to a lesser extent in 
pressure ulcers (Sutcliffe et al, manuscript submitted). These finding suggest 
that high expression at the wound edge may be detrimental to healing. This is 
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supported by experiments where Cx26 was overexpressed ectopically in the 
epidermis of transgenic mice and impaired healing (Djalilian et al. 2006). 
Homozygous mutations were lethal due to impaired skin barrier function, but a 
heterozygous mutation resulted in a hyper-thickened epidermis, though 
differentiation of the epidermis was normal. However, these mice exhibited very 
poor wound healing compared to wild type littermates, and interestingly this was 
alongside an increased inflammatory response. Cx26 expression also remained 
elevated at the wound edge in the transgenic mice following injury, and 
maintained keratinocytes in a hyperproliferative state even after re-
epithelialisation was complete. The re-epithelialising epidermis also displayed 
hyperkeratosis, parakeratosis, hypogranulosis and acanthosis, and the authors 
proposed that Cx26 down-regulation is necessary for the return of full skin 
barrier function (Djalilian et al. 2006). Alternatively, Cx30 deletion in mice was 
not observed to cause any abnormalities in skin, and wounding experiments 
conducted on the tail revealed no improvement or delay in healing compared to 
wild type litter mates (Teubner et al. 2003; Kretz et al. 2003). The effect of 
overexpressing wild type Cx30 on skin formation and wound healing remains to 
be determined.  
 
Cx26 and Cx30 are normally expressed at very low levels, but are highly 
expressed in regions of hyperproliferative epidermis during healing in rodents 
(Goliger & Paul 1995; Coutinho et al. 2003). Interestingly, high levels of Cx26 
and Cx30 are also found in hyperproliferative epidermis such as viral warts, 
psoriasis and porokeratosis (Hivnor et al. 2004; Lemaître et al. 2006; Lucke et 
al. 1999; Labarthe et al. 1998). Thus, both Cx26 and Cx30 have been 
suggested to be markers of hyper-thickened epidermis. Furthermore, many of 
the hyperproliferative skin diseases where Cx26 and Cx30 expression are 
increased are also associated with abnormalities in differentiation, prompting 
authors to suggest they may be involved in abnormal differentiation, or at least 
reliable markers (Labarthe et al. 1998; Lucke et al. 1999). Like other 
differentiation markers connexins are expressed in specific layers of epidermis, 
and induction of differentiation of keratinocytes in vitro with calcium resulted in 
changes in the connexins expressed (Brissette et al. 1994). Additionally, 
treatment of human epidermis with retinoic acid, known to significantly modify 
keratinocyte differentiation, also modified connexin expression, particularly 
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increasing expression of Cx26 (Masgrau-Peya et al. 1997). Cx26 and Cx30 
mutations have also been linked to hyperproliferative and poorly differentiated 
epidermis through connexin related diseases, where patients frequently present 
with hyperkeratosis and parakeratosis (Richard, White, et al. 1998; Lamartine et 
al. 2000; Kelsell et al. 2000). Expression of one Cx26 human mutation (R143W) 
that appears to prevents Cx26 trafficking, in keratinocytes in vitro resulted in 
hyper-thickened organotypic cultures in comparison to wild type Cx26. 
Surprisingly though, this was not in conjunction with abnormal differentiation 
(Man et al. 2007). Expression of another, encoding a stop mutation (35delG) 
that effectively knocks out Cx26, instead reduced the thickness of keratinocyte 
organotypic cultures. However, a Cx30 mutation that causes hidrotic 
ectodermal dysplasia, G11R, caused no apparent differences (Wiszniewski et al. 
2001). Alternatively, expression of a different hidrotic ectodermal dysplasia 
Cx30 mutation (A88V) driven by the endogenous promoter caused mild 
hyperkeratosis in transgenic mice (Bosen et al. 2014), though its effect on 
differentiation and wound healing remains to be tested. A further loss of function 
Cx26 dominant mutation was expressed in a rat epidermal keratinocyte line, 
alongside overexpression of wild type Cx26 (Thomas et al. 2007). Surprisingly, 
neither caused a difference in epidermal thickness or differentiation of the 
keratinocytes. Moreover, neither altered proliferation or migration of the cells. 
Oppositely, over-expression of wild type Cx26 in a human keratinocyte cell line 
(nTERT) resulted in significantly increased proliferation in organotypic cultures 
(Man et al. 2007). It also increased migration rates compared to vector only 
controls. Similarly, overexpression of Cx30 in nTERT keratinocytes caused a 
significant increase in proliferation and migration. Enhanced cell proliferation 
was also observed in head and neck squamous cancer cells where full length 
and partial length Cx30 was over-expressed (Ozawa et al. 2009). Nevertheless, 
in vivo observations do not support a direct association between proliferation 
and either connexin. While Goliger et al observed Cx26 in hyperproliferative 
epidermis during healing, they noted that it was present predominantly in the 
differentiated layers rather than in the proliferative layers (Goliger & Paul 1995). 
Double labelling for Cx26 and Ki67, a marker for proliferation, in human 
hyperproliferative psoriatic lesional epidermis similarly showed most Cx26 
expressing cells did not express Ki67 (Lucke et al. 1999). Additionally a 
negative correlation between the connexins Cx26 and Cx30, and Ki67 was 
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reported during wound healing in the mouse epidermis (Coutinho et al. 2003). 
These conflicting results means that while it is clear Cx26 and Cx30 are 
involved in the wound healing process, the roles they play in proliferation, 
differentiation and migration are elusive, and their ultimate importance is still 
highly contentious. 
 
1.6.3. Connexins in inflammation during wound healing 
Upon wounding, an inflammatory cascade is initiated that results in the release 
of a plethora of pro-inflammatory cytokines and the recruitment of leukocytes. 
Bacteria or other contaminants, which are recognised by the innate immune 
system, also induce an inflammatory response. Cytokines and inflammatory 
stimuli are able to modulate connexin expression and gap junction 
communication in both local cells and recruited immune cells. Both TNF-α and 
IL-1α decreased GJIC in endothelial cells, with TNF-α also decreasing the 
expression of Cx40 and Cx37 (Hu & Xie 1994; van Rijen et al. 1998). 
Alternatively, Staphylococcus epidermidis peptidoglycan, a cell wall component, 
induced Cx43 expression in endothelial cells, alongside increasing GJIC 
(Robertson et al. 2010). Similarly Staphylococcus aureus peptidoglycan 
induced Cx43 expression and GJIC in microglia (Garg et al. 2005). Bacterial 
lipopolysaccharide (LPS), another cell wall component recognised by the innate 
immune system, also increased Cx43 expression, but in kidney cells 
(Fernandez-Cobo et al. 1998). Cx43 is not expressed by circulating neutrophils 
or macrophages, but expression and GJIC was induced when activated by a 
number of growth factors and pro-inflammatory cytokines, such as TNF-α and 
IFN-γ (Eugenin et al. 2003; Jara et al. 1995; Hu & Xie 1994; Zahler et al. 2002). 
Activated leukocytes also form functional gap junctions with endothelial cells 
(Zahler & Hoffmann 2003; Eugenin et al. 2003; Oviedo-Orta et al. 2002). 
 
In reverse, manipulation of connexin expression during wounding has been 
shown to alter inflammation (Qiu et al. 2003; Coutinho et al. 2003; Mori et al. 
2006; Ghatnekar et al. 2009; Djalilian et al. 2006). Reduced neutrophil 
recruitment was observed in pig wounds when they were treated with Cx43 
ACT1 peptide (Ghatnekar et al. 2009). Similarly, transient knockdown of Cx43 
expression in mice with antisense immediately following wounding was found to 
result in reduced neutrophil and macrophage recruitment (Qiu et al. 2003; 
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Coutinho et al. 2005; Mori et al. 2006). It also modulated the expression of 
TGF-β1 (Mori et al. 2006), a cytokine involved in the recruitment of leukocytes 
and fibroblasts (Beanes et al. 2004). Loss of Cx43 was also found to increase 
neutrophil transendothelial migration, whereas blocking gap junction function 
prevented monocyte transendothelial migration (Zahler & Hoffmann 2003; 
Eugenin et al. 2003), suggesting an important role for Cx43 GJIC in controlling 
leukocytes extravasation, which may in part explain the reduced leukocyte 
recruitment in Cx43 antisense and ACT1 peptide treated wounds.  
 
However, Cx43 is not the only connexin involved in inflammation. When 
transgenic mice that ectopically overexpressed Cx26 in the epidermis were 
wounded there was a heightened inflammatory response, with excessive 
infiltration of neutrophils and lymphocytes (Djalilian et al. 2006). Interestingly, 
KID syndrome is caused by mutations in Cx26, and is often associated with 
inflammation. Challenging HeLa cells transfected with Cx26 KID mutations with 
inflammatory stimuli resulted in an increase in hemichannel opening (Donnelly 
et al. 2012), a phenomena which is often also associated with inflammation 
(Eugenin 2014).  
 
1.7. Connexins in oral mucosa and privileged healing 
Connexin expression has been shown to be dynamically regulated in cutaneous 
wound healing, and manipulation of connexin expression and GJIC has shown 
that this is an important part of the healing mechanism (Churko & Laird 2013). 
Oral mucosa exhibit privileged healing status, healing more rapidly and with 
reduced scar formation (Enoch & Stephens 2009). However, little is known 
about connexin expression and dynamics during wound healing in oral mucosa. 
The little that is known is discussed here.  
 
Cx43 is the most studied connexin in oral mucosa. It was found to be expressed 
weakly in the basal layers of parakeratinised rat tongue, expressed more 
strongly in the stratum spinosum and granulosum, but absent from the stratum 
corneum (Xia et al. 2009). A similar distribution was also observed in 
keratinised rat gingiva, but in the rat gingiva expression of Cx43 was absent 
from stratum granulosum (Muramatsu et al. 2008). However, in human gingiva 
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Cx43 was found only in the stratum spinosum (Hatakeyama et al. 2006). Mouse 
gingival keratinocytes were found to express Cx26, Cx30.3, Cx31, Cx32 mRNA 
in addition to Cx43 mRNA (Hatakeyama et al. 2011). In non-keratinised mouse 
labial mucosa Cx43 was simply described as being expressed suprabasally 
(Riau et al. 2008). However, in human non-keratinised buccal mucosa it was 
expressed weakly in the stratum basale and strongly in the intermediate layer, 
but not in the most superficial layer. A similar distribution was also described for 
Cx26 in human buccal mucosa and tongue (Lucke et al. 1999; Ozawa et al. 
2007). However, in parakeratinised rat gingiva Cx26 was found to be expressed 
only in the stratum granulosum and upper part of the stratum spinosum 
(Muramatsu et al. 2008). In human tongue, Cx30 was reported to be expressed 
only in the stratum spinosum (Ozawa et al. 2007). There are considerable 
differences between these finding, suggesting that the distribution of Cx26, 
Cx30 and Cx43 is both species and location dependent in the oral mucosa. 
 
Only one study has investigated connexin expression and dynamics within oral 
mucosa during wound healing. They observed hamster tongue, a 
parakeratinised epithelium, following an excisional wound (Saitoh et al. 1997). 
Immunofluorescence revealed Cx43 expression in the stratum basale and lower 
stratum spinosum of intact tongue, and Cx26 expression in the upper stratum 
spinosum and throughout the stratum granulosum. Upon wounding, expression 
of both connexins decreased within 6 hours at the wound edge, and remained 
low at 24 hours. However, where the connexins were expressed in the 
epithelium near the wound edge, they were expressed throughout the stratum 
basale to the stratum granulosum, with considerable overlap. Additionally, 
despite a reduction in immunofluorescence at the wound edge, in situ 
hybridisation showed that connexin mRNA levels remained constant at the 
wound edges, suggesting post-transcriptional regulation. Expression remained 
high for several days, but began to return to normal after epithelialisation was 
complete. Cx43 dynamics in the hamster tongue epithelium mimicked those 
normally seen in rat and mouse skin. Interestingly though, Cx26 dynamics 
differed from those typically seen in skin, where Cx26 becomes up-regulated 
behind the wound edge following injury (Coutinho et al. 2003; Goliger & Paul 
1995).  
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1.8. Connexins and S.aureus  
Infection with bacteria results in an inflammatory response, both from cells in 
the vicinity, and from leukocytes that are subsequently recruited. A number of 
pro-inflammatory cytokines are able to influence connexin expression and 
function in these cells, and it’s becoming clear that connexins play an important 
role in inflammation (see review by (Eugenin 2014)). However, evidence is also 
starting to emerge showing that a variety of bacterial species can influence 
hemichannel activity, gap junction intercellular communication and the 
expression of connexins. There are also reports that several pathogens use 
their influence on connexins to alter inflammation, their virulence and even their 
invasion into cells (see review by (Ceelen et al. 2011)). The influence of the 
pathogen S.aureus on connexins will primarily be focused on here, although 
research into the relationship between S.aureus and connexins is still in its 
infancy.  
 
Peptidoglycan (PGN) is a component of all bacterial cell walls, though it is much 
more abundant in Gram positive than Gram negative species (Fournier & 
Philpott 2005). Due to the propensity for Staphylococcal infections in skin, the 
effect of PGN on endothelial cells and keratinocytes was investigated (Donnelly 
et al. 2012; Robertson et al. 2010). PGN (10 µg ml-1) derived from S.aureus 
was found to increase the expression of Cx43 mRNA after 6 hours in human 
endothelial cells (HECs) (Donnelly et al. 2012). Similarly, at 6 hours PGN 
derived from the highly related Staphylococcus species S.epidermidis, also 
increased Cx43 mRNA and protein expression in HECs, alongside an increase 
in Cx43 phosphorylation (Robertson et al. 2010). Increased Cx43 expression 
following challenge with S.epidermidis PGN was concomitant with an increase 
in gap junction intercellular communication (GJIC), as assessed by 
microinjection of Lucifer yellow. However, S.aureus PGN was unable to 
stimulate Cx43 mRNA expression in the human keratinocyte HaCaT cell line, 
but instead increased Cx26 mRNA expression (Donnelly et al. 2012). In 
addition to affecting connexin expression levels, PGN was also found to alter 
hemichannel activity. When HaCaT cells overexpressing Cx26 were incubated 
with S.aureus derived PGN for 15 minutes they opened their hemichannels, as 
determined by a 2 fold increase in ATP release, which could be blocked by the 
gap junction blocker carbenoxolone (CBX) (Donnelly et al. 2012). PGN derived 
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from S.epidermidis, though, could not elicit this response in the keratinocyte 
HaCaT cells, but it was found to cause hemichannel opening in HeLa cells 
(HeLa cells are connexin deficient) transfected with Cx26, as assessed by the 
same parameters (Donnelly et al. 2012). Furthermore, S.epidermidis PGN also 
caused activation of hemichannels in HeLa cells transfected with Cx43 
(Robertson et al. 2010). Interestingly, when the HaCaT cells were transfected 
with a mutant Cx26, S.aureus PGN increased ATP release 3-4 fold, a significant 
increase in the hemichannel activity seen when overexpressing wild type Cx26 
(Donnelly et al. 2012). The Cx26 mutant was from a Keratitis ichthyosis 
deafness (KID) syndrome mutation, a skin disease where patients are prone to 
inflammation and infection, particularly with Gram-positive bacteria. The same 
response wasn’t seen in Cx26 mutants derived from other Cx26 related 
diseases which are not related to increased skin infection (Vohwinkel syndrome 
and other palmoplantar keratoderma mutants), suggesting that Cx26 
hemichannel activity might be involved in the excessive inflammatory response 
seen in KID patients. A role for Cx43 hemichannels in inflammation has also 
been reported. PGN is recognised by host cells and elicits the release of 
several pro-inflammatory cytokines. Challenging HaCaT and HEC cells with 
S.aureus PGN for 24 hours resulted in the concentration dependent production 
of IL-6 (Donnelly et al. 2012). PGN from S.epidermidis also caused HECs, but 
not HaCaT cells to release IL-6 (Donnelly et al. 2012; Robertson et al. 2010). 
Interestingly, blocking hemichannel activity with CBX in HEC cells prevented 
the increase in IL-6 release caused by S.epidermidis PGN, suggesting Cx43 
hemichannels might be involved in the initial inflammatory response (Robertson 
et al. 2010). At this point it is not known whether the same response will be 
elicited when challenged with S.aureus PGN. Although S.aureus and 
S.epidermidis are highly related, it is clear that PGN derived from these two 
Staphylococci differ in their effects on cells. Moreover, the effect of S.aureus 
PGN on connexins is not universal, but dependent on the cell type.  
 
The effect of S.aureus PGN has also been investigated in neuronal cells, as 
S.aureus infection is commonly involved in brain abscesses (Garg et al. 2005; 
Esen et al. 2007; Karpuk et al. 2011). Looking at mouse primary astrocytes, and 
again using a concentration of 10 µg ml-1, it was found that incubation with 
S.aureus derived PGN for 6 or 24 hours significantly attenuated Cx43 mRNA 
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and protein expression (Esen et al. 2007). Incubation with 107 colony forming 
units (CFU) of intact but heat killed S.aureus (HKSA) similarly reduced Cx43 
expression. The group also investigated the effect of PGN and HKSA on Cx30 
and Cx26 expression. Cx30 expression was attenuated similarly to Cx43, but in 
contrast, Cx26 mRNA and protein expression was induced by the stimulation. 
By blocking protein production with cyclohexamide (CHX) they investigated 
whether the reduction in Cx43 and Cx30 expression was a direct result of 
interaction with the HKSA or PGN, or whether it was in response to 
inflammatory cytokines produced by the stimulated cells. CHX inhibits protein 
synthesis so prevents astrocytes from producing pro-inflammatory cytokines 
after stimulation with HKSA or PGN. Incubation with CHX did not prevent the 
reduction in Cx30 and Cx43 expression caused by stimulation with PGN or 
HKSA, suggesting that interaction with the bacteria, and not stimulation of pro-
inflammatory cytokines, was responsible for the change in connexin expression 
(Esen et al. 2007). The consequence of S.aureus infection on astrocytes was 
also investigated in vivo (Karpuk et al. 2011). Mice with GFP astrocytes were 
given an intracerebral inoculation of live S.aureus, and their brain slices 
examined after 3 or 7 days. In contrast, it was found that immunofluorescence 
of Cx43 and Cx30 at 3 and 7 days respectively increased in cells for a large 
region around the S.aureus brain abscess. The authors did not directly address 
the discrepancies between the in vitro and in vivo findings, but did state that the 
in vivo brain slices were comprised of multiple cell types, including neurons and 
microglia (Karpuk et al. 2011). Microglia are mononuclear phagocytes of the 
central nervous system, and observations of primary mouse microglia in culture 
showed that incubation with 10 µg ml-1 of S.aureus derived PGN increased 
Cx43 mRNA and protein expression (Garg et al. 2005), which may have 
contributed to the increase in Cx43 seen in the brain slices. Microglia in cell 
culture do not form functional gap junctions, but after 48 hours incubation with 
PGN there was a small but significant increase in microglia GJIC. In contrast, 
cultured astrocytes are usually gap junction coupled, and Lucifer yellow dye 
injection showed that HKSA and PGN significantly reduced GJIC (Esen et al. 
2007). Similarly, whole patch clamp recording of astrocytes surrounding the 
S.aureus brain abscesses revealed that astrocyte GJIC was impaired in the 
region immediately around the abscess, with communication increasing in 
relation to the distance from the abscess (Karpuk et al. 2011). In contrast, 
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analysis of ethidium bromide uptake (which could be prevented with gap 
junction blockers) indicated at day 3 that hemichannel activity was higher 
nearer the abscess.   
 
In addition to S.aureus, connexin expression changes have been reported in 
response to a number of different bacteria. For example, both P.aeruginosa and 
Escherichia coli derived lipopolysaccharide (LPS) have been reported to cause 
both up and down-regulation of a range of connexins in different cell types 
(Sarieddine et al. 2009; Yeh et al. 2005; Fiorini et al. 2006; De Maio et al. 2000; 
Oviedo‐orta et al. 2000; Simon et al. 2004; Liao et al. 2010). An in depth 
discussion of these are beyond the scope of this thesis, but for more details see 
(Ceelen et al. 2011). However, the investigations into how these bacteria 
induced connexin expression changes have revealed that connexin expression 
changes are brought about by a variety of different mechanisms. Cx43 protein 
expression was found to be reduced in microglia by Gram negative bacterial 
lipopolysaccharide (LPS), but without a reduction in Cx43 mRNA levels, 
suggesting increased protein degradation (Hinkerohe et al. 2010). Alternatively, 
S.aureus PGN decreased Cx43 expression in astrocytes at both the mRNA and 
protein level (Esen et al. 2007). Decreased Cx32 mRNA in hepatocytes 
exposed to LPS was found to be through a shortening of the polyA tail, leading 
to degradation of the mRNA (Gingalewski et al. 1996; De Maio et al. 2000), and 
increased Cx43 mRNA expression after LPS incubation in hepatocytes was 
found to be through direct increase in Cx43 promoter activity (Fernandez-Cobo 
et al. 1998). This illustrates the range of mechanisms adopted when connexin 
expression is influenced by exposure to different bacterial components.  
 
Like connexin expression, GJIC has been reported to be both increased or 
decreased in response to bacteria or their components (Uchida et al. 2005; 
Esen et al. 2007; Eugenín et al. 2007). In some cases this is associated with 
concomitant changes in connexin expression (Robertson et al. 2010), but this is 
not always the case; C3 toxin from the Gram positive Clostridium botulinum 
reduced GJIC in primary rat cardiomyocytes but without altering Cx43 
expression or phosphorylation, but instead by increasing the interaction 
between Cx43 and ZO-1 (Derangeon et al. 2008).  
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Hemichannel opening has also been reported in response to several 
pathogenic bacteria, including Shigella flexneri, Yersinia enterocolitica, 
Citrobacter rodentium and S.aureus (Tran Van Nhieu et al. 2003; L. A. 
Velasquez Almonacid et al. 2009; Guttman et al. 2010; Karpuk et al. 2011). This 
response appears to be involved in the ability of several bacterial species to 
invade the cells. In Cx43 transfected HeLa cells, Cx43 hemichannel opening 
was induced by Cx43 phosphorylation, and increased Y.enterocolitica uptake (L. 
A. Velasquez Almonacid et al. 2009). Similarly, S.flexneri infection in Cx26 
stably transfected HeLa cells caused ATP release via hemichannel opening, 
which further increased bacterial invasion (Tran Van Nhieu et al. 2003), but 
expression of Cx30 and Cx31 expression did not (Man et al. 2007). Cx43 
expression has also recently emerged as an important determinant of cell death 
or mortality (Radin et al. 2014; Anand et al. 2008). When epithelial cells were 
challenged by the Helicobacter pylori VacA toxin, a reduction in Cx43 
expression was protective; expression of Cx43 in HeLa cells resulted in VacA 
induced death (Radin et al. 2014). The authors did not determine if Cx43 
hemichannel opening was involved, but they speculated that hemichannel 
activity could potentially be involved in Cx43 expression susceptibility. In 
contrast, Anand et al found reduced Cx43 expression in Cx43 heterozygous 
transgenic mice increased the mortality rate following E.coli infection (Anand et 
al. 2008). Interestingly, they also observed this when Cx43 expression was 
normal but gap junction activity was blocked with oleamide.  
 
The complexity of how bacteria, and S.aureus specifically, influence connexin 
expression, GJIC and hemichannel activity is beginning to emerge. The 
relationship is dependent on the bacterial species, and the cell type, as well as 
being tied into the inflammatory response. In order to understand it, 
comprehension of the consequences for both the host’s cells and the bacteria, 
is needed. 
 
 	   70	  
 
 
 
 
 
 
 
 
 
 
Chapter 2. Materials and Methods 
General materials and methods are listed in this chapter. See the beginning of 
each results chapter for materials and methods specific to that chapter. 
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2.1. Common Reagents and buffers 	  
Table 2.1. List of common buffers and their composition. 
Reagent/ Buffer Composition 
Western blot T/G/S running 
buffer 
(Brought from Bio-Rad) 25 mM Tris, 190 mM 
glycine, 0.1% sodium dodecyl sulphate 
(SDS) 
Western blot transfer buffer  25 mM Tris, 190 mM glycine, 20% methanol 
Western blot blocking buffer 4 % skimmed milk in phosphate buffer saline 
(PBS, Oxoid) with 0.1 % tween 20 
Ponceau S staining buffer 0.1% Ponceau crystals, 5 % acetic acid 
Radioimmunoprecipitation 
(RIPA) buffer 
1% Triton X-100, 0.5% sodium 
deoxycholate, 0.1% SDS, 50 mM Tris-
hydrochloric acid, 150 mM sodium chloride 
Senescence associated β 
galactosidase staining solution 
(SA-β-gal) 
40 mM citric acid/ sodium phosphate buffer, 
5 mM potassium ferrocyanide, 5 mM 
potassium ferricyanide, 150 mM sodium 
chloride, 2 mM magnesium chloride, 1 mg 
ml-1 (5-bromo-4-chloro-3-indolyl-β-D-
galactopyranosidase (X-gal, Sigma)) in 
distilled water. Solution must be pH 6.0 and 
freshly prepared just prior to use.   
 
Immunofluorescence blocking 
buffer 
0.05% Triton X-100, 0.1 M L-lysine 
monohydrochloride, made in phosphate 
buffer saline (PBS, Oxoid) 
 
2.2. Bacterial components 
2.2.1. Bacterial strain and growth 
Staphylococcus aureus subspecies. aureus ATCC® 29213™ (hereafter referred 
to as S.aureus), a strain originally isolated from a wound, was grown in Luria 
broth (LB) media at 37 °C and 250 RPM over night. Over night suspensions 
were washed in DMEM (Sigma-Aldrich) supplemented with 10% DBS (Gibco) 
and re-suspended in the same medium. A CamSpec M330 spectrophotometer 
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(Spectronic CamSpec) was used to take OD600 absorption readings and cells 
were diluted to the appropriate concentration. For all experiments, solutions of 
bacteria were serially diluted, plated on LB agar and incubated at 37 °C 
overnight. Colonies were counted the following day to confirm bacterial 
concentration.  
 
2.2.2. Heat Killed Staphylococcus aureus (HKSA) 
After dilution to the required concentrations, bacterial solutions to be heat killed 
were placed at 70 °C for one hour, then cooled to room temperature. An aliquot 
was plated on LB agar and incubated at 37 °C overnight to ensure death.  
 
2.2.3. Biofilm Conditioned Medium (BCM) 
This protocol is adapted from the method used in (Kirker et al. 2009). Millicell 
cell culture inserts with 0.4 µm pores (Millipore) were placed into six well plates 
with 2.1 ml of DMEM supplemented with 10% DBS in each well. A sterile mixed 
cellulose ester hydrophilic membrane filter disc with 0.22 µm pore size 
(Millipore) was placed in each well. An initial overnight culture of S. aureus was 
washed in DMEM with 10% DBS and then resuspended and diluted in in the 
same media to an optical density of 0.05 at 600 nm. Seven 10 µl drops of the 
diluted overnight culture were placed onto the filter disc in each culture insert 
and biofilms were allowed to develop and mature for 72 hours. Every 24 hours 
for four days thereafter, the growth medium was collected, filter sterilized, pH 
adjusted to 7.2, and replaced with fresh media. The collected medium is 
referred to as biofilm conditioned media (BCM), and was pooled to provide 
sufficient quantities of media to perform all experiments, and to eliminate daily 
variations that might occur in the biofilm cultures.  
 
2.3. General In Vitro experimental methods 
2.3.1. Cell culture 
NIH 3T3s (mouse embryonic fibroblasts cell line) were grown in Dulbecco’s 
Modified Eagle Medium (DMEM, Sigma-Aldrich) supplemented with 10% donor 
bovine serum (DBS, Gibco) and 2% penicillin/streptomycin (P/S, Gibco) in 5% 
CO2 at 37 °C. Cells were washed prior to all experiments to remove traces of 
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antibiotics. All experimental media contained no antibiotics. Cells will be 
referred to as 3T3s hereafter.  
 
2.3.2. Transfection of fibroblasts 
A stable 3T3 cell line with Cx43 expression knocked down, and an empty vector 
control, was previously created by Dr Peter Cormie, a post doc previously of 
University College London, and kindly made available for my use (Mendoza-
Naranjo, Cormie, A. Serrano, et al. 2012). The knocked down cell line was 
made by transfecting 3T3 cells with a pSuper.retro.puro vector (OligoEngine) 
containing the Cx43 specific shRNA sequence (GGTGTGGCTGTCAGTGCTC), 
kindly donated by W.H. Moolenar. An empty vector control (hereafter referred to 
as EV) was also created using a retroviral pSuppressor vector (Imgenex 
Corporation). GP2-293 (Clontech) packaging cells were seeded at 20% 
confluence in DMEM with 10% foetal calf serum (Gibco) and transfected with 15 
µg of retroviral plasmid by calcium phosphate precipitation to produce retroviral 
supernatants. The culture media was collected after 2 days and filtered, and 
used to infect 3T3 fibroblasts. 3T3 fibroblasts containing the Cx43 shRNA 
retrovirus were selected and maintained by incubation with 2 µg ml-1 of 
puromycin (Invitrogen). Cells containing the Psuppressor empty vector were 
selected and maintained by incubation with 500 µg ml-1 of gentamicin (Sigma-
Aldrich).  
 
2.3.3. Live imaging of proliferation and propidium iodide uptake 
Cells were grown in flat bottom 96 well plates. Prior to imaging, cells were 
incubated with media containing 0.5 µg ml-1 Hoechst for 30 minutes. This 
concentration was selected following a pilot study and was not toxic to the cells. 
The media containing Hoechst was removed, the cells washed with PBS, and 
media (DMEM supplemented with 10% DBS) or BCM was added which 
contained 1 µg ml-1 of propidium iodide. S.aureus or HKSA was added as 
appropriate. Cells were then live imaged every hour for 24 hours on an 
ImageXpress® Micro XL system (Molecular Devices).  MetaXpress 5.0 software 
(Molecular Devices) cell count analysis was used to determine the total number 
of cells in each image (Hoechst positive) and the number of dead cells (cells 
that had taken up propidium iodide from the media).  
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2.3.4. Western blotting 
Protein extraction 
Cells were grown in 6 well plates to 90-100% confluence before commencing 
experiments. They were incubated in experimental conditions for the time 
indicated in the figures. Following the incubation period, cells were placed on 
ice and washed with cold PBS. Samples were harvested using cold RIPA buffer 
(see table 2.1) supplemented with phosphatase inhibitors and protease 
inhibitors (Roche), and using a cold cell scraper (Greiner bio-one). Samples 
were sonicated for 30 seconds in a USC100T Ultrasonic cleaner (VWR), then 
kept on ice for 30 minutes, before centrifuging for 30 minutes at 15000 x g at 
4 °C. Protein concentrations were quantified using a Pierce BCA protein assay 
kit (ThermoScientific), following the manufacturer’s protocol and determining 
absorbance with an ELx800 Absorbance Microplate Reader (BioTek) using 
Gen5 plate reading software (BioTek).  
 
Western blots 
Equal amount of protein were re-suspended in 4x Laemmli buffer (Bio-Rad), 
supplemented with β-mercaptoethanol as per the manufacturer’s instructions. 
Samples were then boiled at 95 °C for 5 minutes. Samples were separated on 
10% Mini-Protean® TGX™ gels (Bio-Rad), alongside a Precision Plus Protein™ 
Dual Colour Standard (Bio-Rad) in a mini protean Tetra cell tank (Bio-Rad) in 
T/G/S running buffer (Bio-Rad) at 100 volts for up to 2 hours. Samples were 
then transferred to a Hybond™ C nitrocellulose membrane (Amersham 
Biosciences) for 1 hour at 100 volts in western blot transfer buffer (see table 2.1. 
for recipe). Membranes were blocked in western blot blocking buffer (see table 
2.1) for 30 minutes. Blots were incubated with primary antibodies (see table 2.2) 
made in western blot blocking buffer (see table 2.1) for the time indicated. They 
were then washed 3 times in PBS containing 0.1% Tween 20, before incubating 
with the relevant secondary antibody (also made in western blot blocking buffer) 
for the time indicated. Secondary antibodies were horse-radish peroxidase 
(HRP) conjugated and protein levels were visualised using an enhanced 
chemiluminescence (ECL) system (ThermoScientific) on a ChemiDoc™ MP 
Imaging System (Bio-Rad). Densitometry was used to quantify protein bands 
using Quantity One® Version 4.6.3 software (Bio-Rad). α-tubulin or GAPDH 
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expression were used as loading controls, and the ratio of Cx43 to α-tubulin or 
GAPDH was determined. 
 
Table 2.2. Table of primary and secondary antibodies used to do western blots. 
Concentrations and incubation periods are shown.  
Antibody 
antigen  
Species 
raised in 
Company 
and code 
Concentration Incubation 
time 
Anti-Cx43 Rabbit Sigma-Aldrich 
(C6219) 
1:4000 1 hour at room 
temperature 
Anti-α-
tubulin 
Rat Abd 
(MCA77G) 
1:2500 1 hour at room 
temperature 
Anti-GAPDH Rabbit Sigma-Aldrich 
(G9545) 
1:1000 1 hour at room 
temperature 
Anti-rabbit 
HRP 
Goat Sigma-Aldrich 
(A6154) 
1:1000 1 hour at room 
temperature 
Anti-rat HRP Goat CalbioChem 
(401416) 
1:2000 1 hour at room 
temperature 
 
2.3.5. Immunofluorescence and auto-fluorescence 
Immunofluorescent staining 
Cells were grown on Millicell EZ slides (Millipore) to 90-100% confluence before 
commencing experiments. They were incubated in experimental conditions for 
the time indicated in the figures. Following the incubation period, cells were 
washed with PBS then fixed with 4% paraformaldehyde (PFA) for 5 minutes. 
They were washed twice more with PBS, then blocked in immunofluorescence 
blocking buffer for 30 minutes (see table 2.1). Samples were incubated with 
rabbit anti-Cx43 antibody (Sigma-Aldrich, C6219, 1:2000) at room temperature 
for 1 hour. Samples were washed with immunofluorescence blocking buffer, 
then incubated with goat anti-rabbit Alexa Fluor® 488 (Invitrogen, A11008, 
1:400) for 1 hour at room temperature. Cells incubated with BCM for 7 days had 
high levels of auto-fluorescence when excited with a 488 laser, so were instead 
incubated with goat anti-rabbit Alexa Fluor® 633 (Invitrogen, A21070, 1:400). 
Samples were counterstained with Hoechst (Sigma-Aldrich, H33342, H33258, 
1:50,000), washed in PBS and mounted in Citifluor® (Glycerol/PBS solution, 
Citifluor Ltd). 
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Confocal Imaging 
Immunofluorescence was imaged on a Leica SPE upright or inverted confocal 
microscope. Optimal gain and offset were set in advance and kept constant 
during image acquisition. A 488 nm laser was used to excite Alexa 488, a 633 
nm laser was used to excite Alexa 488 and a 405 nm laser to excite the 
Hoechst stain. Where cells were incubated with BCM for 7 days a 488 nm laser 
was instead used to determine the extent of auto-fluorescence.  
 
The regions imaged were selected at random by only observing the Hoechst 
channel, and single optical sections were obtained. A minimum of three regions 
was imaged of each biological replicate. A negative control, using no primary 
antibody but following all other conditions, was done for each experiment and 
used to threshold images during quantification.  
 
Quantification of immunofluorescence and auto-fluorescence 
Images were imported into Image J (National Institute of Health) for 
quantification. 8 bit images were identically thresholded, to create a binary 
image. The total area of connexin expression or auto-fluorescence was 
measured and was normalised to the number of nuclei in each image. The 
results from experimental replicates were averaged.  
 
2.4. General In vivo experimental methods 
2.4.1. Animals 
Individually housed 6 week old male imprinting control region (ICR) mice were 
obtained from Harlan, and kept in accordance with UK Home Office regulations. 
All animal experiments had UK Home Office approval. 
 
2.4.2. Surgery 
Mice were anaesthetised with 4% isofluorane in oxygen at 2 L m-1 and nitric 
oxide at 1 L m-1. 0.1 mg kg-1 of buprenorphine (Vetergesic, Recknitt Benckiser 
Healthcare) was injected subcutaneously in the scruff of the neck. Mice were 
placed on a heated mat and received either cheek or back wounds, as indicated 
in figure 2.1. After surgery they were observed to ensure full recovery and 
returned to their home cages and observed daily.  
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Figure 2.1. In vivo wound sites. (A) Schematic of a mouse head with the major blood vessels 
indicated in blue. The site of incision for cheek wounds is indicated in red. (B) H&E of a cheek 
wound showing the wound passing through the full thickness of the tissue, from external 
epidermis through to internal mucosa. (C) Schematic of a mouse viewed from above, showing 
the regions of back punch biopsies.  	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2.4.3. Tissue harvesting and processing  
Mice were euthanised by a rising concentration of CO2, and death confirmed by 
cervical dislocation using a tool. Tissue was excised and fixed in 4% PFA in 
PBS overnight at room temperature. The tissue was then washed three times 
with PBS, then transferred to 20% sucrose in PBS with 0.1% sodium azide at 
4 °C overnight. Tissue was frozen into O.C.T (Tissue-Tek, Sakura) and stored 
at -80 °C until further processing. Cross sections of wounds were cut on a 
cryostat (Leica) at 10 or 12 µm thickness. Slides with sectioned tissue were 
stored at -20 °C. 
 
2.4.4. Haematoxylin and & Eosin (H&E) staining  
H&E staining 
Fixed tissue sections were brought to room temperature, and washed in tap 
water for 10 minutes to dissolve all O.C.T. Slides were then placed in Harris’s 
Haematoxylin stain (Sigma-Aldrich HH532) for 30 seconds, then washed in 
running tap water for 5 minutes to remove excess stain. They were briefly 
dipped in acid alcohol (70% ethanol, 1% hydrochloric acid) then washed again 
in running tap water for a further 5 minutes. The slides were then 
counterstained by placing in 1% eosin Y solution (Sigma-Aldrich HT110232,) for 
1 minute. Slides were dipped in water to remove excess stain before 
dehydrating by transferal through increasing concentrations of ethanol as 
shown in table 2.3. Sections were then mounted on coverslips using DPX 
(VWR).  
 
 
Table 2.3. H&E dehydration steps 
Solution Time (minutes) 
70% ethanol 1 
100% ethanol 2 
100% ethanol 2 
100% xylene 3 
100% xylene 3  
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Quantification of H&E images 
H&E stained sections were imaged on a Leica DMLB microscope (Leica) or on 
an AxioScan Z1 slide scanner (Zeiss) using x10 or x20 objectives. Images were 
opened in NIH Image J (http://rsbweb.nih.gov/ij/) or Zen 2012 software (Zeiss) 
respectively.  
 
Measuring re-epithelialisation  
Re-epithelialisation was measured from the wound edge (where the incision 
was made and normal dermis or sub-mucosa was present) to the tip of the new 
growth. Re-epithelialisation was measured at both wound edges in a minimum 
of 2 sections, taken from different regions of the wound. The measurements 
were averaged. 
 
2.4.5. Immunofluorescence  
Immunofluorescence staining 
Sections were brought to room temperature and washed in PBS for 10 minutes 
to remove O.C.T. They were then permeabilised in cold acetone for 5 minutes. 
Samples were blocked in immunofluorescence blocking solution (see table 2.1) 
for 30 minutes. Sections were incubated with one of the antibodies listed in 
table 2.4. for 1 hour at room temperature. 
 
Table 2.4. Primary antibodies used to immuno-stain mouse tissue.   
Antigen 
raised 
against 
Species 
raised in 
Company 
and code 
Concentration Monoclonal / 
Polyclonal 
Cx26 Rabbit Millipore 
(AB8143) 
1:100 Polyclonal 
Cx30 Rabbit Invitrogen 
(71-2200) 
1:200 Polyclonal 
Cx43 Rabbit Sigma-Aldrich 
(C6219) 
1:2000 Polyclonal 
 
Sections were washed with immunofluorescence blocking solution, then 
incubated with goat anti rabbit Alexa Fluor® 488 (Invitrogen, A11008, 1:400). 
Sections were counterstained with Hoechst (Sigma-Aldrich, H33342, H33258, 
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1:50,000), washed in PBS and mounted in Citifluor® (Glycerol/PBS solution, 
Citifluor Ltd).  
 
Confocal imaging and quantification 
Immunofluorescence was imaged on a Leica SPE inverted or upright confocal 
microscope. Optimal gain and offset were set in advance and kept constant 
during image acquisition. A 488 nm laser was used to excite Alexa 488, and a 
405 nm laser to excite the Hoechst stain, and single optical sections obtained. 
To quantify connexin expression changes in in vivo samples single optical 
section images were taken of a distal region (up to 1 mm from the wound), the 
wound edges (the region where the wound was made, and the original dermis 
or lamina propria is still present), and the tip of new growth. Images were taken 
at x40 magnification (1024x1024 pixels). Images were imported into Image J for 
quantification. 8 bit images were identically thresholded, to create a binary 
image, and the region to be measured was demarked. The total area of 
connexin expression was measured in pixels, normalized to the area of the 
region of interest, and presented as pixels / µm2 (Wang et al. 2007). Where 
indicated, wound edge connexin expression was then normalized to expression 
distal to the wound, and presented as the percentage connexin was down-
regulated at the wound edge.  
 
2.5. Statistical analysis 
All N numbers indicate independent experiments conducted separately. 
Additionally, data from each in vitro experiment is an average from several 
replicates. All error bars on graphs indicate the standard error of the mean 
(SEM). 
 
Assumptions of statistical tests were checked before commencing each 
statistical analysis. All parametric tests used assume Gaussian normal 
distribution, and this was tested using a Shapiro-Wilk test. Data not conforming 
to a Gaussian normal distribution was transformed by taking the common 
logarithm or the square root. If this did not result in a normal distribution then 
the appropriate non-parametric test was used instead. Statistical differences 
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were inferred if p<0.05. All statistical analysis was performed in SPSS® version 
21 statistical analysis software (IBM) unless otherwise stated.  
 
2.5.1.1.  Student’s t-tests 
Unpaired Student’s t-tests were used to determine statistical differences 
between two groups, using Welch’s correction for data with unequal variances. 
Mann Whitney U tests were used on data not showing a normal distribution 
after transformation.  
 
2.5.1.2. One-way ANOVAs 
One-way ANOVAs were used when there were more than two groups. 
Homogeneity of variances was tested using Levene’s test. Post hoc tests were 
performed using Bonferroni or Tukey’s adjustments as appropriate when 
multiple comparisons were made. A Games-Howell post hoc was used if the 
variances differed significantly.  
 
2.5.1.3. Mixed design ANOVAs 
A mixed design ANOVA was used when there were two or more data sets that 
were subject to repeated measures, in this case time. Sphericity of the 
covariance matrix was tested using Mauchly’s sphericity test, and if sphericity 
was violated a Greehouse-Geisser correction was used. Homogeneity of 
variance was tested with Levene’s test. A Tukey’s post hoc was used to 
compare individual groups, or Games-Howell if variances between the groups 
differed significantly.  
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Chapter 3. Connexin Dynamics in 
the Privileged Wound Healing of 
the Buccal Mucosa 
This chapter is published. Minor re-formatting of text and figures has been done 
to fit with the thesis style and figure 3.6 is a new addition. The remainder has 
not been altered from the published version (Davis et al. 2013). 
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3.1. Introduction 
The ability of skin to heal is of enormous importance in maintaining 
homeostasis within the body, and in preventing infection. Healing proceeds 
through four overlapping phases: haemostasis, inflammation, granulation tissue 
formation and tissue remodelling. Re-epithelialisation involves the proliferation 
of epidermal keratinocytes, and their migration over granulation tissue in the 
wound bed in order to re-establish skin integrity (Martin 1997). A plethora of 
signals from different cells and tissues must be coordinated to ensure correct 
healing in the skin, and there is a growing body of evidence demonstrating a 
critical role for gap junctions during the repair process (Goliger & Paul 1995; Qiu 
et al. 2003; Kretz et al. 2003; Coutinho et al. 2003; Lampe et al. 1998). Gap 
junctions are intercellular pores comprised of two hemichannels, known as 
connexons, which in turn consist of 6 connexin (Cx) protein subunits (Makowski 
et al. 1977). Each adjacent cell provides a hemichannel, which dock to one 
another and allow a direct connection between the cells’ cytoplasm. Gap 
junctions enable the passive diffusion of small molecules through them but 
discriminate against molecules larger than 1 kDa (Veenstra et al. 1995; Elfgang 
et al. 1995).  
 
Ten different connexins have been reported to be expressed in the epidermis 
including Cx26 and Cx30, though the most highly expressed is Cx43 (Risek et 
al. 1992; Goliger & Paul 1994; Di et al. 2001; Coutinho et al. 2003). In intact 
skin Cx43 is normally expressed at moderate levels in the lower spinous and 
basal layers of the epidermis, whereas Cx26 and Cx30 are both expressed at 
low levels within the granular layer (Goliger & Paul 1994; Coutinho et al. 2003). 
Upon wounding of skin, connexin expression changes dynamically throughout 
the healing process (Goliger & Paul 1995; Coutinho et al. 2003). Cx43 
expression becomes down-regulated in the epidermal wound edge 
keratinocytes as they become migratory over 24-48 hours, returning to normal 
following complete re-epithelialisation. Conversely Cx26 and Cx30 are up-
regulated in the migratory keratinocytes, with levels returning to normal upon 
wound closure (Goliger & Paul 1995; Coutinho et al. 2003).  
 
Healing rates were observed to be enhanced in Cx43 knockout mice and in 
mice where Cx43 expression was targeted by application of Cx43 antisense 
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oligodeoxynucleotides (Cx43asODNs) (Mori et al. 2006; Qiu et al. 2003; Kretz 
et al. 2003). The requirement for Cx43 reduction at the wound edge, in order for 
migration to take place normally, is supported by observations that Cx43 was 
abnormally up-regulated in the wound edge keratinocytes and fibroblasts of 
diabetic rats and that preventing this with application of Cx43asODNs rescues 
the rate of healing (Wang et al. 2007; Mendoza-Naranjo, Cormie, A. Serrano, et 
al. 2012). Fibroblast migration in in vitro scratch wound studies also 
demonstrated a requirement for Cx43 to be down-regulated in order for cells to 
extend long lamellipodia and migrate rapidly (Mendoza-Naranjo, Cormie, A. 
Serrano, et al. 2012).  
 
Some regions of the body exhibit privileged healing, whereby they heal more 
rapidly than other regions and without scarring. One such region is the oral 
mucosa (Sciubba et al. 1978; Szpaderska et al. 2003), which is comprised of 
parakeratinised regions such as the tongue and gingiva, and non-keratinized 
regions such as labial and buccal mucosa (Squier & Brogden 2011). Oral 
mucosa is described as “proceeding through the same stages of healing as 
other parts of the body” (Enoch & Stephens 2009). However, some differences 
such as earlier onset and the shape of the migratory cells have been described 
in the re-epithelialisation process in parakeratinised rat tongue (Sciubba et al. 
1978) and studies investigating privileged healing in the oral mucosa have 
identified features including a reduced inflammatory response (Szpaderska et al. 
2003) and increased fibroblast migration rate (P Stephens 1996). 
 
Despite the importance of connexin expression and dynamics in skin healing, 
little research has been performed on connexin expression in oral mucosa 
during the healing process. The aim of this work was to observe healing in 
buccal mucosa, and to ascertain if connexin expression and dynamics may 
contribute towards the privileged healing status of this epithelium.   	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3.2. Materials and methods 
3.2.1. Animals 
Individually housed 6 week old male ICR mice were kept in accordance with UK 
Home Office regulations. Mice were anaesthetized with 4% isofluorane in 
oxygen at 2 L m-1 and nitric oxide at 1 L m-1, and then 0.1 mg kg-1 of 
buprenorphine was injected subcutaneously in the scruff of the neck. Mice were 
then injected intraperitoneally with 75 mg kg-1 ketamine, and 1 mg kg-1 
medetomidine. A full thickness incision through the skin and buccal mucosa of 3 
mm width was made in each cheek with a scalpel above the lip as indicated 
(Figure 2.1. A, B), avoiding the major blood vessels in the region. Mice were 
subsequently revived by administration of 1 mg kg-1 of subcutaneously injected 
antipamezole. They were observed to ensure full recovery and returned to their 
home cages. Soft wet food was made available to these mice. All animal 
experiments had UK Home Office approval.  
 
3.2.2. Tissue harvesting and processing  
Mice were anaesthetised then euthanized by cervical dislocation using a tool to 
prevent trauma to the facial tissue. Nine mice were harvested at each time 
point: 6 hours, 24 hours and 48 hours. Wounds were excised and fixed in 4% 
PFA overnight, washed, then transferred to 20% sucrose in PBS with 0.1% 
sodium azide at 4 °C overnight. Tissue was frozen into O.C.T and stored at -
80 °C until further processing. Cross sections of wounds were cut on a cryostat 
at 10 µm thickness, or at 5 µm for H&E staining.  
 
3.2.3. Measuring re-epithelialisation  
Sections were H&E stained and imaged on a Leica DMLB microscope or a slide 
scanner (Laser 2000).  The extent of re-epithelialisation was measured from the 
wound edge (where the incision was made and normal dermis/submucosa was 
present) to the tip of new growth using an eyepiece graticule and a stage 
micrometre. Results from a minimum of 2 sections per sample, from different 
regions of the wound, were averaged.  
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3.2.4. Immunofluorescence imaging and quantification 
Sections were permeabilised in cold acetone for 5 minutes, and blocked in PBS 
lysine (0.1 M) for 30 minutes. Sections were incubated with rabbit anti-Cx43 
antibody (Sigma-Aldrich, C6219), rabbit anti-Cx26 (Millipore, AB8143) or rabbit 
anti-Cx30 (Invitrogen, 712200) at room temperature for 1 hour. Sections were 
washed with PBS lysine (0.1 M) then incubated with goat anti rabbit Alexa 
Fluor® 488 (Invitrogen, A11008). Sections were counterstained with Hoechst 
(Sigma-Aldrich, H33342, H33258), washed in PBS and mounted in Citifluor® 
(Glycerol/PBS solution). Immunofluorescence was imaged on a Leica SPE 
inverted confocal microscope. A 488 nm laser was used to excite Alexa 488, 
and a 405 nm laser to excite the Hoechst stain, and single optical sections 
obtained. To quantify connexin expression changes following wounding single 
optical section images of a distal region (up to 1 mm from the wound) and the 
wound edges were taken at x40 magnification (1024 pixels X 1024 pixels). 
Microscope settings were kept constant when comparing connexin expression 
levels between the cheek epidermis and the buccal mucosa, using the buccal 
mucosa region to select settings. Images were imported into image J (NIH) for 
quantification. 8 bit images were identically thresholded, to create a binary 
image, and the region of the epithelium to be measured was demarked. The 
total area of connexin expression was measured and normalized to the total 
demarked area (Wang et al. 2007). Wound edge connexin expression was then 
normalized to expression distal to the wound, and presented as the percentage 
connexin was down-regulated at the wound edge. 
 
3.2.5. Statistics  
Unpaired Student’s t-tests were used to determine statistical differences 
between the epidermis and buccal mucosa for data having normal Gaussian 
distribution, using Welch’s correction for data with unequal variances. Data not 
showing normal distribution was transformed by taking the natural log and, if 
now normal, t-tests were used. Mann Whitney U tests were used on data not 
showing a normal distribution after transformation. All analysis was performed in 
prism V5, statistical analysis software. 	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3.3. Results 
3.3.1. The re-epithelialisation process in buccal mucosa differs 
from the process in skin 
In skin, re-epithelialisation is characterized by a thin tongue of flattened, 
elongated keratinocytes (figure 3.1.A) that crawl down the edge of the wounded 
dermis (figure 3.1.Ai) and over the granulation tissue which forms in the wound 
bed (figure 3.1.Aii). This process continues until the migrating cells from each 
wound edge meet and form a continuous intact epithelium (figure 3.1.Aiii) 
(Martin 1997). Despite the fact oral mucosa is considerably thicker than the skin 
epidermis, and comprised of many more layer of cells, re-epithelialisation in this 
epithelium has been described as proceeding through the same stages as skin 
(Enoch & Stephens 2009). However, here it is shown that there are distinct 
differences in the way the buccal mucosa heals.  
 
It was found that the wound edge epithelial cells of the buccal mucosa migrated 
in a thick lip or ‘wedge’ (figure 3.1.Bi), rather than a thin tongue of cells as in the 
epidermis. In the epidermis in the first 24 hours the leading migratory cells 
became flattened and elongated; however, in the buccal mucosa the leading 
cells largely retained their thickness and shape, only becoming slightly thinner 
(figure 3.2.A-D). The cells migrated rapidly down the wound tract in a ‘wedge’ 
(figure 3.1.Bii) until they met and joined up, forming a ‘V’ in the tissue (figure 
3.1.Biii). There appeared to be little or no granulation tissue in the wound bed, 
with cells migrating instead over the underlying sub-mucosa. The ‘V’ then 
rapidly filled with cells until they occupied the entire space between the two 
sides of the wound leaving a solid ‘delta’ shape of epithelial cells projecting into 
the underlying connective tissue (figure 3.1.Biv). The tissue then underwent 
remodelling and the ‘delta’ of epithelial cells retracted (figure 3.1.Bv) until there 
was very little evidence of the wound’s location (figure 3.1.Bvi).  
 
Interestingly, a deviation from the accepted model of oral mucosa was also 
found, as the presence of large hairs was noted within unwounded buccal 
mucosa in these mice. Hair is not normally found in non-keratinized buccal 
mucosa, but is usually restricted to keratinized epithelia. While hairs were 
infrequent very large hair follicles were consistently identified (figure 3.2.E).  
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Figure 3.1. The stages of re-epithelialisation in the skin epidermis and the buccal mucosa.  
In the skin (A) the keratinocytes form a thin tongue of cells at the wound edge (i), which migrate 
over granulation tissue (ii) until the two tongues meet and form a continuous epithelium (iii). In 
the buccal mucosa (B) the epithelial cells form a thicker wedge during the ‘initiation’ of re-
epithelialisation (i), which ‘migrate’ into the wound (ii) until the two sides meet and form a ‘V’ (iii). 
The ‘V’ becomes filled to form a ‘delta’ (iv), which is then ‘retracted’ (v) during remodelling, until 
the process is ‘complete’ (vi). The black and white dotted lines indicate the wounded region, 
where apparent. The black arrows indicate the thin epidermal re-epithelialisation (A) and the 
thicker buccal mucosa re-epithelialisation (B) All scale bars indicate 100 µm (Bi-ii= 6 hours; Ai-
ii= 24 hours; Biii-vi and Aiii=48 hours).   
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Figure 3.2. Cell shape at the migrating edge differs in skin and buccal mucosa. (A) Distal 
keratinocytes in the skin epidermis are rounded, but at the wound edge (24 hours post 
wounding) (B) they become thin and elongated. (C) Distal cells in the buccal mucosa are also 
rounded, but at the wound edge (6 hours post wounding) (D) they retain their shape fairly well. 
Arrows indicate the tip of the wound edge. Scale bars indicate 50 µm. (E) An example of a hair 
follicle in buccal mucosa. Scale bar indicates 200 µm. 
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3.3.2. Re-epithelialisation is more rapid in buccal mucosa than 
in skin 
Full thickness wounds through the cheek skin and the buccal mucosa were 
made. Tissue was harvested at 6 hours, 24 hours or 48 hours. Histological 
evaluation of wounds at 6 hours, 24 hours and 48 hours post-wounding were 
used to determine the extent of re-epithelialisation in the epidermis and buccal 
mucosa (figure 3.3). Contraction is reported to be greater in the oral mucosa 
than skin (P Stephens 1996; Shannon et al. 2006; McKeown et al. 2007), so re-
epithelialisation was measured rather than wound area to prevent contraction 
from confounding the results, as this study focuses on epithelial rather than 
connective cells. After 6 hours no re-epithelialisation could be seen in the 
epidermis of skin wounds. At 24 hours there was a tongue of migrating 
keratinocytes with an average re-epithelialisation of 53 µm (±10.16). In the 
buccal mucosa there was significantly more growth than in the epidermis both 
at 6 hours and 24 hours (p<0.05). At 6 hours the average re-epithelialisation in 
buccal mucosa was 55 µm (±12.32), and at 24 hours it was 82 µm (±10.59). 
Due to the manner in which buccal mucosa heals, the exact location of re-
epithelialisation initiation wasn’t always distinct. To ensure a fair comparison 
between the tissues, measurements of re-epithelialisation in the buccal mucosa 
were conservative, and actual re-epithelialisation in this tissue may be greater. 
By 48 hours 87.5% of buccal mucosa wounds had completed re-
epithelialisation, compared to only 55.6% of the epidermal wounds (figure 
3.3.Ci).  Of the buccal mucosa wounds that had completed re-epithelialisation 
66.7% of these had not only joined up but had entirely completed the 
remodelling process of retracting the delta of wound epithelium, and the 
wounds were no longer apparent (figure 3.3.Cii).  
 
3.3.3. Cx26, Cx30 and Cx43 expression is significantly higher in 
buccal mucosa than in skin 
Cx26 was expressed at very low levels suprabasally in intact facial epidermis. 
However, it was much more strongly expressed in the buccal mucosa 
throughout the intermediate and lower superficial layers but not basal layers 
(figure 3.4.A-B).  
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Figure 3.3. Re-epithelialisation of skin and buccal mucosa. (A) Images show examples of 
re-epithelialisation in skin epidermis (top row) and buccal mucosa (bottom row) at 6, 24 and 48 
hours. Black and white dotted lines indicate re-epithelialisation. Red and black dotted lines in 
the 48 H images indicate the original site of the wound. (B) Graph showing the re-
epithelialisation distance in skin epidermis and buccal mucosa at 6 and 24 hours. Mean ± SEM 
are shown (n=7 in the skin and n=6 in the buccal mucosa at 6 hours, and n=8 at 24 hours in 
both tissues (* p<0.05)). (Ci) Graph showing the percentage of samples with completed re-
epithelialisation at 48 hours. (Cii) Pie chart showing, of the buccal mucosa samples that had 
completed re-epithelialisation, the percentage at each stage of healing as described in figure 
3.1.    
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Cx30 was not easily detectable in the intact facial epidermis, but for the first 
time it is shown that Cx30 is strongly expressed in the intermediate and lower 
superficial layers of the buccal mucosa of mice (figure 3.4.A, C). Interestingly 
neither Cx26 nor Cx30 were strongly expressed in the proliferative basal cells of 
the buccal mucosa.  
 
Cx43 is the most ubiquitous connexin in skin, and in intact epidermis Cx43 was 
found in the basal and spinous layers as previously reported (Goliger & Paul 
1994). In the buccal mucosa, however, Cx43 was found in all layers except the 
superficial layer, but had lower expression in the basal than other layers (figure 
3.4.A, D).   
 
Cx26, Cx30 and Cx43 were all expressed at significantly higher levels in the 
buccal mucosa than in cheek skin (p<0.002) (figure 3.4.B-D). There was 326-
fold more Cx26, 490-fold more Cx30 and 24-fold more Cx43 in the buccal 
mucosa than in the cheek epidermis.  
 
3.3.4. Cx26, Cx30 and Cx43 are down-regulated rapidly at the 
buccal mucosa wound edge  
Connexin expression changes in the back skin epidermis have previously been 
reported with Cx26 and Cx30 increasing in wound edge keratinocytes and Cx43 
down-regulating concomitantly (Coutinho et al. 2003; Goliger & Paul 1995). 
Similar results were found in the cheek epidermis. Cx26 expression increased 
in the epidermis behind the wound edge within 6 hours, and significantly 
increased between 6 and 24 hours (* p<0.05) (figure 3.5.A). Similarly, Cx30 
expression increased behind the wound edge but within 24 hours (figure 3.5.C). 
In contrast, Cx43 became down-regulated at the wound edge within 6 hours by 
57% (±13.94%), and expression remained very low at 24 hours (figure 3.5.E).  
 
However, the buccal mucosa wound edge was noticeably different in its 
connexin response to injury, with a rapid global down-regulation of Cx26, Cx30 
and Cx43 at the wound edge within 6 hours of injury (figure 3.5.B, D, F).   
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Figure 3.4 Connexin expression in the cheek epidermis and in buccal mucosa. (A) An 
H&E image is shown of the epidermis transitioning into oral mucosa. Images of Cx26, Cx30 and 
Cx43 in the cheek epidermis (left) and buccal mucosa (right) are shown. Connexin staining is in 
green as indicated, and Hoechst is in blue. The epidermal and buccal mucosa images were 
taken using the same settings (note: the Cx43 expression levels in the epidermal image have 
been increased in this image only, to enable the Cx43 expression to be seen). The dotted white 
lines indicate the dermal-epidermal junction, and the mucosal-sub-mucosal junction. (B) Graph 
showing C26, (C) Cx30 and (D) Cx43 expression per µm2 in cheek epidermis and buccal 
mucosa. Mean ± SEM are shown (B and C, n=7; D, n=6 (** p<0.002)). 
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Figure 3.5. Connexin expression in a distal region and at the wound edge in skin and 
buccal mucosa at 24 hours following wounding for Cx26 (A-B), Cx30 (C-D) and Cx43 (E-F) 
are presented. Hoechst (nuclei) are in blue, and connexins are green as indicated. Dotted white 
lines represent the epidermal-dermal, or mucosal-sub-mucosal junction, and the white arrows 
indicate the tip of the wound edge. Graphs show the connexin down-regulation or up-regulation 
at the wound edge from the distal region at 6 hours and 24 hours. Mean ± SEM are given (Aiii 
n=5 at 6 H and n=6 at 24 H; Biii n=4; Ciii n=4 at 6 H and n=5 at 24 H; Diii n=4 at 6 H and n=5 at 
24 H; Eiii n=4 at 6 H and n=7 at 24 H; Fiii n=6 at 6 H and n=7 at 24 H; (*p<0.05)).  
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Cx26 and Cx30 were both rapidly down-regulated by 84% (±9.11%) and 80% 
(±5.01%) respectively at 6 hours (figure 3.5.B,F). Cx26 expression at the wound 
edge returned a little at 24 hours, to only 39% (±15.91%) down-regulation, but 
Cx30 expression remained very low at 70% (±7.01%) down-regulation. By 48 
hours, expression of both connexins was starting to return to normal levels. 
Expression, though, was highly variable, as at this time the majority of buccal 
mucosa wounds had completed re-epithelialisation and were at various stages 
in the remodelling process.  
 
At 6 hours after wounding Cx43 expression was 65% (±5.17%) lower at the 
wound edge than in distal regions (figure 3.5.F). At 24 hours very little Cx43 
expression was present, with 95% (±1.69%) of the Cx43 expression down-
regulated at the wound edge. At 48 hours, as with Cx26 and Cx30, Cx43 
expression levels were starting to return to normal levels. Cx43 dynamics 
followed a slightly different pattern to Cx26 and Cx30, taking longer to reach its 
maximal down-regulation.  
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3.4. Discussion  
Buccal mucosa is described as exhibiting “privileged healing” within adults. 
However, despite the importance of connexin expression and dynamics in the 
normal skin healing process, no research has been conducted into the connexin 
dynamics in buccal mucosa. Here, a rapid re-epithelialisation rate was observed, 
and differences noted in the re-epithelialisation process and connexin 
expression dynamics when compared to skin.  
 
Re-epithelialisation in oral mucosa is often described as proceeding through the 
same stages as skin (Enoch & Stephens 2009), although with a dramatically 
increased proliferation rate (Thomson et al. 1999). However, it was noted in an 
EM study of healing in rat tongue, a parakeratinised oral mucosa, that re-
epithelialisation onset was earlier than in skin epidermis. It was also reported 
that migratory mucosal cells retained their shape in comparison to skin 
keratinocytes, which become elongated (Sciubba et al. 1978). In this study, 
early onset and shape retention of migratory cells in buccal mucosa wounds 
was similarly observed. Differences in the buccal mucosal re-epithelialisation 
process are also described, namely the leading cells at the wound edge migrate 
in a wedge rather than a thin tongue. Whilst other studies have observed re-
epithelialisation in various oral mucosae, this phenomenon has not previously 
been reported. This may be due to several possible reasons. Few studies have 
examined the histology earlier than 24 hours after wounding, and many report 
complete re-epithelialisation (Szpaderska et al. 2003; Schrementi et al. 2008; 
Mak et al. 2009). Furthermore, this mechanism could be limited to incisional 
wounds that heal by primary intention, and may differ from wounds closing by 
secondary intention.  Alternatively the wound location may influence the 
mechanism, as buccal mucosa is reported to proliferate more rapidly that 
keratinised oral mucosa like gingiva or dorsal tongue (see (Squier & Kremer 
2001) for more information). The species may also be important, as the 
thickness and turnover of the oral mucosa differs between species (see (Squier 
& Kremer 2001)). 
 
Previous research has shown that oral mucosa fibroblasts differ from skin 
dermal fibroblasts in several ways, one of which is a significantly increased 
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contractile ability (P Stephens 1996; Shannon et al. 2006). This rapid 
contraction of the sub-mucosa wound bed may create a different migratory path 
for buccal mucosa epithelial cells, whereby they migrate into the wound bed 
rather than over granulation tissue, resulting in the ‘V’ and ‘delta’ described in 
the results, and a different process to that observed in skin epidermal wound 
healing. 
 
In addition to differences in the healing mechanism, it was shown that the intact 
buccal mucosa has a significantly higher level of connexin expression 
compared to skin (figure 3.6). While Cx26 and Cx43 have previously been 
reported in various unwounded oral mucosae (Hara et al. 1999; Hatakeyama et 
al. 2006; Muramatsu et al. 2008; Saitoh et al. 1997), to the best of our 
knowledge Cx30 expression in normal buccal mucosa is described here for the 
first time. In addition it was shown that the connexin dynamics in buccal mucosa 
wound healing differ considerably from those seen in the skin with all three 
connexins rapidly down regulating at the wound edge within 6 hours of injury 
(figure 3.6).  
 
It is widely accepted that Cx43 must be down-regulated in order for cells to 
migrate during wound healing (Qiu et al. 2003; Kretz et al. 2003; Mori et al. 
2006; Mendoza-Naranjo, Cormie, A. Serrano, et al. 2012; Wang et al. 2007). 
Thus, such high levels of Cx43 expression in buccal mucosa compared to skin 
might be expected to result in slower healing. Nevertheless, these results have 
shown that buccal mucosa re-epithelialisation is significantly faster, 
commencing sooner and reaching completion more rapidly. In this regard, the 
results have also shown here that rapid healing correlates with very rapid down-
regulation of Cx43 within 6 hours, with 95% of Cx43 removed within 24 hour. 
The change in connexin dynamics reported here is consistent with the necessity 
of Cx43 down-regulation for cell migration. It is possible that this prompt 
response may enable the rapid onset of buccal mucosa re-epithelialisation, and 
thus contribute to the privileged healing status of this tissue, though further work 
is required to confirm this. 
 
The high levels of Cx26 and Cx30 in unwounded buccal mucosa are also 
interesting. Both Cx26 and Cx30 have been suggested as markers for  
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Figure 3.6 Diagram of the connexin expression in the cheek epidermis and in buccal 
mucosa in intact tissue and at 24 hours after wounding. The expression patterns of Cx43 
(A), Cx26 (B) and Cx30 (C) are shown. The darkness of the colours indicate the extent of 
expression, with darker colours representing high expression levels, and lighter colours 
indicating lower expression levels.   
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hyperproliferative epidermis; high levels of Cx26 are found in hyperproliferative 
epidermis such as viral warts, psoriasis and porokeratosis (Hivnor et al. 2004; 
Lucke et al. 1999); and high levels of Cx30 are present in the epidermis in 
psoriatic and porokeratotic skin (Lemaître et al. 2006). Whilst buccal mucosa 
isn’t hyperproliferative, it is a very thick epithelium with a rapid rate of 
proliferation, thus sharing some similarities with hyperproliferative epidermis.  
 
Cx26 expression has been implicated in keratinocyte proliferation and 
differentiation (Brissette et al. 1994; Goliger & Paul 1995), though the precise 
role Cx26 plays in either process is still contentious. Double labelling for Cx26 
and Ki67, a marker for proliferation, in hyperproliferative psoriatic lesional 
epidermis showed most Cx26 expressing cells did not express Ki67 (Lucke et al. 
1999). However, in in vitro experiments where Cx26 was over-expressed 
significantly in keratinocytes, cells exhibited both significantly increased 
proliferation and migration rates compared to vector-only controls (Man et al. 
2007). Furthermore, ectopic over-expression of Cx26 in the epidermis of 
transgenic mice also increased proliferation of keratinocytes, and resulted in a 
hyper-thickened epidermis. However, these mice exhibited impaired wound 
healing compared to wild type litter mates, with only 42% completing re-
epithelialisation by day 21 compared to full wound closure in all wild type mice 
by day 14 (Djalilian et al. 2006). Upon wounding in skin Cx26 becomes elevated 
in the epidermis at the leading edge (Coutinho et al. 2003), but interestingly, in 
the faster healing buccal mucosa, it was found to be rapidly down-regulated. 
Cx26 down-regulation at the wound edge following injury has likewise been 
shown in hamster tongue, a slower healing parakeratinised oral mucosa that 
also highly expresses Cx26 (Saitoh et al. 1997).  
 
The presence of high levels of Cx30 in buccal mucosa, and its subsequent 
rapid down-regulation at the wound edge are shown here for the first time. The 
rapid reduction in Cx30 expression in the epidermis upon wounding is similar to 
that of Cx26 (Coutinho et al. 2003), and similarly its role in the process remains 
elusive. As with Cx26, overexpression of Cx30 in keratinocytes reportedly 
caused a significant increase in migration and proliferation compared to vector 
only controls (Man et al. 2007). Enhanced cell proliferation was also observed 
in Cx30 over-expressing cancer cells (Ozawa et al. 2007), but conversely, 
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double labelling of Cx30 and Ki67 in in vivo wound healing suggest an inverse 
relationship between Cx30 and proliferation (Coutinho et al. 2003).  
 
Thus, the dynamics of Cx26 and Cx30 in oral wound healing are different from 
those seen in skin as instead of increasing in expression they rapidly decrease, 
and this feature may reflect the faster healing process.  Both Cx26 and Cx30 
are able to bind to other junctional and cytoskeletal proteins such as Zonular 
Occludens-1, Occludin, Actin and Tubulin (Penes et al. 2005; Nusrat et al. 
2000; Qu et al. 2009). Whilst expression of Cx26 and Cx30 may be involved in 
proliferation, elevated Cx26 and Cx30 expression in the wound edge cells of 
skin lesions, and the subsequent binding to other junctional and cytoskeletal 
elements, may slow their migration in skin wounds.  It remains to be determined 
whether re-epithelialisation of skin lesions is improved in the absence of either 
Cx26 and or Cx30. It is possible the gap junction communication requirements 
for the healing of these two different epithelia are different and that 
communication is required in the leading edge cells of the skin but not in the 
buccal mucosa. 
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4.1. Introduction 
Cutaneous wound healing is a complex process, involving the coordination of a 
plethora of cell types and signals (Shaw & Martin 2009). Fibroblasts play an 
important role during healing; they must proliferate and migrate into the wound 
bed, laying down extracellular matrix to form granulation tissue, over which 
keratinocytes in the epidermis will migrate in order to restore barrier function.  
 
Wound healing does not always proceed as it should though, which is the case 
for chronic wounds, which are open for 3 months or more (Menke et al. 2007). 
These wounds typically have dermal fibrosis, defective granulation tissue 
formation and poor ECM remodelling (Herrick et al. 1992; Menke et al. 2007). 
Several abnormal features have been reported in fibroblasts isolated from 
chronic wounds, including reduced proliferation and migration (M. V Mendez et 
al. 1998; Brem et al. 2007; Ågren & Steenfos 1999). High levels of senescence 
have also been reported in chronic wound fibroblasts, with increased rates of 
senescence observed in one study in regions of higher bacterial load (Ågren & 
Steenfos 1999; M. V. Mendez et al. 1998;  a C. Stanley et al. 1997; Vande Berg 
et al. 1998).  
 
A common feature of chronic wounds is a sustained but low-level of 
inflammation, which is associated in part with bacterial contamination. Bacterial 
infection is in fact thought to be one of the underlying causes of impaired 
healing in chronic wounds, primarily by causing the sustained inflammation 
which in turn causes tissue damage (Mustoe et al. 2006; Bjarnsholt et al. 2008). 
Bacteria in these wounds are typically found within a biofilm, a community of 
sessile bacteria encased in a self-produced matrix (James et al. 2007). 
Staphylococcus aureus is a pathogenic species, and is one of the species most 
commonly isolated from chronic wounds, where it was detected in 89-95% of 
venous leg ulcers (Davies et al. 2004; Gjødsbøl & Christensen 2006). S.aureus 
secrete a range of exotoxins, and proteomic and gene expression analysis has 
showed that the products they secrete when in biofilms differ from those 
secreted by freely moving planktonic bacteria (Resch & Rosenstein 2005; Secor 
et al. 2011). S.aureus biofilm secreted products can be collected in cell culture 
growth medium, and is referred to as biofilm conditioned medium (BCM). BCM 
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from a methicillin resistant clinical isolate of S.aureus was found to reduce the 
viability and migratory ability of both keratinocytes and fibroblasts (Kirker et al. 
2009; Kirker & James 2012).  
 
Connexin43 (Cx43) is expressed by numerous cell types in the skin, including 
keratinocytes, fibroblasts and endothelial cells, and is important during wound 
healing (Di et al. 2001; Richard 2000). Its expression affects multiple cellular 
processes, including apoptosis, proliferation and migration, and low levels of 
expression have also been suggested as a marker of senescence (Dbouk et al. 
2009; Statuto et al. 2002; Stein et al. 2008; Zhao et al. 2004). Cx43 expression 
changes dynamically during wound healing, initially becoming down regulated 
at the wound edge in both keratinocytes and fibroblasts (Goliger & Paul 1995; 
Coutinho et al. 2003; Mendoza-Naranjo, Cormie, A. Serrano, et al. 2012). 
Genetic knockout of Cx43 in skin, or a rapid reduction in expression through the 
use of Cx43 antisense, increased the rate of healing by increasing the rate of 
re-epithelialisation, granulation tissue production and maturation (Qiu et al. 
2003; Mori et al. 2006; Kretz et al. 2003).  
 
In chronic wounds Cx43 expression is abnormal, remaining high (Brandner et al. 
2004), or even becoming elevated, at the epidermal and dermal wound edge 
(Mendoza-Naranjo, Cormie, A. E. Serrano, et al. 2012; Mendoza-Naranjo, 
Cormie, A. Serrano, et al. 2012). The cause of abnormal Cx43 expression in 
chronic wounds is as yet unknown. However, these wounds are contaminated 
with bacteria, commonly S.aureus. S.aureus, or molecules derived from this 
bacterium, can alter Cx43 expression in multiple cell types including fibroblasts, 
keratinocytes and endothelial cells (Garg et al. 2005; Esen et al. 2007; 
Robertson et al. 2010; Donnelly et al. 2012). It is not known whether S.aureus 
biofilm exotoxins also affect Cx43 expression. The hypothesis tested in this 
chapter is that one mechanism by which S.aureus exotoxins impair healing is 
by contributing to the abnormal Cx43 expression seen in dermal chronic 
wounds. 
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4.2. Materials and methods 
See Chapter 2 for general materials and methods. Materials and methods used 
only in this chapter are described here.  
 
4.2.1. Biofilm Conditioned Medium (BCM) 
DMEM supplemented with 10% DBS was added to wells in a 6 well plate. Each 
well held a 0.4 µm pore cell culture insert containing a sterile mixed cellulose 
ester hydrophilic membrane filter disc with 0.22 µm pore size. An overnight 
culture of Staphylococcus aureus subspecies. aureus ATCC® 29213™ 
(hereafter referred to as S.aureus) was washed and diluted to an OD600 of 
0.05. Seven 10 µl drops were placed on each filter disc and biofilms were 
allowed to develop and mature for 72 hours. The media was harvested every 24 
hours for four days thereafter and filter sterilized. The collected medium is 
referred to as BCM. 
 
4.2.2. MTT assay 
Cells were grown in flat bottom 96 well plates with good optical quality (Falcon), 
and incubated with HKSA or BCM at varying concentrations for 24 or 48 hours 
in 100 µl. At the end point of the experiment 10 µl of 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyl tetrazolium bromide (MTT, Millipore) was added per well. Cells 
were incubated at 37 °C for 2 hours. The media was carefully removed, and the 
MTT formazan dissolved in 100 µl of isopropanol with 0.04 N HCl. The 
absorbance at 570 nm was measured on an ELx800 Absorbance Microplate 
Reader (BioTek) using Gen5 plate reading software (BioTek). The absorbance 
at 630 nm was also measured as a reference wavelength, and deducted from 
the 570 nm reading. Results were quantified as a percentage of the control’s 
absorbance.  
 
4.2.3. Cell counts 
Cells were grown in 6 wells plates in BCM or DMEM supplemented with 10% 
DBS. At the indicated time points cells were washed, trypsinised, and re-
suspended in media. The number of cells in an aliquot were counted using a 
Scepter™ hand held automated cell counter (Millipore) using 60 µm sensors 
(Millipore) and gating identically.  
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4.2.4. Senescence associated β-galactosidase activity stain 
Cells were grown for 7 days with BCM, changing the media every 2-3 days. On 
day 6 the BCM cultured cells and control cells were plated in 24 well cell culture 
plates for imaging. On day 7 the media was removed and cells washed with 
PBS before fixing in 4% PFA in PBS for 5 minutes at room temperature. They 
were washed again and the senescence associated β-galactosidase (SA-βGal) 
staining solution added to each well (see table 2.1. for the recipe). Cells were 
incubated with the staining solution in the dark at 37 °C for 24 hours then 
washed twice in PBS. Cells were imaged on a Ix81-ZDC microscope (Olympus) 
equipped with an DP72 digital colour camera (Olympus), using Xcellence rt 
imaging system software (Olympus). 15 regions were imaged per well. The 
percentage of cells in each image with senescence associated β-galactosidase 
activity (as determined by the blue colour) was determined. Images were 
blinded to attenuate potential observer bias.  
 
4.2.5. Measuring nuclear size 
Images of cells used to assess (SA-βGal) were imported into Image J. The free 
hand tool was used to draw around the nuclei and the area was measured in 
pixels, and then converted to µm2. 
 
4.2.6. Scratch wound experiments 
Cells were plated in 96 well ImageLock tissue culture plate (Essen BioScience) 
48 hours before the experiment and grown to confluence. All scratch wound 
experiments were conducted both with and without the growth inhibitor, 
mitomycin C. On the day of the experiment, the media was removed from wells 
that were to be treated with growth inhibitor. This was replaced with DMEM 
supplemented with 10 µg ml-1 mitomycin C from Streptomyces caespitosus 
(Sigma) and incubated for 2 hours. This concentration was chosen after a pilot, 
and was tested for growth inhibitory effects and cytotoxicity by live imaging of 
proliferation and propidium iodide uptake (see protocol 2.4.3.). After 2 hours the 
media was removed from all wells, and cells were washed with PBS. A scratch 
wound was made using a WoundMaker™ (Essen BioScience), and the cells 
washed again. BCM, or DMEM supplemented with 10% DBS (controls), was 
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added and each well imaged every 2 hours for 48 hours on an IncuCyte™ FLR 
(Essen BioScience). The relative wound density (RWD) was calculated using 
the IncuCyte 2010A software (Essen BioScience). This is a percentage 
measure of the density of the wound region relative to the density of the cell 
region. The distances migrated were calculated by importing 0, 4 and 12 hour 
images into Image J software (NIH) and manually drawing the leading edge. A 
plugin, written by Daniel Cintar in UCL Data Analysis, was used to determine 
the distance migrated from the average central point of the leading edge at 0 
hours to the average central point of the leading edge at 4 and 12 hours.  
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4.3. Results 
4.3.1. Incubation with BCM reduces the rate of proliferation 
It was determined whether BCM, created using the toxic ATCC® 29213™ 
S.aureus strain, affected the viability of 3T3 fibroblasts. Fibroblasts were 
incubated with increasing concentrations of BCM for 24 or 48 hours, and then 
their viability, compared to controls, was assessed using MTT assays (figure 4.1. 
A and B). The MTT assay is a colorimetric technique often used to assess 
viability of cells, as only live cells with active NAD(P)H-dependent 
oxidoreductase enzymes are capable of reducing yellow MTT to insoluble blue 
formazan crystals; the extent of blue coloration is measured by absorbance at 
570 nm and reflects the number of viable cells (Meerloo et al. 2011). A trend 
was apparent, particularly at the 48 hour time point, whereby increasing 
concentrations of BCM were associated with decreasing absorbance. At both 
the 24 and 48 hours incubation with 75% and 100% BCM caused a significant 
reduction in the absorbance reading, with the effect greatest after 48 hours.  
 
Although MTT assays are normally used as an indicator of the viability of a 
population of cells, changes in metabolic activity can also influence the results; 
a reduction in both metabolic activity and the number of viable cells will reduce 
the production of formazan from MTT (Sumantran 2011). Therefore to support 
the results of the MTT assays, cell counts were also taken of controls and of 
fibroblasts incubated with 100% BCM, at 0, 24 and 48 hours (figure 4.1.C). 
Incubation with 100% BCM resulted in significantly fewer cells than in controls 
at both 24 and 48 hours. Moreover, the population of control fibroblasts more 
than doubled between 0 and 24 hours (2.7±0.4 fold), and doubled again 
between 24 and 48 hours (1.9±0.1 fold), whereas fibroblasts incubated with 
100% BCM proliferated slower, growing 1.7±0.3 fold between 0 and 24 hours, 
but barely proliferating between 24 and 48 hours (1.08±0.004 fold increase in 
cell count).   
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Figure 4.1. Incubation with biofilm conditioned medium (BCM) reduces cell number. (A, 
B) Graphs illustrating MTT absorbance at 24 (A) and 48 (B) hours when 3T3 fibroblasts were 
incubated with increasing concentrations of BCM. A one-way ANOVA showed significant 
differences between the groups at 24 hours (p<0.05) and 48 hours (p<0.001). A Tukey’s post 
hoc revealed that incubation with 75% and 100% BCM caused significant differences from 
controls at both time points.  N=4. (C) Graph showing the number of cells counted in controls, or 
after incubation with 100% BCM, over 48 hours. Independent Student’s t-tests showed that 
there were significantly less cells in the 100% BCM group compared to controls at both 24 and 
48 hours. N=3. All error bars are SEM.  *p<0.05, **p<0.01. 	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Cell death is usually accompanied by a change in cell volume: apoptosis 
causes cell shrinking, while necrosis results in swelling (Orrenius & Sten 2001). 
The cell counts used to assess cell viability when incubated with 100% BCM 
were made using a Scepter™ handheld automated cell counter, which creates 
histograms of the cell’s volumes and diameters. However, no statistically 
significant differences were observed in the volume or diameter of fibroblasts 
incubated with 100% BCM (figure 4.2.A-B), suggesting that the cells exposed to 
BCM were not dying. As neither of the techniques previously used to access 
viability (MTT assays or cell counts) allow a distinction to be made between 
cytostatic and cytotoxic effects it was possible that the fibroblasts were not 
dying, but instead failing to proliferate. To investigate this, the nuclei of cells 
incubated with 100% BCM for 24 hours were visualised by staining with 
Hoechst, and then observed for signs of apoptosis or necrosis. Apoptosis 
normally causes nuclear fragmentation and chromatin condensation, and 
necrotic cells exhibit nuclear swelling (Orrenius & Sten 2001). However, the 
nuclei of cells incubated with 100% BCM for 24 hours appeared healthy, 
exhibiting no morphological signs of either necrosis or apoptosis (figure 4.2.C). 
This agrees with the data showing cell volume and diameter are not altered by 
incubation with 100% BCM, and indicates that the reductions seen in cell 
counts and in absorbance in the MTT assays were not the result of reduced 
viability, but of reduced overall cell number. To determine if this was the case 
fibroblasts were incubated with 100% BCM or control media and imaged hourly 
over 24 hours (figure 4.2.D-E). The cell’s nuclei were labelled with Hoechst, 
which enabled the rate of cell proliferation to be assessed by comparing the 
total number of cells at each time point. Throughout the experiment the medium 
also contained propidium iodide (PI). This dye is excluded by viable cells but 
readily enters cells that have lost membrane integrity, and so it is often used to 
assess cell viability (Johnson et al. 2013). By imaging both Hoechst (total 
number of cells per image) and PI labelled cells (non-viable cells), the changing 
percentage of non-viable cells in the population could be determined. By 
observing the fold change in cell number (figure 4.2.D), it was evident that 
incubation with 100% BCM significantly reduced the proliferation of 3T3 
fibroblasts. The growth rate in the BCM group began diverging from controls at 
around 8 hours; the fold change of the controls remained exponential, whereas 
the fold change of BCM incubated cells began to plateau. At 11 hours   
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Figure 4.2. Incubation with 100% biofilm conditioned medium (BCM) prevents cell 
proliferation but doesn’t reduce cell viability. (A-B) Graphs demonstrating the (A) diameter 
and (B) volume control and 100% BCM incubate cells at 0, 24 and 48 hours. (C) Confocal 
images of nuclei from 3T3 fibroblasts controls (left) and fibroblasts incubated with 100% BCM 
for 24 hours (right). The images are representative of 3 experiments. Scale bars indicate 50 µm. 
(D) Graph presenting the fold change in cell number over 24 hours as determined by live 
imaging of Hoechst labelled cells. There were significant differences in proliferation between 
control and 100% BCM at every time point after 11 hours (p<0.05 or <0.01). (E) The number of 
propidium iodide positive cells, as a percentage of the whole population over 24 hours is shown 
for control 3T3 fibroblasts, and fibroblasts incubated with 100% BCM. Mixed design ANOVAs or 
independent Student’s t tests were used to test statistical differences as appropriate. A-B, N=3; 
D-E, N=4. All error bars are SEM. *p<0.05, **p<0.01. 
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significant differences between control and BCM incubated groups emerged, 
and the groups differed significantly at every time point thereafter. By 12 hours 
the fold change in cell number no longer increased in the BCM incubated group, 
suggesting that the cells had stopped proliferating, and had entered cell cycle 
arrest. The viability of the population was also assessed, by determining the 
percentage of the total population that were positive for PI (figure 4.2.E). This 
was low in both controls and cells incubated with 100% BCM. Less than 1% of 
cells were PI positive, and there were no differences between the groups  
 
4.3.2. Incubation with 100% BCM for 7 days induces a 
senescent phenotype 
Previous analysis revealed that incubation with 100% BCM attenuates 
proliferation of fibroblasts without affecting viability (figure 4.2.). Cessation of 
cell proliferation is the most prominent marker of senescence (Kuilman et al. 
2010). Consequently, it was investigated whether cells incubated with BCM also 
were positive for other markers of senescence.  
 
Cells were incubated with control medium or 100% BCM for 7 days. Senescent 
cells often exhibit morphological changes, such as enlargement of the cell and 
nuclei (Kuilman et al. 2010), and observations of the 100% BCM incubated 
fibroblasts suggested that they were enlarged with increased nuclear size. An 
example of a cell with these morphological features is indicated by the arrow in 
figure 4.3.C. Quantification confirmed that incubation with 100% BCM resulted 
in an increased nuclear size compared to controls (Figure 4.3.A), suggesting 
that incubation with 100% BCM may be inducing senescence.  
 
Senescence associated β-galactosidase (SA-β-gal) activity is probably the most 
commonly used biomarker to determine senescence in cell culture. This is a 
cytochemical technique, which uses the substrate X-gal to detect lysosomal β-
galactosidase activity at the suboptimal pH of 6.0 (Dimri et al. 1995; van der 
Loo et al. 1998). At this pH only senescent cells produce the blue stain, a result 
of increased levels of the lysosomal β-galactosidase enzyme (Kurz et al. 2000). 
To assess if BCM was inducing this marker of senescence, 3T3 fibroblasts were 
incubated with 100% BCM or control medium for 7 days, then examined for SA- 
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Figure 4.3. β-galactosidase activity in fibroblasts. (A) Graph illustrating the average nuclear 
area in µm2. (B) Graph showing the percentage of imaged cells that were positive for β-
galactosidase activity, as indicated by blue staining. (C) Images are shown of the β-
galactosidase activity at pH 6.0, of controls (top panel), and of fibroblasts incubated with 100% 
BCM for 7 days (bottom panel), at both low and high magnification. The arrow indicates an 
example of an enlarged cell with a enlarged nuclei. (D) Example images are shown of cells 
incubated with 100% BCM, showing varying intensities of β-galactosidase activity, increasing 
from left to right. Independent Student’s t tests were used to test statistical differences. N=3. All 
scale bars indicate 50 µm. All error bars are SEM. *p<0.05, ****p<0.0001.  
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β-gal activity (figure 4.3.B-D). Few controls cells exhibited any SA-β-gal staining 
(4.1% ± 0.9%). Conversely, 100% BCM incubated cells had elevated levels of 
SA-β-gal activity, with over 80.0% (± 3.7%) of the cells positive for SA-β-gal 
stain (figure 4.3.B-C). The extent and intensity of blue staining did vary between 
individual cells as is illustrated in figure 4.3.D. Some cells exhibited only small 
amounts of granular blue stain, such as in the example on the left of the panel, 
while others had intense blue stains, as in the example on the right of the panel. 
This variation suggests that there may be variability in the sensitivity of the 
population to incubation with BCM. 
 
Another common feature of senescence is an increase in auto-fluorescence 
(Zglinicki et al. 1995). This is largely due to the lysosomal accumulation of 
lipofuscin, an auto-fluorescent pigment thought to be comprised of oxidatively 
damaged protein and lipids (Zglinicki et al. 1995). Fibroblasts were again 
incubated with 100% BCM or control medium for 7 days, and then examined for 
auto-fluorescence (figure 4.4). This was assessed on a confocal microscope, 
using a 488 nm laser. Control cells exhibited only faint auto-fluorescence. 
Conversely, many of the cells incubated with 100% BCM displayed intense 
granular cytoplasmic auto-fluorescence. Auto-fluorescence was not limited to 
excitation with a 488 nm laser, but also occurred to some extent when using a 
405 nm laser. Regions that auto-fluoresced with both lasers appear pale blue in 
the combined 405 and 488 nm images. As with the SA-β-gal staining, the 
intensity of auto-fluorescence varied from between cells. Quantification of the 
auto-fluorescence per cell (figure 4.4.C) though, confirmed that the 100% BCM 
incubated cells exhibited significantly higher levels of auto-fluorescence than 
control cells. This analytical method normalises to the number of cells per 
image, so to validate this method it was confirmed that the number of cells per 
image didn’t differ significantly between the groups (p=0.92; figure 4.4.D).   
 
The combination of morphological signs of senescence and a reduction in 
proliferation, as well as increased SA-β-gal activity and auto-fluorescence 
provides credible evidence that incubation with 100% BCM for 7 days induces 
senescence in 3T3 fibroblasts.  
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Figure 4.4. Incubation with 100% biofilm conditioned medium (BCM) induces senescent 
associated auto-fluorescence. (A) Images are shown of the auto-fluorescence emitted when 
controls (top panel) or fibroblasts incubated with 100% BCM for 7 days (bottom panel) were 
activated with a 488 nm laser. Low magnification images of auto-fluorescence are shown on the 
left, with nuclei counterstained with Hoechst (blue). High magnification images are shown of the 
auto-fluorescence only (middle), and of auto-fluorescence with nuclei counterstained (right). (B) 
Example images are shown of cells incubated with 100% BCM, showing varying intensities of 
autofluorescence, increasing from left to right. (C) Graph showing pixels per nuclei calculated 
from images of 488 nm auto-fluorescence. (D) Graph showing the average number of nuclei in 
the auto-fluorescent images. Independent Student’s t tests were used to test for statistical 
differences between the groups. There was no difference in the average number of nuclei in 
each group. N=3. All scale bars indicate 50 µm. All error bars are SEM. **p<0.01. 
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4.3.3. Incubation with 100% BCM retards cell migration in 
scratch wound closure 
It was determined whether BCM derived from the ATCC® 29213™ S.aureus 
strain impaired scratch wound closure. Confluent fibroblasts were scratched, 
and 100% BCM added to them immediately afterwards. The wounds were 
imaged every 2 hours for 48 hours. The impact on overall scratch wound 
closure was evaluated first (figure 4.5). Over 48 hours control wounds closed 
completely, leaving no visible sign of the original scratch (figure 4.5.A. top 
panel). Oppositely, incubation with BCM prevented the full closure of the 
scratch wounds in this time frame, as can be seen from the representative 
images taken at 24 and 48 hours after scratching (figure 4.5.A, bottom panel). 
Towards 48 hours, some BCM incubated cells did succeed in migrating across 
the whole distance of the scratch, coming into contact with cells from the other 
leading edge. However the cells did not migrate loosely together as is normal 
for fibroblasts, but rather individually. Quantification of the relative wound 
density (RWD, a percentage measure of the density of the wound region 
relative to the density of the cell region, calculated by the IncuCyte™ software) 
similarly showed that the scratches failed to close (figure 4.5.B). RWD 
increased only gradually in the BCM cells and plateaued at 55-60%, unlike the 
controls, which approached 90% within 30 hours. Significant differences 
between controls and the BCM incubated groups emerged after 20 hours, 
although the RWD of the BCM incubated cells appeared to begin diverging from 
controls after approximately 12 hours.  
 
RWD analysis is a useful measure of wound closure, as it takes into account 
both the width of the wound and the density of cells within that wound. It thus 
provides information on the scratch closure that accounts for a combination of 
both proliferation and cell migration, the two major components of wound 
closure in cell culture. However, previous analysis of data has shown that 
incubation with 100% BCM prevents proliferation (figure 4.2). It is not known 
though, whether failure to close the scratch wounds was due entirely to the 
effect of BCM incubation on proliferation, or whether BCM also has an effect on 
cell migration. To determine whether incubation with BCM impairs migration   
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Figure 4.5. Incubation with 100% biofilm conditioned medium (BCM) prevents scratch 
wound closure of fibroblasts. (A) Images are shown of controls (top panel) and fibroblasts 
incubated with 100% BCM (bottom panel) at 0, 24 and 48 hours following scratching. Scale bars 
indicate 300 µm. (B) Graph showing the relative wound density, as calculated by Essen 
Bioscience IncuCyte™ 2010A software. A mixed design ANOVA was performed comparing the 
relative wound density of controls with 100% BCM incubated cells. The ANOVA showed that 
there was a significant difference between the groups. Independent Student’s t tests showed 
significant differences at all time points after 20 hours. N=3. All error bars are SEM. **p<0.01. 
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manual measurements of the average distance migrated by the leading edge of 
cells was performed (figure 4.6). 
 
Measurements were made at 4 and 12 hours. An early time point of 4 hours 
was selected, as this would indicate if initiation of migration was prevented.  A 
later time point of 12 hours was also chosen, as this would reveal more subtle 
differences where migration was reduced, rather than prevented. Time points 
later than 12 hours could not be measured. This is because the top and bottom 
leading edge of many control wounds had come into contact, making it 
impossible to determine which leading edge each cell originated from. 
 
Manual analysis of cell migration at 4 hours showed that there was no 
difference in the distance the leading edge had moved in controls and 100% 
BCM incubated cells at this time point (figure 4.6.B). At 12 hours, though, the 
leading edge of the controls had migrated significantly further than in the 100% 
BCM incubated group (figure 4.6.C), suggesting that by 12 hours incubation 
with 100% BCM had retarded migration. As previous analysis had revealed that 
at 12 hours incubation with BCM there was a significant reduction in 
proliferation compared to controls (figure 4.2.B), these experiments were also 
conducted with a proliferation blocker, mitomycin C. Mitomycin C is a powerful 
DNA crosslinker, which prevents cell proliferation (Tomasz 1995). This attribute 
means it is commonly used in scratch wound experiments to ensure only 
migration, and not proliferation, is being observed ((Liu et al. 2009). A 
concentration of 10 µg ml-1 was selected as it stopped proliferation, but was 
below cytotoxic levels (figure 4.7.A-B). As a control, it was also confirmed that 
treating control cells with mitomycin C had no significant impact on the distance 
they migrated compared to cells that had not been incubated with mitomycin C, 
at both 4 and 12 hours (figure 4.7.C-D). The same comparison was made for 
fibroblasts incubated with 100% BCM for 4 or 12 hours (figure 4.7.C-D); 
however, treatment with mitomycin C significantly increased the migration of 
100% BCM incubated cells at 12 hours (figure 4.7.D). A comparison was then 
made of the distances migrated by scratched cells treated with mitomycin C 
then incubated with either control medium or 100% BCM (figure 4.7.C-D).   
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Figure 4.6. Incubation with 100% biofilm conditioned medium (BCM) impairs the 
migration of 3T3 fibroblasts. (A) Images are shown of controls (left panel) and fibroblasts 
incubated with 100% BCM (right panel) at 0 (black dotted line), 4 (blue dotted line) and 12 (red 
dotted line) hours following scratching. Scale bars indicate 300 µm. (B) Graph showing the 
distance migrated by cells by 4 hours. (C) Graph showing the distance migrated by cells by 12 
hours. Independent Student’s t tests showed no significant differences in the distance migrated 
by the groups at 4 hours, but significant differences at 12 hours. N=3 control, N=4 BCM treated. 
All error bars are SEM. **p<0.01. 
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Figure 4.7. Incubation with 100% biofilm conditioned medium (BCM) impairs the 
migration of 3T3 fibroblasts when proliferation is also blocked. (A) The fold change in cell 
number, as determined by live imaging cells stained with Hoechst, is shown over 12 hours for 
controls and fibroblasts incubated with 10 µg ml-1 mitomycin C for 2 hours prior to imaging. A 
mixed design ANOVA showed there was significantly less proliferation in the 100% BCM group 
compared to the controls. (B) Graph showing the number of propidium iodide positive cells, as a 
percentage of the whole population over 12 hours.  A mixed design ANOVA showed there were 
no significant differences between the groups. (C-D) Graphs showing the distances migrated by 
control or 100% incubated fibroblasts with and without mitomycin C at (C) 4 or (D) 12 hours. (E-
F) Graphs showing the distance migrated by cells at (E) 4 or (F) 12 hours. Independent 
Student’s t tests were used to determine statistical differences in the distances migrated. N=3. 
All error bars are SEM. **p<0.01. 
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Blocking proliferation did not alter the effect incubation with 100% BCM had on 
the distance migrated by the leading edge of cells; at 4 hours there was no 
difference in the distance migrated by controls and BCM incubated cells (figure 
4.7.C), but at 12 hours the controls had migrated significantly further than the 
BCM incubated cells (figure 4.7.D), just as seen with the cells not treated with 
mitomycin C (figure 4.6). This shows that regardless of the impact BCM had on 
proliferation, incubation with 100% BCM also retarded migration of the leading 
edge of cells. However, the effect was not immediate as there were no 
differences in the distance migrated at 4 hours. 
 
As well as differences in the distance migrated, the migrating BCM incubated 
cells exhibited altered morphology compared to controls (figure 4.8). The 
controls at the leading edge migrated loosely together, creating a relatively neat 
and uniform leading edge, where the cells primarily appeared cigar shaped. In 
contrast, the BCM incubated cells migrated more individually and appear less 
polarised towards the wound edge. The cells became very thin, their nuclei also 
appeared more prominent, and their lamellipodia became elongated and thin. 
Cells extended lamellipodia into the scratched region, but few of the cell bodies 
appeared to migrate forward compared to the controls, and it appears as 
though they may not be effectively retracting their tails. Interestingly, this 
phenotype was only observed when the 100% BCM incubated cells were 
scratch wounded, and not when they were static.  
 
4.3.4. Prolonged incubation with 100% BCM reduces Cx43 
protein expression  
It was investigated whether S.aureus BCM altered Cx43 expression in 3T3 
fibroblasts. An early time point (9.5 hours) was included to examine relatively 
rapid changes in Cx43 expression, and a 7 day time point to observe the effect 
of prolonged exposure to 100% BCM. 9.5 hours was selected as at this time 
point proliferation rates did not differ significantly from controls (section 4.3.1. 
and figure 4.2.B), which is important as cell density influences Cx43 expression. 
For the 7 day time point controls, an appropriate number of cells were plated 24 
hours prior to the time point, in order to have a control cell density comparable 
to the BCM incubated cells.  
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Figure 4.8. Incubation with 100% biofilm conditioned medium (BCM) alters the 
morphology of migrating cells. Representative images of the leading edge of migrating 
control cells (A) and cells incubated with 100% BCM (B) at 12 hours after scratching. Scale 
bars indicate 50 µm.   
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After 9.5 hours of incubation with 100% BCM, western blots showed that there 
was no change in total Cx43 expression compared to controls (figure 4.9.B). A 
comparison of the α-tubulin expression in each group validated this protein as a 
loading control, as its expression doesn’t differ significantly between controls 
and BCM incubated cells (p=0.63) (figure 4.9.C). Cx43 separates into three 
bands when it is visualised by western blot. The fastest migrating band is 
referred to here as Cx43, and the two slower migrating bands are commonly 
referred to as Cx43 P1 and Cx43 P2. Cx43 can be phosphorylated at multiple 
sites, and the proteins at each western blot band are thought to be 
phosphorylated differently, resulting in different conformations related to the 
functional location of the protein within the cell (Solan & Lampe 2009). 
Densiometric analysis of the western blot confirmed that there were no 
detectable changes in the amount of each protein band (figure 4.9.D). From this 
it was concluded that incubation with 100% BCM for 9.5 hours does not 
influence Cx43 expression or phosphorylation in 3T3 fibroblasts. In contrast, 
incubation with 100% BCM for both 1 and 7 days resulted in a significant 
reduction in total Cx43 expression (figure 4.10.A-B). A comparison of the levels 
of each protein band showed that this was due to a significant reduction in 
expression of the Cx43 and Cx43-P1 protein bands (figure 4.10.E). A 
comparison of the α-tubulin expression in each group showed that it too was 
reduced by incubation with 100% BCM (figure 4.10.C). Instead, values were 
normalised to GAPDH expression. GAPDH was validated as a loading control, 
as its expression didn’t differ significantly between controls and BCM incubated 
cells (figure 4.10.D). 
 
4.3.5. Incubation with 100% BCM does not alter Cx43 location 
within cells 
Western blots demonstrated that Cx43 protein expression is reduced when 
incubated with 100% BCM for 7 days, but not for 9.5 hours. However, western 
blot analysis does not allow visualisation of the location of connexins within the 
cells. Connexin distribution can be altered by several factors, including infection 
(Campos de Carvalho et al. 1998; Martínez & Sáez 2000), and so Cx43 protein 
expression was also visualised using immunofluorescence. 
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Figure 4.9. Incubation with 100% biofilm conditioned medium (BCM) for 9.5 hours has no 
effect on Cx43 protein levels. (A) A western blot showing Cx43 protein expression in controls 
and in fibroblasts incubated with 100% BCM for 9.5 hours. α-tubulin expression was used as a 
loading control. (B) Graph quantifying the total Cx43 expression relative to α-tubulin expression. 
(C) Graph quantifying the α-tubulin expression for control samples, and samples incubated with 
100% BCM for 9.5 hours. (D) Graph quantifying the different bands of Cx43 seen on the 
western blot, which indicate the different phosphorylation statuses of Cx43. Expression is 
relative to total α-tubulin expression. Independent Student’s t tests were used to test for 
statistical differences. These showed no significant differences between controls and BCM 
incubated. N=4. All error bars are SEM. 	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Figure 4.10. Prolonged incubation with 100% biofilm conditioned medium (BCM) reduces 
Cx43 and α-tubulin protein expression. (A) A western blot showing Cx43 and α-tubulin 
protein expression from a fibroblast control sample, a sample incubated in 100% BCM for 1 day, 
and a sample incubated in 100% BCM for 7 days. As a loading control, the GAPDH expression 
from the samples is also shown. (B) Graph quantifying the total Cx43 expression relative to 
GAPDH. (C) Graph quantifying the α-tubulin expression relative to GAPDH. (D) Graph 
quantifying the GAPDH expression. (E) Graph quantifying the different bands of Cx43 seen on 
the western blot, which indicate the different phosphorylation statuses of Cx43. Expression is 
relative to total GAPDH expression. Independent Student’s t tests were used to test for 
statistical differences. N=3. All error bars are SEM. *p<0.05, **p<0.01, ***p<0.001. 	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Confocal images were taken of Cx43 immunofluorescence after 9.5 hours or 7 
days incubation with 100% BCM (figures 4.11 and 4.12 respectively). 
Quantification of confocal images of Cx43 immunofluorescence at 9.5 hours 
(figure 4.11) confirmed the results seen by western blot (figure 4.9), as no 
differences in Cx43 expression levels were found. As this analytical method 
normalises to the number of cells per image, it was confirmed that the number 
of cells per image didn’t differ significantly between the groups (p=0.26) (figure 
4.11.C). Furthermore, no differences in the cellular location of Cx43 
immunofluorescence were apparent following incubation with BCM for 9.5 hours. 
Quantification of confocal images following incubation with 100% BCM for 7 
days (figure 4.12.A) also confirmed the results from western blots (figure 4.10), 
as a significant reduction in Cx43 expression was found (figure 4.12.B). The 
number of cells per image didn’t differ significantly between the groups, 
validating the use of nuclei number as a normalisation method (p=1.0) (figure 
4.12.D). Interestingly, as well as a reduction in Cx43 expression, the 
immunofluorescent images showed a significant reduction in the average Cx43 
plaque size (figure 4.12.C). There was also a change in distribution of Cx43. In 
control cells Cx43 expression was high in foci around the nuclei and at 
intercellular junctions, with some diffuse cytoplasmic expression. In fibroblasts 
incubated with 100% BCM for 7 days, Cx43 was instead located diffusely 
throughout the cytoplasm (figure 4.12.A). 
 
4.3.6. Incubation with 100% BCM reduces proliferation 
independently of Cx43 expression 
It was investigated whether the effect of BCM incubation on proliferation would 
differ in fibroblasts where Cx43 has been knocked down. An 85% (±5%) 
reduction in Cx43 expression by 3T3 fibroblasts using shRNA was first 
confirmed by western blot (figure 4.13). 3T3 empty vector controls (EVs: it was 
confirmed that there were no statistical differences between EVs and non-
transfected 3T3s in any of the assays performed in this chapter, data not 
shown) and fibroblasts with Cx43 constitutively knocked down (Cx43 shRNAs) 
were incubated with control medium or 100% BCM and imaged hourly for 24 
hours. 	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Figure 4.11. Cx43 localisation and expression within the cell is unaffected by incubation 
with 100% biofilm conditioned medium (BCM) at 9.5 hours. (A) Examples of 
immunofluorescent confocal images showing nuclei (blue) and Cx43 (green) in controls (top 
row) and in fibroblasts incubated with 100% BCM for 9.5 hours (middle row). A negative control 
using secondary antibody only is shown in the bottom panel. Scale bars indicate 50 µm. (B) 
Graph illustrating the Cx43 protein expression levels as quantified from confocal images, shown 
as Cx43 pixels per nuclei. (C) Graph showing the average number of nuclei in the Cx43 
immunofluorescent images used to quantify Cx43 expression. Independent Student’s t tests 
were used to test statistical differences. These showed no significant differences. N=4. All error 
bars are SEM.  
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Figure 4.12. Cx43 expression is reduced by prolonged incubation with 100% biofilm 
conditioned medium (BCM). (A) Examples of immunofluorescent images of nuclei (blue) and 
Cx43 (red) in controls (top row) and in fibroblasts incubated with 100% BCM for 7 days (bottom 
row). Scale bars indicate 50 µm. (B) Graph showing Cx43 expression as pixels per nuclei. (C) 
Graph showing the average size of Cx43 plaques in pixels. (D) Graph showing the average 
number of nuclei in the Cx43 immunofluorescent images used to quantify Cx43 expression. 
Independent Student’s t tests were used to test statistical differences between control and BCM 
incubated groups. N=3. All error bars are SEM. **p<0.01, ***p<0.001. 
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Figure 4.13. Cx43 is knocked down in Cx43 shRNA 3T3 cells. (A) Western blot showing 
Cx43 and α-tubulin expression in normal 3T3, EV, and Cx43 shRNA cells. (B) Graph showing 
Cx43 expression relative to α-tubulin expression. A One-way ANOVA and Tukey’s post hoc 
showed a significant reduction in Cx43 expression in Cx43 shRNA cells compared to 3T3 and 
EV controls. N=3. All error bars are SEM. **p<0.01.  
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The nuclei were labelled with Hoechst and PI was included in the media, 
enabling determination of both proliferation and viability (figure 4.14). The fold 
change in cell number was compared (using a mixed design ANOVA) between 
all four groups: EV controls, EV incubated with 100% BCM, Cx43 shRNA 
controls and Cx43 shRNA incubated with 100% BCM (figure 4.14). Cx43 
knockdown was previously shown to reduce the rate of fibroblast proliferation 
over 90 hours (Mendoza-Naranjo, Cormie, A. Serrano, et al. 2012). In line with 
previous evidence, control Cx43 shRNA cells appeared to proliferate slower 
than EV controls, but there was no statistically significant difference over this 
time period (24 hours). Incubation with 100% BCM significantly reduced 
proliferation in EVs and Cx43 shRNAs. However there were no significant 
differences in the fold changes between BCM incubated EV or Cx43 shRNA 
cells (figure 4.14.A). Knockdown of Cx43 expression did not alter the cell’s 
proliferative response to incubation with 100% BCM. The percentage of PI 
positive cells was also compared for all four groups (figure 4.14.B). This was 
low in both controls and cells incubated with 100% BCM, with less than 1.5% of 
cells PI positive. Statistical analysis showed that there were no significant 
differences in the PI uptake of control EVs and Cx43 shRNA cells compared to 
the 100% BCM incubated counterparts.  
 
4.3.7. The effect of incubation with 100% BCM on migration is 
independent of Cx43 expression 
It was investigated whether the effect of incubation with 100% BCM on 
migration would differ in Cx43 shRNA cells. Scratch wound experiments were 
performed on EV and Cx43 shRNA fibroblasts, and the distance migrated by 
the leading edge was measured. All experiments were performed both with and 
without the proliferation blocker mitomycin C. As a control, it was first 
investigated whether treating cells with mitomycin C had an impact on the 
distance migrated by the cells (figure 4.15), by statistically comparing the 
distance migrated by the treated and untreated cells in each experimental 
condition. Blocking proliferation with mitomycin C had no significant impact on 
the distance migrated by control or 100% BCM incubated EV or Cx43 shRNA 
fibroblasts at 4 hours (figure 4.15.A and C).  
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Figure 4.14. Incubation with biofilm conditioned medium (BCM) reduces proliferation in a 
Cx43 independent manner. (A) The fold change in cell number over 24 hours is shown for EV 
and Cx43 shRNA fibroblast controls and cells incubated with 100% BCM. A mixed design 
ANOVA comparing the fold change for all groups revealed significant differences (p<0.001). A 
Tukey’s post hoc revealed that treating cells with 100% BCM significantly reduced fold change 
in cell number in both EV and Cx43 shRNA cells. (B) The number of propidium iodide positive 
cells, as a percentage of the whole population over 24 hours is shown for EVs and Cx43 shRNA 
fibroblast controls and cells incubated with 100% BCM. A mixed design ANOVA was performed 
comparing all groups which showed that there were significant differences. However Levene’s 
Test of Equality of Error Variances showed there were considerable differences in variances, 
and a Games Howell post hoc was conducted which revealed that treating cells with 100% BCM 
had no significant effects on the percentage of propidium iodide positive cells. N=3. All error 
bars are SEM. **p<0.01, ***p<0.001. 
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Interestingly though, at 12 hours there was a significant increase in the distance 
migrated by mitomycin C perturbed control EV and Cx43 shRNA cells 
compared to untreated controls (figure 4.15.B). The reason for this is unclear 
but suggests incubation with mitomycin C may have unexpected off target 
effects on migration in these cells. However an increase in migration when 
treated with mitomycin C was also apparent in the 100% BCM incubated EV 
and Cx43 shRNA cells, as these also migrated significantly further than their 
untreated counterparts (figure 4.15.D). This means that although mitomycin C 
may be increasing the rate of migration, it is occurring independently of the 
BCM perturbation of migration. As migration of both control and BCM incubated 
cells is similarly increased, the migration of cells treated with mitomycin C can 
still be compared.  
 
Manual analysis was performed of the distance migrated by EV and Cx43 
shRNA fibroblasts at 4 and 12 hours, with and without mitomycin-C (figure 4.16). 
In agreement with previous findings (Mendoza-Naranjo, Cormie, A. Serrano, et 
al. 2012) at 4 hours the Cx43 shRNA controls migrated significantly further than 
the EV controls, both with and without mitomycin C. Cx43 shRNA cells also 
migrated significantly further at 12 hours without pre-treatment with mitomycin C. 
This demonstrates that Cx43 knockdown with shRNA increases the rate of 
migration (figure 4.16.A and C). In contrast, at 4 hours incubation with 100% 
BCM (without mitomycin-C) had no significant effect on the distance migrated 
by the cells compared to controls in either the EV or Cx43 shRNA fibroblasts 
(figure 4.16.A). However, at 12 hours, incubation with 100% BCM (without 
mitomycin-C) had significantly reduced the distance migrated compared to 
controls in cells both with and without Cx43 expression (figure 4.16.B). 
Moreover, there were no differences in the distances migrated by BCM 
incubated EV or Cx43 shRNA BCM cells. The same results were obtained at 
both time points when the experiments were repeated with the proliferation 
blocker mitomycin C (figure 4.16.C and D). As the inhibitory effect incubation 
with 100% BCM has on migration occurs both in EV and Cx43 shRNA cells, the 
effect incubation with 100% BCM has on migration is independent of Cx43 
expression. 
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Figure 4.15. A comparison of the distance migrated by empty vector (EV) and Cx43 
shRNA control and 100% biofilm conditioned medium (BCM) incubated fibroblasts, both 
with and without the proliferation blocker mitomycin C. Graphs illustrating the distance 
migrated at (A and C) 4 and (B and D) 12 hours by EV and Cx43 shRNA (A and B) controls 
and (C and D) cells incubated with 100% BCM. The indicated cells were treated with 10 µg ml-1 
mitomycin-C for 2 hours prior to scratching to prevent proliferation. Independent Student’s t 
tests showed that mitomycin-C had no significant effect at 4 hours, but at 12 hours it had 
stimulated migration in all groups. N=3. All error bars are SEM. ns = not significant, **p<0.01, 
***p<0.001. 
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Figure 4.16. Incubation with 100% biofilm conditioned medium (BCM) impairs migration 
independently of Cx43 expression. Graphs illustrating the distance migrated at 4 (A) or 12 
(B) hours by EV and Cx43 shRNA controls and cells incubated with 100% BCM. Graphs are 
also shown of migration over 4 (C) or 12 (D) hours when the cells were treated with 10 µg ml-1 
mitomycin C for 2 hours prior to scratching to prevent proliferation. Independent Student’ t-tests 
showed no significant differences at 4 hours with or without mitomycin C treatment. They did 
show significant differences at 12 hours where, both with and without mitomycin C, EV and 
Cx43 shRNA controls had migrated significantly further than their 100% BCM incubated 
counterparts. (C and D). Student’s t tests also showed that Cx43 shRNA control cells at 4 hours 
migrated significantly further than EV controls. N=3. All error bars are SEM. *p<0.05, **p<0.01, 
***p<0.001. 
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4.4. Discussion 
S.aureus is a pathogenic species of bacteria commonly found in wounds 
(Davies et al. 2004; Gjødsbøl & Christensen 2006) where the bacteria primarily 
exist within a biofilm (James et al. 2007). Biofilm S.aureus secrete a plethora of 
virulence factors, which differ when found in the planktonic and biofilm states 
(Resch & Rosenstein 2005; Secor et al. 2011). Cx43 expression is abnormal in 
chronic wounds (Brandner et al. 2004; Mendoza-Naranjo, Cormie, A. Serrano, 
et al. 2012; Mendoza-Naranjo, Cormie, A. E. Serrano, et al. 2012) and 
interestingly, studies have found that S.aureus derived peptidoglycan (PGN), a 
component of the cell wall, can alter Cx43 expression in astrocytes, microglia, 
keratinocytes and endothelial cells (Garg et al. 2005; Esen et al. 2001; Donnelly 
et al. 2012). However, no previous studies have characterised the effect of 
S.aureus biofilm exotoxins on Cx43 expression, which has been done here. The 
hypothesis investigated in this chapter was that one mechanism through which 
S.aureus exotoxins impair healing is by contributing to the abnormal Cx43 
expression seen in dermal chronic wounds.  
 
Initially, the effect BCM had on fibroblasts was characterised. Live imaging of PI 
uptake showed that S.aureus (ATCC® 29213™) BCM was not toxic to 3T3 
fibroblasts. It was unexpected that BCM didn’t increase PI uptake, as infection 
with live bacteria of this strain of S.aureus was previously found to be cytotoxic 
to fibroblasts (Krut et al. 2003). It is possible that the products secreted by the 
bacteria in the biofilm form are less toxic than those secreted when planktonic. 
However, a number of experiments from different groups, using various strains 
of S.aureus, have suggested that the bacteria’s ability to induce apoptosis, but 
not necrosis, is dependent on internalisation into the host cell (Mempel et al. 
2002; Krut et al. 2003; Haslinger-Löffler et al. 2005; Kubica et al. 2008). 
Nevertheless, Kirker et al found that BCM from a methicillin resistant S.aureus 
(MRSA) strain was toxic to fibroblasts, though they did not investigate whether 
the cells underwent apoptosis or necrosis (Kirker & James 2012). Nonetheless, 
differences in the toxicity of the two BCMs suggests that the virulence factors 
secreted by the two strains differ.  
 
BCM incubation caused significant reduction in cell number compared to 
untreated controls, by impairing proliferation. Planktonic condition medium from 
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several strains of S.aureus has previously been reported to reduce proliferation 
in MAC-T cells (Zavizion et al. 1995). A few S.aureus secreted toxins have also 
been found to inhibit cell proliferation. Enterotoxin B, inhibited proliferation of 
nasal fibroblasts (Pérez-Novo et al. 2008), and the S component of Panton-
Valentine leukocidin (LukS-PV), was reported to induce G0/G1 cell cycle arrest, 
although exposure was found to ultimately result in apoptosis (Bu et al. 2013). 
From these data it is not possible to determine at what phase of the cell cycle 
cells became arrested at, or whether LukS-PV or enterotoxin B were some of 
the secreted factors in the BCM. It is possible that these, or another as yet 
unknown secreted products, are responsible for the prevention of proliferation.  
 
As BCM incubation reduced cell proliferation, it was investigated whether BCM 
induced premature senescence in fibroblasts. Cellular senescence is the state 
of irreversible cell cycle arrest in viable and metabolically active cells 
(Georgakopoulou et al. 2013). There is no single marker that can be used to 
confirm senescence, and instead a combination of several markers are required 
for verification (Kuilman et al. 2010). After 7 days incubation with BCM the 
fibroblasts displayed increased nuclear size, increased SA-β-gal activity and 
increased lipofuscin related autofluorescence, all markers of senescence 
(Kuilman et al. 2010; Zglinicki et al. 1995). This suggests that it is highly likely 
that incubation with BCM induced premature senescence, although it would be 
beneficial to ensure that returning the fibroblasts to normal culture conditions 
would not restore proliferation, which would confirm unequivocally that 
proliferative potential has been lost (Blagosklonny 2011). Unlike replicative 
senescence, premature senescence is not a result of telomere shortening, but a 
result of exposure to stresses. These stresses include loss of a tumour 
suppressor (Chen et al. 2005), activation of an oncogene (Serrano et al. 1997), 
oxidative stress (Liu et al. 2014), and impairment of autophagy (Kang et al. 
2011). Evidence for the mechanism of BCM induced senescence could be 
gained through observing additional senescence markers, including detection of 
reactive oxygen species (ROS), the cell cycle markers p53 or p16INK4A-RB, and 
DNA damage markers like γ-H2AX (Kuilman et al. 2010). 
 
The induction of senescence in fibroblasts incubated with BCM is of particular 
interest because senescent fibroblasts have been reported in chronic wounds 
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(M. V Mendez et al. 1998; Ågren & Steenfos 1999; A. C. Stanley et al. 1997; 
Vande Berg et al. 1998; Wall et al. 2008). Fibroblasts isolated from venous leg 
ulcers showed increased characteristics of senescence compared to fibroblasts 
from the contralateral leg (M. V Mendez et al. 1998); it was further noted that 
this was more prominent in older chronic wounds, of 3 years or more, compared 
to younger wounds (Ågren & Steenfos 1999). Similar results were observed in 
fibroblasts isolated from pressure ulcers, where 60-70% of fibroblasts stained 
positive for terminin, another marker for senescence (Vande Berg et al. 1998). 
Wall et al showed that fibroblasts in venous leg ulcers became senescent 
independent of telomere length, providing evidence that senescence in chronic 
wound fibroblasts is not early onset of replicate senescence as previously 
thought, but premature stress induced senescence (Wall et al. 2008). Moreover, 
senescent fibroblasts have been observed in vivo in clusters in the wound beds 
by staining for terminin; of interest, the authors also observed a correlation 
between the extent of bacterial infection and the lack of proliferative potential of 
chronic wound fibroblasts (Vande Berg et al. 1998). However, premature 
senescence has not previously been reported in cells in direct response to 
S.aureus, although interestingly, it has been observed following challenge with 
toxins from two other bacterial species. Escherichia coli colibactin toxin induced 
senescence in both human lung fibroblasts and rat intestinal epithelial cells, and 
Pseudomonas aeruginosa pyocyanin toxin induced senescence in human 
epithelial like cells (Muller 2006; Secher et al. 2013). Both species, like 
S.aureus, are commonly found in chronic wounds (Davies et al. 2004; Gjødsbøl 
& Christensen 2006).   
 
When observing lipofuscin autofluorescence and SA-β-gal activity, it was 
evident that there was variation in the extent of each marker between cells. The 
variation may reflect real variety in the population’s sensitivity to BCM. This is 
potentially the case, as it is normal for some cells within a population to not 
express stress induced senescent markers when exposed to a stress stimuli 
(Kang et al. 2011; Chen et al. 2005). Similarly, variations in senescence were 
observed in vivo in pressure ulcer chronic wounds (Vande Berg et al. 1998). 
Alternatively, 7 days incubation with BCM may not be a sufficient period of time 
for all the cells to fully develop the markers used to access senescence. In 
some studies considerably longer time periods (up to 21 days) have been used 
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when inducing senescence, although shorter periods (3-4 days) have also been 
reported (Kang et al. 2011; Chen et al. 2005; Liu et al. 2014). Observation after 
incubating cells with BCM for 14 or more days may clarify which is the case.  
 
As well as impairing proliferation and inducing senescence, incubation of 
fibroblasts with BCM impaired migration. Significant differences in the distances 
migrated were observed at 12 hours. This is close to the time point of 11 hours 
where proliferation was first significantly reduced by incubation with BCM. 
However, blocking proliferation with mitomycin C showed that the difference 
was a result of reduced migration, and not an artefact of reduced proliferation. 
Impaired scratch wound closure was similarly shown for human keratinocytes 
and fibroblasts incubated with BCM from a MRSA strain (Kirker et al. 2009; 
Kirker & James 2012). However, in both studies the BCM also significantly 
reduced cell viability, which would clearly have impacted the ability of the cells 
to close the wound. Of note, impaired migration has also been reported in 
fibroblasts isolated from chronic wounds (Brem et al. 2007). These fibroblasts 
exhibited an abnormal morphology, and are described as ‘misshaped’ with 
enlarged nuclei. Interestingly, the MRSA BCM also caused morphological 
changes in human keratinocytes, though those changes were not reported in 
fibroblasts, and did not occur when the keratinocytes were incubated with PCM 
(Kirker et al. 2009). The authors describe the formation of dendrite like 
extensions and abnormal nuclear morphology, both of which were apparent in 
the 3T3 fibroblasts incubated with BCM. In contrast though, Kirker et al 
observed changes in keratinocytes when simply cultured with MRSA BCM, but 
morphological changes in 3T3 fibroblasts were only apparent when scratched, 
and then only at the scratch wound edge. Interestingly, the fibroblast 
morphology closely resembled that of RhoA or ROCK1 depleted cells (Vega et 
al. 2011). RhoA is a member of the Rho family of GTPases that regulate 
cytoskeletal dynamics, and the authors describe RhoA depleted cells as 
elongated with narrow protrusions and defective migration. A similar phenotype 
was observed when RhoA was depleted in several different cell types, showing 
that this isn’t specific to one cell type. Depletion of ROCK1, a Rho regulated 
kinase, also produced a similar cell morphology, as well as defective tail 
retraction during migration. These features closely mimic those seen in the 
migrating fibroblasts incubated with BCM. Furthermore, S.aureus can secrete 
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epidermal cell differentiation inhibitor (EDIN), a C3-like ADP-ribosyltransferase, 
which very selectively inactivates Rho(A/B/C/E); this has been shown to inhibit 
migration in endothelial cells and macrophages by abolishing the formation of 
actin stress fibres (Aepfelbacher et al. 1997; Rotsch et al. 2012). It too causes 
an elongated morphology in 3T3 fibroblasts (Rotsch et al. 2012), and it would 
be interesting to determine whether EDIN is present in BCM. It would also be 
worth investigating if actin dynamics, and RhoA and ROCK1 expression, were 
abnormal in migrating BCM incubated fibroblasts, to determine if this is the 
mechanism for BCM impaired migration.  
 
Interestingly, incubation with BCM reduced the expression of α-tubulin, as 
observed by western blot, within 24 hours. Both α- and β-tubulin are 
components of microtubules, which are vital for polarised cell migration 
(Etienne-Manneville 2013). The microtubule cytoskeleton is controlled by 
RhoGTPases, in a bidirectional relationship. It will therefore be interesting to 
determine if the microtubule dynamics and microtubule organising centre 
(MTOC) are perturbed in the migrating scratched wounded fibroblasts that were 
incubated with BCM.  
 
To investigate the hypothesis that S.aureus exotoxins impair healing through 
inducing abnormal Cx43 expression, it was first determined whether Cx43 
expression is influenced by incubation with BCM. Incubation with S.aureus 
BCM was found to have no effect on Cx43 protein expression within 9.5 hours, 
and no changes were observed in the levels of each differentially 
phosphorylated protein band. However, after incubation with BCM for 7 days 
distinct changes in Cx43 were apparent, with a significant reduction in the Cx43 
and Cx43-P1 bands. Each protein band represents Cx43 with different states of 
phosphorylation, which are thought to signify separate conformational states 
that are associated with particular cellular locations; both the Cx43-P1 and 
Cx43-P2 bands were reported to preferentially be found at the plasma 
membrane, with Cx43-P2 solely in gap junctions (Lampe et al. 2006; Solan et al. 
2007). The reduction in the Cx43-P1 band in the western blot was reflected in 
the immunofluorescent images; Cx43 no longer appeared to be primarily at the 
plasma membrane, but diffusely through the cytoplasm. The reduction in Cx43 
expression may be a direct influence of prolonged incubation with BCM. 
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Alternatively, there is growing evidence that Cx43 expression is reduced in 
senescent cells of multiple origins, including fibroblasts (Statuto et al. 2002; 
Stein et al. 2008; Zhao et al. 2004), and loss of Cx43 protein expression has 
even been suggested as a marker for senescence (Statuto et al. 2002). 
Immunofluorescent images showing loss of Cx43 expression in human 
fibroblasts with both replicative and premature senescence mimics the loss 
Cx43 expression seen after BCM incubation, with the remaining Cx43 present 
diffusely in the cytoplasm (Statuto et al. 2002; Zhao et al. 2004).  It has also 
been shown that Cx43 can mediate the induction of senescence (Zhang et al. 
2006; Taniguchi Ishikawa et al. 2012). In glomerular mesangial cells (GMCs) an 
increase in SA-β-gal positive cells was observed when exposed to the 
senescence inducing stress of high glucose levels; this was abrogated by 
overexpression of Cx43 (Zhang et al. 2006). Similar results were found using 
Cx43 deficient hematopoietic stem cells (Taniguchi Ishikawa et al. 2012).  
 
Cx43 can influence a number of cellular responses, including proliferation, 
viability and migration (Matsuuchi & Naus 2013; Vinken, Decrock, Vanhaecke, 
et al. 2012), all of which are altered by incubation with BCM. It was investigated 
whether the effect BCM has on these processes was mediated by Cx43 
expression using Cx43 shRNA cells. In agreement with previous findings control 
Cx43 shRNA fibroblasts migrated further than control EVs (Mendoza-Naranjo, 
Cormie, A. Serrano, et al. 2012; Pollok et al. 2011; Wright et al. 2012). However, 
when incubated with BCM, Cx43 expression did not appear to influence the cell 
viability, proliferation or migration of fibroblasts. Thus it was concluded that 
mechanisms behind the effects of BCM on fibroblasts were independent of 
Cx43.  
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Chapter 5. Cx43 Involvement in 
Staphylococcus aureus 
Internalisation and Virulence in 
Fibroblasts  
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5.1. Introduction 
Fibroblasts are the most abundant cell type in the dermis. They are important 
during wound healing, as they must proliferate and migrate into the wound bed 
in order to lay down new extracellular matrix (Shaw & Martin 2009). Fibroblasts 
express the gap junction protein, Connexin43 (Cx43) (Guo et al. 1992). 
Changes in the expression of this protein play an important role during 
cutaneous wound healing (Mendoza-Naranjo, Cormie, A. Serrano, et al. 2012; 
Pollok et al. 2011). Cx43 expression in the dermis is reduced at the wound edge 
following injury, and further reducing it using Cx43 antisense has been shown to 
result in faster maturation of granulation tissue and improved healing (Mendoza-
Naranjo, Cormie, A. Serrano, et al. 2012; Mori et al. 2008). In chronic wounds, 
wounds that remain open for 3 months or longer, Cx43 expression dynamics 
are abnormal, as they remain elevated at the dermal wound edge (Brandner et 
al. 2004; Mendoza-Naranjo, Cormie, A. Serrano, et al. 2012; Mendoza-Naranjo, 
Cormie, A. E. Serrano, et al. 2012). This is thought to contribute to the impaired 
healing of these wounds, but the reason for the high Cx43 expression is as yet 
unidentified.   
 
Staphylococcus aureus is a bacterial pathogen. It frequently colonises skin as a 
commensal, but it is primarily pathogenic. As such it is one of the species most 
commonly isolated from skin wounds, particularly chronic wounds where it was 
detected in 89-95% of venous leg ulcers (Davies et al. 2004; Gjødsbøl & 
Christensen 2006).  
 
There are now several studies showing that different bacterial species and their 
components can alter connexin expression and gap junction intercellular 
communication (GJIC) in a variety of mammalian cell types (Ceelen et al. 2011). 
This occurs either directly or by inducing cytokine production, which then 
influences connexin expression (Esen et al. 2007; Robertson et al. 2010). How 
connexin expression and GJIC is altered is dependent on both the bacterial 
species and the origin of the host cell. S.aureus derived peptidoglycan (10 µg 
ml-1), a major component of the bacterial cell wall, increased Cx43 mRNA and 
protein expression and gap junction intercellular communication (GJIC) in 
human endothelial cells, but had no influence on human keratinocyte HaCaT 
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Cx43 expression (Donnelly et al. 2012). PGN (10 µg ml-1) was also reported to 
increase Cx43 expression in mouse microglia, but decrease expression and 
GJIC in mouse astrocytes (Esen et al. 2007; Garg et al. 2005). Heat killed 
S.aureus similarly decreased Cx43 expression and GJIC in mouse astrocytes 
(Esen et al. 2007).  
 
S.aureus is an opportunistic intracellular pathogen, and is able to invade cells, 
including fibroblasts (Sinha et al. 1999). Heat killed S.aureus are also 
internalised into cells (Kahl et al. 2000). S.aureus binds fibronectin and uses it 
as bridge to host expressed integrin α5β1. The bound S.aureus is then actively 
endocytosed by the cell (Sinha & Fraunholz 2010). The fate of internalised 
S.aureus is largely dependent on the bacterial strain (Krut et al. 2003). Some 
strains exert little effect and are destroyed by the host cells. Other strains can 
persist within the cell and influence cellular function, such as by reducing 
proliferation (Alekseeva et al. 2013). Alternatively, some strains are cytotoxic 
and induce apoptosis or necrosis of the host cells (Krut et al. 2003). In fact 
invasion is increasingly thought to be a necessity for S.aureus to induce 
apoptosis, but not necrosis (Sinha & Fraunholz 2010), and there is mounting 
evidence that cell invasion is a key part of S.aureus virulence and pathogenesis 
in a physiological setting (Colombo et al. 2013; Hamza et al. 2013; Edwards et 
al. 2010). Interestingly, connexins are reportedly involved in the internalisation 
of several bacterial species, including Yersinia enterocolitica and Shigella 
flexneri (Tran Van Nhieu et al. 2003; L. Velasquez Almonacid et al. 2009; Man 
et al. 2007). However, it is not currently known how infection with S.aureus 
influences Cx43 expression in fibroblasts, and whether Cx43 in turn influences 
S.aureus invasion.   
 
It was hypothesised that Cx43 expression may regulate the internalisation of 
S.aureus into fibroblasts, and subsequently the response the cells have to the 
infection. Furthermore, it was hypothesised that S.aureus, or its surface proteins, 
in turn might influence Cx43 expression in fibroblasts, and be contributing to the 
abnormal dermal Cx43 expression seen in chronic wounds.  
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5.2. Materials and methods 
See Chapter 2 for general materials and methods. Only the materials and 
methods specific to this section of work are described here.  
 
5.2.1. Bacterial cytotoxicity assay 
This protocol was adapted from others previously published (Krut et al. 2003; 
Mempel et al. 2002). Briefly, cells were grown in 6 well plates. They were 
washed to remove all antibiotics, and media replaced with DMEM 
supplemented with 10% DBS. S.aureus or HKSA were added per well. For 
groups testing the cytotoxicity of internalised bacteria a multiplicity of infection 
(MOI) of 500 was used: for groups where cells were incubated with the bacteria 
over night a MOI of 70 was used. A non-infected control group was always 
included. Cells were incubated at 37 °C and 5% CO2. For groups testing the 
cytotoxicity of internalised bacteria the cells were washed after 90 minutes, and 
media supplemented with 200 ug ml-1 gentamicin sulphate added. Cells were 
incubated overnight, after which they were washed, trypsinised and re-
suspended in media. All washes and media were kept and pooled with the re-
suspended cells. An aliquot was diluted 1:2 with trypan blue solution (Sigma) 
and incubated for 5 minutes. An aliquot was introduced into a haemocytometer 
and the percentage of non-viable cells determined.  
 
5.2.2. Bacterial internalisation assay 
This protocol was adapted from others previously published, using a 
comparable MOI and incubation periods (Krut et al. 2003; Agerer et al. 2003; 
Agerer et al. 2005). Briefly, cells were grown on sterile glass coverslips. All 
washes were performed by dipping the coverslips in sterile PBS. DMEM 
supplemented with 10% DBS was added to cells and approximately 3.5 x105 
CFU of S.aureus were added per well, resulting in an average MOI of 11. Cells 
were incubated with the bacteria at 37 °C and 5% CO2 for 90 minutes to allow 
internalisation of the bacteria. The media was then removed and replaced with 
media containing 200 ug ml-1 gentamicin sulphate, which kills all extracellular 
bacteria but has no effect on internalised bacteria. This was left on the cells for 
60 minutes. As a negative control, after the 60 minutes media was plated on LB 
agar and incubated overnight, to ensure all extracellular bacteria had been 
Chapter 5 
	   144	  
killed. If any colonies grew from the lysate in this well the experiment was 
excluded.  
 
After killing extracellular bacteria, cells were dip washed in sterile PBS before 
lysing in 0.5% Triton X-100 in PBS. Solutions of lysed cells were serial diluted 
and plated on LB agar. Plates were incubated at 37 °C overnight and colonies 
counted the following day. To ensure all colonies were from the S.aureus added 
during the experiment, a non-infected negative control was included. If any 
colonies grew from the negative control lysate then the experiment was 
discarded.  
 
5.2.3. Bacterial infection cell counts 
The total number of cells present in 8 mm2 was counted using a 
haemocytometer. Total cell counts included both viable and non-viable cells (as 
determined by trypan blue exclusion). Cell counts were conducted on EV and 
Cx43 shRNA cells after 24 hours under the following conditions: uninfected cells, 
cells infected with HKSA (MOI of 70), cells infected with live S.aureus (MOI of 
70), or cells incubated with internalised live S.aureus (MOI of 500 for 90 
minutes-protocol described in more detail in 5.2.4). Cell counts were presented 
as a ratio of the largest count within the cell type in each experimental replicate.  
 
5.2.4. Quantitative PCR 
RNA extraction 
Cells were grown in 6 well plates to 90-100% confluence before commencing 
experiments. They were incubated with S.aureus at a MOI of 5 for 24 hours. 
Following the incubation period, RNA was extracted using the RNeasy® mini kit 
(Qiagen) following the manufacturer’s instructions. An on column DNA digestion 
was performed using the RNase-free DNase set (Qiagen), and the purified RNA 
re-suspended in 30 µl of RNase-free water (Qiagen). RNA was quantified using 
a NanoDrop® ND-1000 (NanoDrop Technologies). The A260/280 and 
A260/230 were determined and samples falling below a value of 2.0 were 
excluded. Samples were frozen at -80 °C until further use.  
 
 
Chapter 5 
	   145	  
cDNA synthesis 
RNA was reverse transcribed to cDNA using a TC-5000 thermal cycler 
(Techne) and the thermal cycling conditions in table 5.1. A master mix was 
made containing random primers (Invitrogen), Oligo dT15 (Promega), dNTP 
(Invitrogen), 5 X first strand buffer (Invitrogen), DTT (Invitrogen), RNase OUT™ 
ribonuclease inhibitor (Invitrogen) and Superscript® II Reverse Transcriptase 
(Invitrogen). 10 µl of master mix was added to 10 µl of RNase-free water 
(Qiagen) containing 2 µg of RNA. A no enzyme control was also included which 
did not contain reverse transcriptase.  
 
Table 5.1. Thermal cycling conditions for cDNA synthesis. 
Temperature (°C) Duration (minutes) 
65 5 
25 10 
42 60 
70 15 
4 hold 
 
 
qPCR and primer efficiency 
A master mix was made containing SYBR green™ JumpStart Taq Ready mix 
(Sigma-Aldrich), and 400 nM each of forward and reverse primers (see table 5.2. 
for primer information). Primers design was taken from (Mylvaganam et al. 
2009). The optimal concentration of primers was determined by comparing 
cycle threshold (Ct) values from qPCR reactions using different combinations of 
forward and reverse primer concentrations. Efficiency of the primers was 
determined by creating four serial dilutions of cDNA, and performing qPCR as 
described below. The data was used to plot a standard curve and the following 
equation used: 
 
Efficiency % = (10(-1/slope)-1)*100 
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Table 5.2. Connexin43 primer information 
 Cx43 Forward Primer (5’) Cx43 Reverse Primer (3’) 
Primer 
sequence 
TCATGCTGGTGGTGTCCT
TG 
CCCTTCACGCGATCCTTAA
C 
Melting 
temperature 67 °C 65 °C 
GC content 55% 55% 
Optimal 
Concentration 400 nM 400 nM 
Efficiency 105% 
 
5 µl of cDNA previously diluted 1:10 was added to 20 µl of master mix in a 96 
well Hard Shell PCR plate (Bio-Rad). All samples were assayed in triplicate. A 
no template control (containing water instead of cDNA) and a no enzyme 
control (containing reverse transcription product from the cDNA no enzyme 
control) were run for each primer set to ensure there was no contamination or 
genomic amplification respectively. The data was not used if any amplification 
occurred in these wells. The plate was sealed with PCR Microseal® ‘B’ film 
(Bio-Rad) and run on a CFX Connect™ Real-Time 96 well PCR Detection 
System (Bio-Rad). See table 5.3. for thermal cycling conditions. A melt curve 
was performed at the end of each PCR to ensure that only a single product was 
present in each well.  
 
Table 5.3. qPCR thermal cycling conditions.  
Temperature (°C) Duration Cycles 
94 2 minutes  
94 15 seconds  
60 30 seconds X 49 
72 30 seconds  
60-90 Melt curve  
 
Selecting a reference gene 
A geNorm reference gene selection kit (PrimerDesign Ltd) was used to select a 
normalisation gene that was stable between control and S.aureus infected 
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samples. Five genes were tested for stability: 18S, GAPDH, EIF4A2, ACTB and 
SDHA. The manufacturer’s instructions were followed and the stability of the 
genes between the groups determined using the geNorm analysis software, 
qbasePLUS (PrimerDesign Ltd). The most stable gene as determined by the 
software, 18S, was used as a reference gene. PrimerDesign supplied all 
primers.  
 
Analysis of qPCR results 
Each sample was run in triplicate, and any outliers removed. Cycle thresholds 
(Cts) for each sample were averaged. The 2- Δ ΔCT method was used to analyse 
results, using 18S as a reference gene.  
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5.3. Results 
5.3.1. Selecting optimal concentrations of live and heat killed 
S.aureus 
S.aureus can be commensal, co-existing apparently harmlessly with 
mammalian cells. However many strains are cytotoxic, including the ATCC® 
29213™ strain investigated here (Krut et al. 2003). Infection of 3T3 fibroblasts 
with ATCC® 29213™ S.aureus results in considerable cell death. In order to 
investigate the effect S.aureus infection has on Cx43 expression, a sublethal 
concentration of bacteria had to be determined. This was vital as Cx43 
expression is influenced by cell confluence: cells at low cell density express less 
Cx43 than cells at high cell density. Substantial loss of viability in infected cells 
would reduce cell density, and thus could potentially reduce Cx43 expression, 
irrespective of any affect the bacterium may have.   
 
To determine a sublethal concentration of S.aureus infection, 3T3 fibroblasts 
were incubated with a range of S.aureus inoculums. The nuclei of live 
fibroblasts were visualised by staining with Hoechst and then imaged hourly 
over a 24 hour incubation. Cell viability was assessed throughout the 
experiment by the addition of propidium iodide (PI) to the media. PI enters cells 
that have lost membrane integrity but is excluded by viable cells, and so it is 
frequently used to assess cell viability (Johnson et al. 2013). By imaging both 
Hoechst (total number of cells per image) and PI labelled cells (non-viable cells), 
any changes in the percentage of PI positive cells over the 24 hour incubation 
period could be determined. Additionally Hoechst labelling enabled the rate of 
cell proliferation to be assessed by comparing the total number of cells at each 
time point. This is an important control, as if infection reduced the proliferation 
of the fibroblasts there would also be an impact on cell density over time, and 
consequently on Cx43 expression. Differences were assessed using a mixed 
design ANOVA. This analysis determines the influence of both infection 
concentration and time on the dependent variable (fold change in cell number, 
or the percentage of PI positive cells). A Tukey’s post hoc analysis was then 
used to compare the overall data from the time course for statistical differences, 
but not individual time points, as it was important to determine the overall 
influence of infection over the 24 hour time course. The highest concentration of 
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live S.aureus tested, 5.5 x105 CFU ml-1, caused a significant increase in PI 
positive cells (figure 5.1.A). While lower concentrations caused a trend showing 
a marginal increase, this did not differ significantly from controls. While PI is 
normally used to assess viability, it has been reported that in circumstances 
where cells are stressed it can enter them through open hemichannels (Kondo 
et al. 2000). Bacterial infection could induce hemichannel opening, resulting in 
cells being incorrectly labelled as non-viable. However, as the lower 
concentrations of S.aureus do not significantly alter PI uptake compared to 
controls, mislabelled viable cells will have no significant impact on cell density. 
Proliferation, as assessed by determining the fold change in cell number, also 
didn’t differ significantly between controls and infected samples (figure 5.1.B). 
As a concentration of 2 x105 CFU ml-1 of S.aureus didn’t cause a significant loss 
of viability or decrease in proliferation rate it was determined that this 
concentration was sublethal over 24 hours. This concentration is equivalent to a 
multiplicity of infection (MOI) of 5, meaning that there were 5 bacteria per cell at 
the onset of infection. Therefore this concentration was used in all further 
experiments where a sublethal infection was required.   
 
Heat killing S.aureus maintains many of the surface antigens intact, and 
infection of mouse astrocytes with heat killed S.aureus (HKSA) reduced Cx43 
expression in astrocytes (Esen et al. 2007). As Cx43 expression is influenced 
by cell confluence, in order to investigate if ATCC® 29213™ HKSA alters Cx43 
in 3T3 fibroblasts it was therefore necessary to first determine whether infection 
with HKSA altered cell density over a 24 hour incubation period, by looking at 
viability and proliferation. Fibroblasts were infected with increasing 
concentrations of HKSA and the proliferation rate investigated by live imaging 
Hoechst labelled nuclei and determining the fold change in total cell number. PI 
was included in the media, and the changing percentage of cells that took up PI 
was quantified in order to assess viability. None of the concentrations of HKSA 
tested had a significant effect on the percentage of cells that took up PI (figure 
5.2.A). The fold change in cell number (figure 5.2.B) was similarly unaffected by 
HKSA infection, thus infection with HKSA had no impact on cell density. In 
further experiments a maximum HKSA concentrations of 1.2 x107 CFU ml-1 (an 
MOI of 400, and the highest concentration tested) was used.  
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Figure 5.1. Determining a concentration of live S.aureus that does not cause significant 
loss of cell viability. (A) The number of propidium iodide positive cells, as a percentage of the 
population over 24 hours is shown for control 3T3 fibroblasts, and for fibroblasts incubated with 
increasing concentrations of S.aureus. A mixed design ANOVA showed there was a significant 
differences between the groups and a Tukey’s post hoc revealed that only the highest 
concentration of 5.5 x 105 CFU ml-1 caused a significant increase in the percentage of propidium 
iodide positive cells (p<0.05). (B) The fold change in cell number over 24 hours is shown for 
cells incubated with the same concentrations of S.aureus as (A). A mixed design ANOVA 
showed that there were no significant differences in proliferation between the groups. N=3. All 
error bars are SEM. *p<0.05. 
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Figure 5.2. Determining a concentration of heat killed S.aureus (HKSA) that doesn’t 
cause significant loss of cell viability. (A) The number of propidium iodide positive cells, as a 
percentage of the population over 24 hours is shown for control 3T3 fibroblasts, and for 
fibroblasts incubated with increasing concentrations of HKSA. (B) The fold change in cell 
number over 24 hours is shown for cells incubated with the same concentrations of HKSA as 
(A). Mixed design ANOVAs were used to compare the groups, and showed no significant 
differences in cell death or proliferation between controls and HKSA infected cells. N=3. All error 
bars are SEM.  
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5.3.2. Knockdown of Cx43 reduces the viability of fibroblasts 
when infected with live S.aureus 
Infection of fibroblasts with live ATCC® 29213™ S.aureus is cytotoxic to 3T3 
fibroblasts, and S.aureus can induce cell death through apoptotic mechanisms 
(Fraunholz & Sinha 2012). Importantly, Cx43 can regulate the induction of 
apoptosis. This is through both GJIC and non-junctional mechanisms, and can 
be through either pro- or anti-apoptotic, depending on the circumstances 
(Vinken, Decrock, Leybaert, et al. 2012). Furthermore, a reduction in Cx43 
expression was recently reported to protect epithelial cells from apoptosis 
induced by the Helicobacter pylori VacA toxin (Radin et al. 2014). Therefore, it 
was investigated whether Cx43 expression influenced the viability of fibroblasts 
when infected with S.aureus. The live imaging technique described above, 
using Hoechst labelled nuclei and media containing PI, was again used as it 
enabled simultaneous analysis of both proliferation and viability. 3T3 empty 
vector controls (EVs: mixed design ANOVAs confirmed that there were no 
statistical differences between EVs and non-transfected 3T3s in any of the 
assays performed-data not shown) and fibroblasts with Cx43 constitutively 
knocked down (Cx43 shRNAs) were infected with sublethal concentrations of 
live S.aureus and imaged hourly for 24 hours. A sublethal concentration was 
used due to experimental constraints: higher concentrations caused extensive 
cell death, resulting in large numbers of dead cells detaching from the cell dish. 
Detachment of cells in infections with toxic concentrations would mean 
fallaciously low results were recorded when determining what percentage of the 
population had died. This problem did not occur with a sublethal concentration 
of S.aureus.  
 
The fold change in cell number was compared (using a mixed design ANOVA) 
between all four groups: EV uninfected controls, EV infected cells, Cx43 shRNA 
uninfected controls and Cx43 shRNA infected cells (figure 5.3). Cx43 
knockdown was previously shown to reduce the rate of fibroblast proliferation 
over 90 hours (Mendoza-Naranjo, Cormie, A. Serrano, et al. 2012). In line with 
previous evidence, uninfected Cx43 shRNA cells appeared to proliferate slower 
than EV controls, but there was no statistically significant difference over this 
time period. There were also no significant differences in the fold change   
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Figure 5.3. Knockdown of Cx43 does not alter the proliferation of fibroblasts when 
infected with a sublethal concentration of S.aureus. (A) The fold change in cell number over 
24 hours is shown for EV and Cx43 shRNA fibroblast controls and cells infected with an 
average of 1.4 x105 CFU ml-1 of S.aureus (SA) (MOI of 4). Separate graphs for (B) EVs and (C) 
Cx43 shRNAs are shown for clarity. A mixed design ANOVA comparing the fold change for all 
groups revealed no significant differences. N=3 experiments. All error bars are SEM.  
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between any of the other groups. The percentage of cells that had taken up PI 
was also compared for all four groups (figure 5.4). Infection of EV fibroblasts did 
not cause a statistically significant overall increase in the percentage of PI 
positive cells over the time course (figure 5.4.A and B). However, infection of 
Cx43 shRNA fibroblasts did cause a significant increase in the percentage of PI 
positive cells compared to controls (figure 5.4.A and C). This shows that a 
reduction in Cx43 expression reduced the viability of fibroblasts when infected 
with S.aureus.  
 
Previous analysis revealed that HKSA had no effect on viability in 3T3 
fibroblasts. The response of Cx43 shRNA cells to the challenge was also 
investigated to determine whether Cx43 expression would influence this. There 
were no significant differences in the percentage of PI positive cells between EV 
and Cx43 shRNA control or HKSA infected cells (figure 5.5.A). Similarly, there 
were no significant differences in the fold changes in cell number (figure 5.5.B). 
From this it was concluded that knockdown of Cx43 expression had no effect on 
the viability or proliferation of fibroblasts infected with HKSA.  
 
It has been reported that when cells are under stress, PI can enter a viable cell 
through connexin hemichannels (Kondo et al. 2000). It is therefore possible that 
infection with live S.aureus could be inducing hemichannel opening. However, it 
is highly unlikely that the increase in PI uptake observed in the infected Cx43 
shRNA is a result of hemichannel opening, as Cx43 expression is significantly 
reduced in these cells (figure 4.3) and there are therefore fewer hemichannels. 
Nevertheless, to be certain that the increase in PI positive cells observed in 
Cx43 shRNA cells is predominantly due to a loss of viability and not 
hemichannel opening, trypan blue exclusion was also used to assess S.aureus 
toxicity. Trypan blue is excluded by viable cells (Johnson et al. 2013), but unlike 
PI, it is not able to pass through connexin hemichannels. The percentage of EV 
and Cx43 shRNA cells that had taken up trypan blue was assessed after 24 
hours infection with S.aureus (figure 5.6). A toxic concentration was used (2.6 
x106 CFU ml-1, an MOI of 70), rather than a sublethal concentration, as very 
small differences in viability would be more difficult to accurately determine 
using this technique than the previous. Thus using a toxic concentration of 
S.aureus enabled differences between the groups to be determined with greater   
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Figure 5.4. Knockdown of Cx43 reduces the viability of 3T3 fibroblasts when incubated 
with a sublethal concentration of S.aureus. (A) The number of propidium iodide positive cells, 
as a percentage of the whole population over 24 hours, is shown for controls and EVs and Cx43 
shRNA fibroblast controls and cells infected with an average of 1.4 x105 CFU ml-1 of S.aureus 
(SA) (MOI of 4). Separate graphs for (B) EVs and (C) Cx43 shRNAs are shown for clarity. A 
mixed design ANOVA showed there was a significant differences between the groups and a 
Tukey’s post hoc was conducted which showed that S.aureus infection only caused a significant 
increase in the percentage of propidium iodide positive cells in the Cx43 knockdown fibroblasts 
(p<0.05). N=3 experiments. All error bars are SEM.*p<0.05.  
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Figure 5.5. Knockdown of Cx43 does not alter the proliferation or viability of fibroblasts 
when infected with a sublethal concentration of heat killed S.aureus (HKSA). (A) The 
number of propidium iodide positive cells, as a percentage of the whole population over 24 
hours, is shown for EV and Cx43 shRNA fibroblast controls and cells infected with an average 
of 7.5 x106 CFU ml-1 of HKSA (MOI of 170). (B) The fold change in cell number over 24 hours is 
also shown control and HKSA infected for EV and Cx43 shRNA fibroblast. Mixed design 
ANOVAs comparing all the groups revealed no significant differences. N=4 experiments. All 
error bars are SEM. 
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reliability. Pilot experiments determined that over a 24 hour period less than 
20% of infected EV cells would be killed. There were no significant differences 
in the percentage of trypan blue cells between EV and Cx43 shRNA cells, in 
either the uninfected or HKSA infected groups (figure 5.6). Infection of EVs with 
live S.aureus resulted a small but significant increase in trypan blue positive 
cells compared to both uninfected and HKSA infected EV cells (p<0.05). 
Infection of Cx43 shRNA cells with live S.aureus also caused a significant 
increase in the percentage of trypan blue cells compared to both uninfected and 
HKSA infected Cx43 shRNA cells (p<0.001). Interestingly, the increase in the 
percentage of trypan blue cells compared to uninfected cells was much greater 
in the Cx43 shRNAs than EVs; 41.9% (±2.7%) of Cx43 shRNA cells were 
trypan blue positive compared to 14.7% (±4.4%) of EV cells. The percentage of 
trypan blue positive EV and Cx43 shRNA cells were also statistically compared 
for the S.aureus infected group; there was a significantly greater percentage of 
Cx43 shRNA cells infected with live S.aureus that took up trypan blue than 
infected EV cells (figure 5.6). This shows that knockdown of Cx43 increases the 
loss of cell viability when infected with live S.aureus. These data also supports 
the conclusion drawn from the PI uptake data, which was that S.aureus 
infection was reducing cell viability and not causing hemichannel opening 
(figure 5.4). Together these data show that knockdown of Cx43 expression in 
fibroblasts increases the cytotoxicity observed in these cells when infected with 
live S.aureus.  
 
5.3.3. Knockdown of Cx43 increases the internalisation of live 
S.aureus 
Although S.aureus has traditionally been thought of as an extracellular 
pathogen, there is a growing body of evidence showing that this bacterium is 
internalised by non-phagocytic cells (Fraunholz & Sinha 2012). Bacterial 
internalisation assays were performed to test whether Cx43 expression altered 
the rate of S.aureus invasion. EV and Cx43 shRNA fibroblasts were infected 
with a high concentration of live S.aureus. They were incubated for 90 minutes 
in order for the S.aureus to internalise into the fibroblasts, then all extracellular 
bacteria were killed. Intracellular S.aureus were grown from the lysed fibroblasts, 
and the colony forming units (CFU) counted (Figure 5.7.A).   
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Figure 5.6. Knockdown of Cx43 reduces the viability of 3T3 fibroblasts when incubated 
with a toxic concentration of S.aureus. (A) Graph showing the percentage of EV or Cx43 
shRNA cells that took up trypan blue dye, and were thus not viable, after incubation with 2.6 
x106 CFU ml-1 of HKSA or S.aureus (MOI of 70) for 24 hours. Independent Student’s t-tests 
were performed on uninfected, HKSA infected or S.aureus infected groups comparing the 
percentage of EV and Cx43 shRNA trypan blue positive cells. These revealed no statistical 
differences between EV and Cx43 shRNA cells in the control or HKSA infected groups. They 
showed that infection with S.aureus caused a significant increase in trypan blue positive Cx43 
shRNA cells compared to EV cells (p<0.05). N=4. All error bars are SEM.*p<0.05. 
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The number of CFUs is equivalent to the number of bacteria internalised by the 
fibroblasts. Statistical analysis revealed that there was a significant increase in 
the CFUs grown from Cx43 shRNA cells compared to EV cells (p<0.01). These 
data demonstrate that a reduction in Cx43 expression increases S.aureus 
internalisation into 3T3 fibroblasts.  
 
Previous experiments have shown that reducing Cx43 expression significantly 
increased the loss of cell viability when fibroblasts were infected with live 
S.aureus. In order to determine if an increase in internalised S.aureus is the 
cause of the reduction in viability, trypan blue experiments were again 
conducted on EV and Cx43 shRNA fibroblasts. However, instead of maintaining 
a constant infection in the medium throughout the 24 hour incubation, S.aureus 
were allowed to invade the fibroblasts for 90 minutes then all extracellular 
bacteria were destroyed using antibiotics, the same technique used in the 
internalisation assays. A higher concentration of the bacterium was used (1.8 
x107 CFU ml-1, an MOI of 500) than in the previous trypan blue experiments in 
order to ensure that there was sufficient internalisation of bacteria over the 
incubation period to observe changes in viability. The fibroblasts were incubated 
for a further 22 hours with the internalised S.aureus before assessing viability 
(figure 5.7.B). As found previously in section 5.3.2, only a small percentage of 
uninfected and HKSA infected cells took up trypan blue, and there was no 
significant differences between EV and Cx43 shRNA cells in either condition. 
Under these conditions, internalised S.aureus also did not result in a significant 
increase in trypan blue positive EV fibroblasts compared to uninfected and 
HKSA infected EVs. A comparison between the percentage of trypan blue 
positive EV and Cx43 shRNA cells incubated with internalised S.aureus also 
showed no statistical differences between the groups, although there was an 
8.6 fold increase in the percentage of trypan blue positive Cx43 shRNA cells 
compared to EV cells. In contrast though, Cx43 shRNA cells incubated with 
internalised live S.aureus had a significantly greater percentage of trypan blue 
positive cells, compared to uninfected and HKSA infected cells. Knockdown of 
Cx43 was previously shown to increase the internalisation of S.aureus. Thus, 
these data suggest that internalisation of S.aureus may be an important factor 
influencing the viability of fibroblasts when challenged by S.aureus infection,  
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Figure 5.7. Knockdown of Cx43 expression increases the internalisation of S.aureus (SA), 
reducing viability and proliferation. (A) Graph showing the number of colony forming units 
(CFU) of S.aureus internalised by EV and Cx43 shRNA cells when inoculated with 3.8 x107 
CFU ml-1 S.aureus. An independent Student’s t-tests showed a statistical difference between 
the groups (p<0.01). (B) Graph showing the percentage of EV and Cx43 shRNA cells that took 
up trypan blue dye. Cells were incubated for 2 hours with 1.8 x107 CFU ml-1 of HKSA or SA 
(MOI of 500). External bacteria were then killed and the cells grown for a further 22 hours 
before assessing viability by trypan blue exclusion.  Statistical differences were determined 
using one-way ANOVAs and independent Student’s t tests as appropriate. (C) Graph 
demonstrating the fold in cell number when EV or Cx43 shRNA fibroblasts were infected with 
HKSA, S.aureus, or incubated with internalised S.aureus. The cell number is presented as a 
ratio of the largest cell count in each experimental replicate. Statistical differences were 
determined using one-way ANOVAs. A, N=4; B, N=4, C, N=4. All error bars are SEM. Ns=not 
significant, *p<0.05, **p<0.01, ***p<0.001. 
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and that increased internalisation of S.aureus is likely contributing to the 
reduction in cell viability when Cx43 is knocked down. 
 
Of additional interest, whilst determining viability using trypan blue exclusion it 
was observed that there appeared to be fewer cells in the live S.aureus infected 
samples. To ascertain if this was the case, a comparison was made of the total 
number of cells (viable and non-viable cells) for the following groups: uninfected, 
infected with HKSA, infected with live S.aureus, or incubated with internalised 
S.aureus (figure 5.7.C). Cell numbers were presented as a ratio, relative to the 
highest number of cells counted in each experimental replicate. One-way 
ANOVAs showed that infection with live S.aureus, but not HKSA, reduced the 
total number of cells present after 24 hours in both EV and Cx43 shRNA cells. 
As the cell count included both viable and non-viable cells, this suggested that 
as well as reducing viability, infection with S.aureus retarded proliferation. 
Furthermore, the total cell number was also significantly reduced compared to 
uninfected and HKSA infected cells when EV or Cx43 shRNA cells incubated 
only with internalised S.aureus. There was no significant difference in total cell 
number between the S.aureus infected and internalised S.aureus only infected 
cells. This indicates that internalisation of the bacteria might be playing a role in 
the effect S.aureus has on fibroblast proliferation.  
 
5.3.4. Infection with live S.aureus reduces Cx43 protein 
expression 
Fibroblasts were infected with increasing concentrations of HKSA (MOI from 15 
to 300), and total cell protein was harvested after 24 hours. As a control the 
same technique for protein extraction was used on an aliquot of HKSA, and the 
lysate run alongside cell protein. Neither the Cx43 or α-tubulin antibodies bound 
to protein in the HKSA lane, confirming that the antibodies used did not bind to 
the HKSA. Additionally, a comparison of the α-tubulin expression in each group 
validated this protein as a loading control, as its expression did not differ 
significantly between controls and HKSA infected cells (p=0.31; figure 5.8.F). 
The western blots showed that after 24 hours infection with varying 
concentrations of HKSA there was no change in total Cx43 expression 
compared to controls (figure 5.8.A and B). When analysed by SDS/PAGE Cx43  
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Figure 5.8. Infection with HKSA has no effect on Cx43 protein levels. (A) A western blot 
showing Cx43 protein expression in fibroblasts infected with increasing concentrations of HKSA 
for 24 hours (MOI ranged from 15 to 300). α-tubulin expression was used as a loading control. 
Protein extracted from HKSA using the same methods as for cells is shown as a negative 
control. (B) Graph quantifying the total Cx43 expression relative to α-tubulin expression. (C-E) 
Graphs showing the relative expression of the different bands of Cx43 seen on the western blot, 
which indicate the different phosphorylation states of Cx43. (F) Graph comparing the α-tubulin 
expression for each group. One-way ANOVAs were used to test statistical differences for 
graphs A-F. N=3. All error bars are SEM.  
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forms three distinct protein bands. The fastest migrating band is referred to as 
Cx43, and the two slower bands are commonly referred to as Cx43 P1 and 
Cx43 P2. The protein bands are known to be phosphorylated at different sites, 
and are thought to indicate conformational changes in Cx43 related to functional 
location within the cell (Solan & Lampe 2009). Densiometric analysis of the 
different bands showed that infection with HKSA also caused no detectable 
changes in phosphorylation (figure 5.8.C-E). Similar results were found when 
fibroblasts incubated with varying concentration of HKSA for 48 hours (data not 
shown). From this it was concluded that HKSA infection therefore does not 
influence Cx43 expression or phosphorylation in 3T3 fibroblasts.  
 
There are few studies investigating the effect S.aureus has on Cx43 expression 
and the majority of these use either heat killed S.aureus or S.aureus derived 
peptidoglycan (Garg et al. 2005; Esen et al. 2007; Karpuk et al. 2011). However, 
metabolically active S.aureus do not always elicit the same response from cells 
as their isolated components or inactivated counterparts (Krut et al. 2003; 
Alekseeva et al. 2013). It was therefore interesting to establish whether infection 
with live S.aureus alters Cx43 expression in fibroblasts. The cells were infected 
with a sublethal concentration of S.aureus (MOI of 5) (figure 5.2), and after 24 
hours the total protein was harvested. As with the HKSA western blots, the 
same technique for protein extraction was used on an aliquot of live S.aureus, 
and the lysate run alongside cell protein. Neither the Cx43 or α-tubulin antibody 
bound to protein in this lane either, again confirming the specificity of the 
antibodies for the murine antigen. A comparison of the α-tubulin expression in 
each group again validated this protein as a loading control, as its expression 
doesn’t differ significantly between controls and S.aureus infected cells (p=0.64; 
figure 5.9.F). Interestingly, the western blots showed a significant reduction in 
Cx43 in the S.aureus infected samples (figure 5.9.A and B). Densiometric 
analysis of the different bands was also conducted. Analysis showed that the 
reduction was in the Cx43 and Cx43 PI protein bands, but not the Cx43 P2 
band (figure 5.9.D). Heat killed S.aureus and its peptidoglycan derivative have 
been reported to attenuate Cx43 expression in astrocytes by both directly and 
indirectly reducing Cx43 mRNA expression (Esen et al. 2007). While western 
blots enable analysis of protein levels they cannot reveal whether the mRNA 
expression is similarly affected. qPCR was therefore performed in order to  
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Figure 5.9. Infection with a sublethal concentration of S.aureus (SA) for 24 hours reduces 
Cx43 protein levels. (A) A western blot showing Cx43 protein expression in controls and in 
fibroblasts incubated with 1.4 x105 CFU ml-1 S.aureus for 24 hours (MOI of 5). α-tubulin 
expression was used as a loading control. (B) Graph quantifying the total Cx43 expression 
relative to α-tubulin expression. (C) Graph quantifying the α-tubulin expression for control 
samples, and samples incubated with SA. (D) Graph quantifying the different bands of Cx43 
seen on the western blot, which indicate the different phosphorylation states of Cx43. 
Expression is relative to total α-tubulin expression. Independent Student’s t tests were used to 
tests statistical differences. N=3. All error bars are SEM. *p<0.05, **p<0.01. 
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ascertain if the reduction in Cx43 protein expression caused by live S.aureus 
infection also correlated with a decline in mRNA expression. Interestingly, no 
difference was observed in Cx43 mRNA expression between control and 
S.aureus infected cells (figure 5.10). This shows that the bacteria are not 
altering the cell’s transcription of Cx43. Instead the bacterium could be 
increasing the degradation of Cx43 protein, though further experiments are 
required to determine if this is the case.    
 
5.3.5. Infection with live S.aureus alters Cx43 cellular location  
Western blots demonstrated that Cx43 protein expression is reduced when 
infected with live S.aureus but not HKSA. However, this technique does not 
enable the visualisation of connexin distribution within the cells. Previous 
studies have shown that connexin distribution within the cell can be altered by 
various factors, including infections (Campos de Carvalho et al. 1998; Martínez 
& Sáez 2000), and so Cx43 protein was also visualised using 
immunofluorescence. Confocal images were taken of Cx43 
immunofluorescence after 24 hours of infection with the highest HKSA 
concentration tested by western blot, 1.2 x 107 CFU ml-1 (MOI of 300: figure 
5.11.A), or infection with 1.4 x 105 CFU ml-1 of S.aureus (MOI: figure 5.12.A). 
Quantification of Cx43 expression in the images confirmed the results seen by 
western blot, as no differences in Cx43 levels were found when infected with 
HKSA (figure 5.11.B), but a significant reduction observed when infected with 
S.aureus (figure 5.12.B). This analytical method normalises to the number of 
cells per image, so to validate this method it was confirmed that the number of 
cells per image didn’t differ significantly between the groups in both the HKSA 
infected (p=0.74: figure 5.11.C) and live S.aureus infected experiments (p=0.58: 
figure 5.12.C). Observations of Cx43 distribution in control cells showed high 
expression in foci around the nuclei and at intercellular junctions, with some 
diffuse cytoplasmic expression. No differences in Cx43 distribution were 
observed in cells infected with HKSA (figure 5.11). In contrast, Cx43 expression 
was reduced throughout the cell in the S.aureus infected cells, with a slight 
change in distribution (figure 5.12). It was still present in some intercellular foci 
and somewhat in the cytoplasm, but appeared to be primarily lost from the 
nuclear foci.  
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Figure 5.10. Infection with a sublethal concentration of S.aureus (SA) for 24 hours does 
not reduce Cx43 mRNA levels. (A) Graph showing Cx43 mRNA expression relative to 18S 
expression, in fibroblasts that had been infected with 1.4 x105 CFU ml-1 S.aureus for 24 hours 
(MOI of 5). A Student’s t test revealed that there was no significant difference. N=3. All error 
bars are SEM.   
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Figure 5.11. Infection with a sublethal concentration of heat killed S.aureus (HKSA) has 
no effect on Cx43 protein levels or cellular location. (A) Examples of immunofluorescent 
confocal images showing nuclei (blue) and Cx43 (green) in controls (top row) and in fibroblasts 
incubated with 1.2 x107 CFU ml-1 HKSA (MOI of 300) for 24 hours (middle row). A negative 
control using secondary antibody only is shown in the bottom panel. Scale bars indicate 50 µm. 
(B) Graph illustrating the Cx43 protein expression levels as quantified from confocal images, 
shown as Cx43 pixels per nuclei. (C) Graph showing the average number of nuclei in the Cx43 
immunofluorescent images used to quantify Cx43 expression. Independent Student’s t tests 
were used to test statistical differences. These showed there were no significant differences. 
N=3. All error bars are SEM. 
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Figure 5.12. Infection with a sublethal concentration of S.aureus (SA) for 24 hours 
reduces Cx43 protein levels, but does not alter cellular location. (A) Examples of 
immunofluorescent confocal images showing nuclei (blue) and Cx43 (green) in controls (top 
row) and in fibroblasts incubated with 1.4 x105 CFU ml-1 S.aureus (MOI of 5) for 24 hours 
(middle row). A negative control using secondary antibody only is shown in the bottom panel. 
Scale bars indicate 50 µm. (B) Graph illustrating the Cx43 protein expression levels as 
quantified from confocal images, shown as Cx43 pixels per nuclei. (C) Graph showing the 
average number of nuclei in the Cx43 immunofluorescent images used to quantify Cx43 
expression. Independent Student’s t tests were used to test statistical differences. N=3. All error 
bars are SEM. *p<0.05.  
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5.4. Discussion 
S.aureus is a pathogenic bacterium. It is internalised by host cells, and 
intracellular S.aureus are increasingly acknowledged to not only be 
physiologically relevant, but to also play an important role in S.aureus virulence 
and recurrent infections. A reduction in Cx43 expression was found to increase 
S.aureus internalisation, and S.aureus in turn was found to reduce Cx43 
expression, thus facilitating its own internalisation.  
 
In fibroblasts S.aureus becomes intracellular through adherence to fibronectin. 
Fibronectin forms a bridge between the bacteria and host cell as it is also 
adhered to by α5β1 integrins on host cells. Clustering of integrins causes the 
activation of several signalling pathways and a cytoskeletal reorganisation that 
results in active endocytosis of S.aureus by the cell (Fraunholz & Sinha 2012). 
Knockdown of Cx43 increases the number of intracellular S.aureus grown from 
a culture of fibroblasts, though at this point it has not been determined whether 
it increases the number of cells containing intercellular bacteria, or the number 
of bacteria per infected cell. FACS analysis of fibroblasts infected with 
immunofluorescent-labelled S.aureus may help to determine which is the case. 
Nevertheless, it is reasonable to presume that Cx43 is somehow involved in the 
process. Moreover, it appears to have a protective role during S.aureus 
infection as a decrease in expression increases intracellular S.aureus. However, 
determining whether overexpression of Cx43 significantly decreases S.aureus 
internalisation is required to show if Cx43 is protective against S.aureus 
internalisation. How Cx43 influences S.aureus internalisation is as yet unknown. 
It is possible that Cx43 might be influencing S.aureus internalisation by directly 
interacting with α5β1, as in osteocytes Cx43 was shown to directly interact with 
α5β1, which influenced hemichannel activity through its activation (Batra et al. 
2012). Alternatively, Cx43 could be influencing S.aureus invasion through 
interactions with other binding partners that could potentially be mutual with 
α5β1. S.aureus is not the only bacterium that exploits α5β1 integrins in order to 
enter host cells. Other bacteria include Bartonella bacilliformis, Myobacterium 
paratuberculosis, Neisseria spp, Porphyromonas gingivalis, Pseudomonas 
aeruginosa, Shigella, Streptococcus spp and Yersinia spp (Scibelli et al. 2007). 
A functional link between connexin expression and bacterial invasion has 
already been established for Yersinia enterocolitica and Shigella flexneri 
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internalisation (L. Velasquez Almonacid et al. 2009; Tran Van Nhieu et al. 2003). 
For internalisation of these species, cellular connexin expression increased 
bacterial internalisation, through a mechanism that was dependent on opening 
of Cx43 and Cx26 hemichannels respectively. As Cx43 expression result in 
fewer intracellular S.aureus, it seems unlikely that the same mechanism is 
employed during S.aureus internalisation into fibroblasts, as Cx43 shRNA cells 
have lower gap junction activity (Mendoza-Naranjo, Cormie, A. Serrano, et al. 
2012), and presumably also reduced hemichannel activity. Nevertheless, Cx43 
may still be influencing internalisation through gap junction or hemichannel 
activity, but via a different mechanism. This is in fact a possibility that was 
investigated in the course of this research, but all gap junction blockers tested 
proved toxic to S.aureus. Further experimentation is thus required to shed light 
on the mechanisms behind Cx43 involvement in S.aureus internalisation, and it 
will be interesting to see whether connexins influence the internalisation of other 
bacterial species that exploit α5β1.  
 
ATCC® 29213™ S.aureus is a toxic strain (Krut et al. 2003), and infection of 
3T3 fibroblasts with it caused a loss of viability, as shown by PI and trypan blue 
uptake. Toxicity was not observed when infected with heat killed S.aureus 
(HKSA), in line with previous reports (Krut et al. 2003; Alekseeva et al. 2013), 
suggesting that the bacteria must be metabolically active in order to instigate 
cell death. Reduction in Cx43 expression increased the toxicity of the infection 
and resulted in increased cell death. Its possible that knockdown of Cx43 could 
have increased the susceptibility of the fibroblasts to S.aureus virulence, as 
reduced Cx43 expression in Cx43 heterozygous mice, or GJIC inhibition in mice 
by treatment with oleamide, increased mortality in an Escherichia coli peritonitis 
in vivo model (Anand et al. 2008). Cx43 expression was also recently related to 
the susceptibility of epithelial cells to the apoptotic effects of Helicobacter pylori 
VacA toxin, where a reduction in Cx43 decreased apoptosis (Radin et al. 2014). 
However, since Cx43 knockdown increased intracellular S.aureus, it seems 
likely that the increased bacterial load may be responsible for the increase in 
cell death. One way to test this would be to prevent S.aureus internalisation into 
Cx43 shRNA fibroblasts by depleting α5β1 expression, and then assessing the 
toxicity of the infection. This would also enable an assessment of whether 
internalisation of S.aureus in these cells is necessary for induction of cell death. 
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This has been found to be the case in a number of cell types infected with 
various S.aureus strains (Mempel et al. 2002; Krut et al. 2003; Haslinger-Löffler 
et al. 2005; Kubica et al. 2008), and is also supported by the finding here; 
internalised S.aureus did not cause a significant increase in trypan blue positive 
EV cells, but did in Cx43 shRNA cells, which were shown to have increased 
intracellular S.aureus. However, the notion that S.aureus must be intracellular to 
induce apoptosis is still considered to be somewhat controversial as toxins 
which are secreted by the bacteria can also cause cell death in isolation 
(Bronner et al. 2004).  
 
Infection with toxic concentrations of S.aureus was also found to affect the 
proliferation of fibroblasts. Proliferation was significantly reduced compared to 
uninfected and HKSA infected cells both when the extracellular S.aureus were 
left in the culture media, and when only intracellular bacteria were allowed to 
persist, suggesting that internalised S.aureus are important for this effect. This 
was also observed by Alekseeva et al, who reported that only intracellular 
metabolically active S.aureus impaired proliferation of epithelial cells, by 
delaying the transition between G2 and M in the cell cycle (Alekseeva et al. 
2013). They showed this using three different strains of S.aureus on both 
human and bovine epithelial cells. In agreement with their observations, it was 
similarly found here that heat killed S.aureus did not impair proliferation, again 
suggesting that the bacteria must be metabolically active to affect proliferation. 
S.aureus planktonic conditioned medium has also been shown to reduce 
proliferation in MAC-T cells (Zavizion et al. 1995), and a few specific S.aureus 
secreted toxins that inhibit cell proliferation have been identified; enterotoxin B, 
inhibited proliferation of nasal fibroblasts (Pérez-Novo et al. 2008), and the S 
component of Panton-Valentine leukocidin (LukS-PV), was reported to induce 
G0/G1 cell cycle arrest (Bu et al. 2013). From the experiments conducted here 
it is not possible to ascertain at what phase of the cell cycle cells underwent 
arrest, but it would be interesting to see whether it was also at the G2/M phase 
as previously shown by Alekseeva et al (Alekseeva et al. 2013). Infection of 3T3 
fibroblasts with sublethal concentrations of S.aureus (MOI of 4) did not appear 
to reduce proliferation though, as assessed by live imaging of Hoechst labelled 
nuclei. Alekseeva et al similarly found that a low concentrations of S.aureus 
(MOI of 5) did not reduce proliferation, while MOIs of 10 or more did (Alekseeva 
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et al. 2013). The reason for this as yet unclear but may be to do with lower 
concentrations of the growth inhibiting toxins within the cells as a result of fewer 
intracellular S.aureus.  
 
Infection of fibroblasts with S.aureus reduced the protein expression of Cx43. A 
reduction in Cx43 expression has previously been seen in astrocytes in culture 
following incubation with S.aureus peptidoglycan (PGN) (Esen et al. 2007). This 
also occurred when PGN was replaced with whole heat killed S.aureus, but 
here HKSA had no effect on either Cx43 expression levels or cellular location. 
Western blot analysis shows three Cx43 protein bands; each band represents 
Cx43 in different states of phosphorylation and conformation, and has also been 
related to cellular location (Solan & Lampe 2009). Both the Cx43-P1 and Cx43-
P2 bands were reported to preferentially be found at the plasma membrane, 
with Cx43-P2 solely in gap junctions (Lampe et al. 2006; Solan et al. 2007). Live 
S.aureus reduced levels of the Cx43-P1 and Cx43 bands, but not the Cx43-P2 
band, suggesting a reduction in Cx43 protein in all differentially phosphorylated 
bands except the one found preferentially in gap junctions. This is also 
suggested by observing the Cx43 immunofluorescent images, and it will be 
interesting to determine if there is still gap junction intracellular communication. 
Moreover, despite a reduction in Cx43 protein, S.aureus infection does not 
result in decreased Cx43 mRNA levels. This suggests that the infection might 
be increasing protein degradation, a theory that could be tested by chemically 
blocking proteasome activity during infection, or by imaging the turnover of 
fluorescently labelled Cx43. Interestingly, it is known that α5β1 can influence 
Cx43 expression. Culturing alveolar epithelial cells on fibronectin increases 
Cx43 expression, but antibodies against α5β1 reduced Cx43 abundance and 
results in its redistribution to the cytosol (Guo et al. 2002). Alternatively, 
activation of α5β1 was shown to increase Cx43 expression in rat 
cardiomyocytes, (Shanker et al. 2005). Thus it is possible that S.aureus may be 
influencing Cx43 expression through its interaction with α5β1. 
 
In this chapter it was shown that S.aureus infection of fibroblasts decreased 
Cx43 protein expression, and that in turn, a reduction in Cx43 increased the 
internalisation of S.aureus, with consequences for the viability of the cell. Thus 
S.aureus influences the host cell in a manner that increases its own virulence. A 
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reduction in Cx43 expression in vivo was also shown to increase the virulence 
of another bacterial species, E.coli, although in contrast, reduced Cx43 was 
shown to protect cells from apoptosis induced by helicobacter pylori VacA toxin 
(Radin et al. 2014; Anand et al. 2008). Cx43 expression in chronic wounds is 
abnormally high at the dermal wound edge (Mendoza-Naranjo, Cormie, A. E. 
Serrano, et al. 2012; Mendoza-Naranjo, Cormie, A. Serrano, et al. 2012). It is 
feasible to speculate that high Cx43 expression could be a protective 
mechanism against S.aureus and other bacterial species commonly found in 
chronic wounds, including E.coli (Davies et al. 2004; Gjødsbøl & Christensen 
2006). However, the clinical roles of intracellular S.aureus in in vivo wounds are 
as yet unknown. Nevertheless, intracellular S.aureus have been shown to have 
physiological relevance in several types of wounds; internalisation is thought to 
aid in the pathogen’s evasion of the immune system, its virulence, persistence, 
and reoccurrence of infections (Kubica et al. 2008; Edwards et al. 2010; Hamza 
et al. 2013; Menzies et al. 2002). Although S.aureus is one of the most common 
pathogens in chronic skin wounds (Davies et al. 2004; Gjødsbøl & Christensen 
2006), the presence of intracellular S.aureus specifically in this type of wound 
has not yet been established. This is the next step in establishing the 
relationship between intracellular S.aureus and Cx43 expression in wounds.  	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Chapter 6. Effects of 
Staphylococcus aureus Infection 
on Healing and Connexin 
Expression in an In Vivo 
Cutaneous Wound Model 
Chapter 6 
	   175	  
6.1. Introduction 
Healing an injury in the skin after wounding requires the coordination of 
numerous cell types (Shaw & Martin 2009). Primarily tissue haemostasis must 
be re-established, and leukocytes are recruited to clear the wound of debris and 
contaminants. Fibroblasts proliferate and migrate into the wound, laying down 
extracellular matrix. Some will terminally differentiate as myofibroblasts, which 
contract the wound. In addition, angiogenesis results in a dense network of 
blood vessels in the wound bed, and together these components form 
granulation tissue. Keratinocytes in the epidermis proliferate and migrate over 
the granulation tissue to reform the skin barrier. Lastly, after wound closure the 
new dermis is remodelled. Excessive blood vessels are retracted, remaining 
vessels mature, collagen type III is exchanged for type I, and myofibroblasts 
undergo apoptosis.  
 
Unfortunately, healing does not always proceed smoothly, and wounds can 
become chronic. Chronic wounds typically have defective granulation tissue 
formation and remodelling (Herrick et al. 1992). They also have hyper-
proliferation of keratinocytes at the wound edge, alongside a failure of migration 
and re-epithelialisation of the wound (Stojadinovic et al. 2005; Usui et al. 2008; 
Brem et al. 2007; Stojadinovic et al. 2008). Chronic wounds are thought to be a 
result of four underlying factors: ischaemic reperfusion, hypoxia, intrinsic host 
disease and bacterial infection (Mustoe et al. 2006). One bacterial species 
commonly isolated from skin wounds, and chronic wounds in particular, is 
Staphylococcus aureus (Davies et al. 2004; Gjødsbøl & Christensen 2006). It is 
thought to primarily exist in wounds in the form of a biofilm, a community of 
sessile bacteria encased in a self-produced matrix (James et al. 2007). 
S.aureus biofilms are formed naturally and rapidly, and mature biofilms have 
been shown in a mouse wound infection model by 24 hours (Akiyama et al. 
1996). Manipulation of biofilm formation in in vivo models of S.aureus infected 
wounds suggest that the ability of S.aureus to form a biofilm is an important part 
of its impairment of wound healing (Gurjala et al. 2011; Schierle et al. 2009). 
Biofilm S.aureus secrete different toxins from their planktonic counterparts 
(Resch & Rosenstein 2005; Secor et al. 2011). Results from in vitro 
experiments using biofilm conditioned medium (BCM) have shown that these 
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exotoxins can impair viability and migration of both fibroblasts and keratinocytes 
(Kirker et al. 2009; Kirker & James 2012), although the toxicity of S.aureus is 
dependent on the particular strain (Krut et al. 2003). Furthermore, results from 
chapter four in this thesis showed that BCM from the ATCC 29213 strain of 
S.aureus could induce a senescence phenotype in fibroblasts in vitro, as well as 
also impairing migration.  
 
Connexins are a group of proteins that form gap junction, and they are 
expressed throughout the skin. Gap junctions are tightly regulated, and appear 
to also have non-junctional roles in several cellular processes, including 
apoptosis, migration, proliferation and differentiation (Dbouk et al. 2009). Cx43 
is expressed at reasonably high levels by fibroblasts in the dermis, and by 
keratinocytes in lower spinous and basal layers of the epidermis (Goliger & Paul 
1994; Coutinho et al. 2003; Risek et al. 1992; Kretz et al. 2003). Cx26 and Cx30 
are expressed at very low levels by keratinocytes in the granular layer of the 
epidermis. Expression of all three connexins changes dynamically during 
wound healing. Cx43 is down-regulated at the epidermal and dermal wound 
edge upon injury, but increased in epidermal hyperproliferative regions behind 
this and throughout the new epidermis following re-epithelialisation (Goliger & 
Paul 1995; Coutinho et al. 2003; Mendoza-Naranjo, Cormie, A. Serrano, et al. 
2012). Cx26 and Cx30 behave like one another; they become up-regulated 
directly behind the wound edge, and remain elevated for some time in the 
hyperproliferative epidermis following re-epithelialisation, before returning to 
normal levels after complete restoration of barrier function (Goliger & Paul 1995; 
Coutinho et al. 2003). Cx26, Cx30 and Cx43 are all abnormally expressed in 
chronic wounds, where they become elevated at the wound edge and for 
several millimetres away (Brandner et al. 2004; Mendoza-Naranjo, Cormie, A. E. 
Serrano, et al. 2012; Mendoza-Naranjo, Cormie, A. Serrano, et al. 2012).  
Experimentally reducing Cx43 expression with Cx43 antisense in both normal 
and diabetic wounds (which heal slowly and have abnormal Cx43 expression) 
in mouse skin has shown to improve the rate of healing (Mori et al. 2006; Wang 
et al. 2007). Ectopic overexpression of Cx26 in the skin of mice impaired wound 
healing, whilst no differences have been observed in skin wound healing in 
Cx30 knockout mice (Djalilian et al. 2006; Kretz et al. 2003). Although there is 
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not yet a complete understanding of their role it is clear that connexins, and 
Cx43 in particular, have important roles during the process of wound healing.  
 
Connexin expression and GJIC can be altered by exposure to several bacteria 
or their components; the effect is dependent on the bacterial species, the cell 
type, and the particular connexin (Ceelen et al. 2011). Peptidoglycan, a 
bacterial cell wall component, was found to increase Cx43 expression and GJIC 
in human endothelial cells. However, it had no influence on Cx43 in human 
keratinocyte HaCaTs, but instead increased Cx26 expression (Donnelly et al. 
2012). In contrast, PGN and heat killed S.aureus (HKSA) were found to 
decrease Cx43 expression and GJIC in mouse astrocytes (Esen et al. 2007), 
whereas no effect on Cx43 expression was observed when 3T3 fibroblasts 
were exposed to HKSA (chapter 5 of this thesis, section 5.3.4-5). Alternatively, 
exposure to live S.aureus decreased Cx43 protein expression (chapter 5 of this 
thesis, 5.3.4), as did exposure to BCM for 7 days (chapter 4 of this thesis, 4.3.6-
7). However, the effects of exposure to S.aureus in vivo can differ from the 
effect in vitro as the in vivo wound healing response involves multiple cell types 
from within the tissue, the recruitment of inflammatory cells, and the release of a 
plethora of cytokines and signals. It is not currently known how BCM, HKSA or 
live S.aureus influence the expression of connexins during the healing of skin 
wounds in vivo, or even whether BCM or HKSA impair healing at all.  
 
It was hypothesised that the presence of S.aureus or its secreted exotoxins 
would impair cutaneous wound healing and cause abnormal connexin 
expression at the wound edges.   
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6.2. Materials and methods 
See Chapter 2 for general materials and methods. Materials and methods used 
only in this chapter are described here.  
 
6.2.1. Surgery 
Six week old male imprinted control region (ICR) mice were anaesthetised with 
4% isofluorane in oxygen at 2 L m-1 and nitric oxide at 1 L m-1. They were then 
injected with 0.1 mg kg-1 of buprenorphine subcutaneously in the scruff of the 
neck. Hair was removed from the backs of mice by shaving. The remaining hair 
was removed by applying a thin layer of Nair® (Church and Dwight, Folkestone, 
UK). Nair and hair was removed using warm moist gauze, and the skin was 
sterilised by wiping with 70% ethanol. Mice were placed on a heated mat during 
the operation, and kept anaesthetised on a nose cone. Four full thickness 
excisional biopsy punch wounds were made in the dorsal skin, 2 on each side 
of the midline (see figure 2.1.C) using 6 mm medical biopsy punches (Kai 
Industries). Heat killed S.aureus (HKSA) and live S.aureus were suspended at 
the appropriate concentrations in DMEM supplemented with 10% DBS and 
containing 30% pluronic F127 (pluronic), and 30% pluronic F127 (pluronic) was 
added to biofilm conditioned medium (BCM) (see Chapter 2.2.3 for the protocol 
to make BCM). Wounds were treated with 20 µl of either HKSA, live S.aureus or 
BCM pluronic gel as indicated, and control wounds were treated with DMEM 
supplemented with 10% DBS and containing 30% pluronic F127 (pluronic) only. 
Pluronic gel is a liquid when cold, allowing delivery, but solidifies rapidly upon 
warming, ensuring that the substance is retained at the wound site as long as 
possible. Wounds were then covered in tegaderm™ (3M), to keep the 
substances in place and to prevent transfer of to the external environment for 
safety reasons. A separate sheet was used for control and infected wounds for 
S.aureus infected wounds, in order to prevent transfer bacteria between the 
wounds. Mice were then allowed to recover in a heated box and returned to 
their home cages. Pre-emptive analgesia was maintained throughout by 
administration of 1.6 mg ml-1 paracetamol, a nonsteroidal analgesic lacking anti-
inflammatory properties in the water. They were weighed daily, and observed 
for signs of discomfort or systemic infection.  
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6.2.2. Tissue harvesting and processing  
Mice were euthanised by a rising concentration of CO2, and death confirmed by 
cervical dislocation. Mice were harvested at 3 or 7 days. Tissue was excised 
and fixed in 4% PFA in PBS overnight at room temperature, except for where 
tissue was to be used to determine senescence associated β-galactosidase 
(SA-β-gal) activity: This tissue was fixed for only 2 hours in 4% PFA. All tissue 
was then washed with PBS, then transferred to 20% sucrose in PBS with 0.1% 
sodium azide at 4 °C overnight. Tissue was frozen into O.C.T and stored at -
80 °C until further processing, except for the tissue to be used for SA-β-gal 
staining which was sectioned immediately and stained that day. Cross sections 
of wounds were cut on a cryostat at 12 µm thicknesses. Serial sections were 
taken across slides, so each slide contained multiple sections spanning 
approximately 200 µm of the wound.  
 
6.2.3. H&E  
H&E staining 
Fixed tissue sections were H&E stained as described in chapter 2 materials and 
methods. They were imaged on an AxioScan Z1 slide scanner (Zeiss) using a 
x20 objective. Images were opened in Zen 2012 software (Zeiss) and all 
measurements made using the tools in the software unless indicated otherwise.  
 
Measuring re-epithelialisation  
Re-epithelialisation was measured from the wound edge (where the incision 
was made and normal dermis was present) to the tip of the new growth. Re-
epithelialisation was measured at both wound edges in a minimum of 2 sections, 
taken from different regions of the wound. The measurements were averaged. 
 
Measuring granulation tissue area 
Granulation tissue was measured from the site of incision at the edge of the 
undamaged dermis. The region encompassed all tissue under the new 
epithelium, with the bottom of the region in line with the layer of muscle beneath 
the adjacent undamaged dermis. Results were averaged from a minimum of 2 
sections, taken from different regions of the wound.  
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Measuring wound width 
Wound width was measured as a straight line from the left wound edge to the 
right wound edge at the epidermal level. An average from a minimum of 3 
sections was taken, from different regions of the wound.  
 
Calculating the wound closure percentage 
The percentage of the wound width that the new epithelial tongue had covered 
(wound closure percentage) was determined by dividing the re-epithelialisation 
length by the wound width, and expressing the result as a percentage.   
 
Measuring epidermal thickness 
The thickness of the epidermis was measured in 3 randomly selected regions 
0.5-1 mm from the wound edge. Both sides of the wound were measured, and 
the thickness averaged over a minimum of 2 sections, taken from different 
regions of the wound.  
 
6.2.4. Counting the number of cells in a section of epidermis 
Confocal images of regions of Hoechst stained distal epidermis in control and 
S.aureus infected wounds were opened in Image J (NIH) image analysis 
software. The number of cells in the epidermis within a 30-40 µm distance were 
counted, and presented as nuclei per µm of epidermis.   
 
6.2.5. Senescence associated β-galactosidase activity stain 
Immediately following sectioning, the tissue was washed in PBS for 10 minutes 
to remove O.C.T. The tissue was incubated in a humidified chamber with the 
senescence associated β-galactosidase (SA-βGal) staining solution (see table 
2.1. for the recipe) in the dark at 37 °C for 24 hours. Slides were then washed in 
PBS, counter stained with nuclear fast red solution (Sigma-Aldrich) for 20 
seconds, and washed again, before mounting in 70% glycerol. Slides were 
imaged on an AxioScan Z1 slide scanner (Zeiss).  
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6.3. Results 
6.3.1. Wound healing is impaired by application of 100% BCM 
Previous analysis showed that in vitro 100% BCM had a significant effect on 
cellular functions that are important in wound repair. It stopped proliferation of 
fibroblasts (figure 4.2), which, after prolonged incubation, became senescent 
(figure 4.3. and 4.4). It also retarded migration of these cells (figure 4.5–7). As 
proliferation and migration are both integral aspects of cellular behaviour during 
tissue repair it was investigated whether BCM also negatively impacted healing 
in vivo. 
 
Full thickness punch biopsy wounds were made in the dorsal skin of mice, and 
100% BCM in pluronic gel applied to the wounds. The wounds were then 
covered, and the tissue harvested after 3 or 7 days. A 7 day time point was 
included as in vitro experiments showed induction of senescence at 7 days 
when fibroblasts were incubated with 100% BCM in cell culture. A pilot 
experiment using 50%, 75% and 100% BCM in wounds showed a trend 
indicating that the higher the concentration of BCM the greater the effect it had 
on retarding re-epithelialisation. Thus for the purpose of this experiment 100% 
BCM was applied to experimental wounds. The extent of healing at 3 and 7 
days was compared between control and BCM applied wounds (figure 6.1). 
Examples of typical wounds on day 7 are shown in figure 6.1.H-I. A technique 
commonly use to quantify the degree of healing is measurement of the re-
epithelialisation length of the epidermis. This is the distance the keratinocytes 
have migrated from the original wound edge into the wound bed as indicated in 
the inset in figure 6.1. Measuring re-epithelialisation at 3 days showed no 
difference between control and BCM applied wounds (figure 6.1.A). Additionally, 
mice heal partly through contraction of their wounds, so to determine if wound 
contraction differed between control and BCM applied wounds the wound width 
was measured. This is a measurement taken from one wound edge to the other 
at the height of the epidermis. The wound width of BCM applied wounds did not 
differ from that of controls at 3 days (figure 6.1.B). While independently useful 
the wound width and re-epithelialisation length measurements can also used to 
assess the percentage of the wound that is closed (figure 6.1.C). At 3 days 
control wounds were 19% (± 4%) closed. This did not differ significantly from   
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Figure 6.1. A single application of 100% biofilm conditioned medium (BCM) to wounds 
inhibits healing at 7 days. (A-C) Graphs showing the (A) length of the re-epithelialisation, (B) 
the wound width (as indicated on the inset) and the (C) percentage of wound closure at 3 days 
after wounding, in controls and wounds where 100% BCM was applied straight after wounding. 
(D-G) Graphs illustrating the (D) length of the re-epithelialisation, (E) the wound width, (F) the 
percentage of wound closure, and (G) the area of granulation tissue at 7 days after wounding in 
control and 100% BCM applied wounds. (H-I) H&E example images of a matched control 
wound (H) and wound where 100% BCM was applied at the time of wounding (I). Statistical 
differences were tested using independent Student’s t tests. Arrows indicate the wound edges. 
3 day, N=10; 7 day, n=12. Scale bars indicate 1 mm. All error bars are SEM. *p<0.05. 
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the BCM applied wounds which were also 19% (± 3%) closed. Therefore it was 
concluded that a single topical application of 100% BCM has no significant 
impact at 3 days on any of the aspects of wound closure assessed here. 
 
The analysis used to assess healing at 3 days was also used to assess healing 
at 7 days after application of 100% BCM.  At 7 days there was a small but 
significant reduction in the re-epithelialisation length in the wounds where BCM 
was applied (figure 6.1.D). In contrast, a comparison of the wound width 
confirmed that this did not differ significantly, showing that contraction of the 
wounds did not differ (figure 6.1.E). As there was no difference in the average 
wound width it is unlikely that the small reduction observed in the epithelial 
tongue length was caused by contraction of the wounds making the BCM 
wounds smaller. Re-epithelialisation length and wound width were also used to 
determine the percentage of wound closure (figure 6.1.F). Control wounds were 
75% (± 9%) closed, while BCM applied wounds were 68% (± 9%) closed; a 
Mann Whitney U test showed that the difference was not significant. 
Interestingly, despite wound width not differing, there was a clear trend 
(p=0.057) for less granulation tissue in the BCM applied wounds (figure 6.1.G). 
Therefore it was concluded that a single topical application of 100% BCM 
reduced the length of re-epithelialisation at 7 days, and could potentially be 
reducing granulation formation. Wound closure was consequently somewhat 
impaired, but a single application of BCM was not sufficient to cause significant 
differences in the percentage wound closure.    
 
In addition to impairing proliferation and migration in vitro, prolonged incubation 
with 100% BCM was previously shown to induce a senescent phenotype in 
fibroblasts (section 4.3.3). To investigate whether a single topical application of 
100% BCM to wounds induced a senescence phenotype in vivo, senescence 
associated β-galactosidase (SA-βGal) activity was observed in tissue harvested 
7 days after wounding (figure 6.2). This was highly variable between animals, 
with some exhibiting almost no SA-βGal activity, as shown in figure 6.2.C-D, 
and others having large amounts of staining, as shown in the example in figure 
6.2.A-B. In most animals though, there appeared to be a small increase in SA-
βGal activity in the wounds where 100% BCM was applied compared to the 
animal matched controls. Staining was particularly apparent in the wound bed   
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Figure 6.2. Application of 100% biofilm conditioned medium (BCM) to wounds appears to 
increase senescence associated β-galactosidase activity at 7 days. (A-D) Images are 
shown of 7 day wounds tested for senescence associated β-galactosidase (SA-β-Gal) activity 
(blue) and counterstained with nuclear fast red (pink). Examples with (A-B) high and (C-D) low 
SA-β-Gal activity are shown. Animal matched controls (A and C) and 100% BCM (B and D) 
wounds are shown. The whole wound is shown for the high SA-βG activity example, with 
enlarged insets of the wound edge. Enlarged images of the wound edge only are shown for the 
low example. All scale bars indicate 1 mm.  
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and in the dermis at the wound edge. It is not possible to be conclusive in the 
finding here, but if this observed trend is correct then this is potentially a 
plausible reason for the slight impairment of healing observed in wounds where 
100% BCM was applied.   
 
6.3.2. Wound healing is impaired by infection with live S.aureus 
but not HKSA 
In vitro infection with S.aureus significantly reduced cell viability (figures 5.1, 
5.6) and proliferation (figure 5.7.C), both of which are vitally important during 
the healing process. Whilst infection with HKSA had no effect on viability or 
proliferation of fibroblasts in the in vitro experiments conducted (figures 5.2, 5.6), 
in vivo healing is complex, involving the coordination of many signals and cell 
types. Therefore it is feasible that HKSA may have an effect on healing in vivo. 
Thus it was investigated whether infection of wounds with either HKSA or live 
S.aureus retarded healing. Only a day 3 time point was included as infection 
with live S.aureus beyond this time point resulted in a spreading infection.  
 
Healing was compared at 3 days for wounds infected with HKSA (figure 6.3). 
Pilots using several concentrations of HKSA revealed no trend, so the highest 
concentration tested in the pilots was selected for proceeding experiments (6 x 
106 CFU ml-1). Typical examples of HKSA day 3 wounds are shown in figure 
6.3.D-E). Infecting wounds with HKSA did not impair re-epithelialisation, as the 
length of the epithelial tongue did not differ between controls and infected 
wounds (figure 6.3.A). Similarly HKSA infection did not alter contraction, as the 
width of the wounds also did not differ (figure 6.3.B). Assessment of wound 
closure showed 15% (± 2%) closure in controls and 16% (±2 %) in HKSA 
wounds (figure 6.3.C). Thus it was concluded that infection with HKSA did not 
impair wound healing at 3 days after infection.  
 
Several pilot experiments were also conducted to select a concentration of live 
S.aureus. This was particularly important as most concentrations tested 
resulted in extensive damage to the surrounding tissue; there was often 
complete loss of the epidermis and de-cellularisation of the dermis for several 
millimetres away from the wound, with no indications of healing. The   
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Figure 6.3. Infection of wounds with heat killed S.aureus does not delay healing at 3 days. 
(A-C) Graphs showing the (A) length of the re-epithelialisation measured from the wound edge 
to the tip of the new growth, (B) the wound width, and (C) the percentage of wound closure at 3 
days after wounding for animals infected with 6 x106 CFU ml-1 of heat killed S.aureus (HKSA). 
(D-E) Representative images are shown of control and HKSA infected wounds at 3 days. Scale 
bars indicate 1 mm. Statistical differences were tested using independent Student’s t tests. N=7. 
All error bars are SEM. 
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concentration finally selected for this experiment was 9 x 104 CFU ml-1. 
Observations of H&E images of the 3 days wounds infected with this 
concentration of S.aureus show clear signs of infection, alongside some signs 
of healing. Typical examples of these 3 day wounds are shown in figure 6.4.D-E. 
Infection was evident in the wound bed, where there was abundant material, 
and the skin often became attached to the underlying fascia (see figure 6.4.E 
for an example). There was re-epithelialisation, although there were indications 
of tissue damage; the re-epithelialising tongue often contained lesions (see red 
arrow in the inset of figure 6.4.E), and some rounded nuclei, indicating potential 
loss of viability. There was also hyperkeratosis (thickened stratum corneum), 
particularly around the wound edge (this is indicated by the black arrow in figure 
6.4.E inset). In order to quantitatively compare healing in control and infected 
wounds, measurements of re-epithelialisation, wound width, and percentage 
wound closure were made. Infection with S.aureus impaired re-epithelialisation 
as the length of the epithelial tongue in infected wounds was significantly 
shorter than in control wounds (figure 6.4.A). Sometimes, but not always, this 
was accompanied by an increase in epidermal thickness of the re-epithelialising 
tongue, as in the example in figure 6.4.E. Interestingly the wound width was 
also significantly reduced by infection with S.aureus (figure 6.4.B), suggesting 
that bacterial infection may increase contraction of the wound. Although the 
wound width of infected wounds was less than in control wounds, the wound 
closure was only 9% (± 1%) in infected wounds compared to 20% (± 2%) in 
control wounds (figure 6.4.C). From this it was concluded that infection with a 
low concentration of S.aureus impairs wound closure by hindering re-
epithelialisation, despite also increasing contraction of the wound.  
 
S.aureus rapidly develop into a biofilm, and previous in vivo wound healing 
models have shown S.aureus biofilms to develop within 24 hours (Akiyama et al. 
1996; Gurjala et al. 2011). It is therefore probable that S.aureus in the wound 
beds of the infected mice would have formed a biofilm. As S.aureus biofilm 
conditioned medium (BCM) induces a senescent phenotype in vitro (section 
4.3.3), and a single topical application appears to increase SA-βGal activity in 
vivo (figure 6.2), it is feasible that infection with S.aureus may also affect 
senescence. This was tested using SA-βGal activity (figure 6.5). At 3 days there 
appeared to be less SA-β-Gal activity than seen at 7 days in the BCM in vivo   
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Figure 6.4. Infection of wounds with live S.aureus inhibits healing at 3 days. (A-C) Graphs 
showing (A) the length of the re-epithelialisation measured from the wound edge to the tip of the 
new growth, (B) the wound width, and (C) the percentage of wound closure at 3 days after 
wounding for animals infected with 9 x104 CFU ml-1 of live S.aureus (SA). (D-E) Representative 
images are shown of control and S.aureus infected wounds at 3 days. The region in the red 
square is inset. The wound edges are indicated by black arrows, and the re-epithelialised region 
by the black dotted line. Red arrows indicate lesions in the epithelial tongue. Scale bars indicate 
200 µm (insets) or 1 mm as indicated. Statistical differences were tested using independent 
Student’s t tests. N=12. All error bars are SEM. *p<0.05, ***p<0.001, ****p<0.0001.  
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Figure 6.5. Infection of wounds with S.aureus appears to increase senescence 
associated β-galactosidase activity at 3 days. (A-B) Images are shown of 3 day wounds 
tested for senescence associated β-galactosidase activity (blue) and counterstained with 
nuclear fast red (pink). An animal matched control (A) and wound infected with 9 x104 CFU ml-1 
S.aureus (B) are shown, with enlarged insets of the wound edge. All scale bars indicate 1 mm.  
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samples (figure 6.2), and there was again high variability between animals. 
However, there was generally appeared to be more SA-β-Gal activity in infected 
than control wounds (an example with relatively high SA-β-Gal activity is shown 
in figure 6.5). This was most visible in the dermis at the wound edge and in the 
wound bed, but there also appeared to be increased staining in the epidermis 
and in the dermis extending away from the wound edge. It is not possible to be 
conclusive in the finding here, but if this observed trend is correct then 
potentially an increase in senescence could have contributed to the impairment 
of healing observed in wounds infected with S.aureus. There was insufficient 
time to conduct the experiment, but it would be interesting to compare the 
extent of senescence in control and infected wounds at a later time point, such 
as 7 or 10 days.   
 
6.3.3. A comparison of the effect of BCM, HKSA and S.aureus 
on Cx43 expression in the dermis 
Cx43 is expressed in the dermis of skin, where fibroblasts are the predominant 
cell type. After wounding, Cx43 becomes down-regulated at the dermal wound 
edge, a change that has been suggested to be necessary for fibroblasts to 
migrate into the wound bed (Mendoza-Naranjo, Cormie, A. Serrano, et al. 2012). 
Previous analysis showed that incubation of fibroblasts in vitro with 100% BCM 
for 7 days caused a reduction in Cx43 expression (figure 4.10 and figure 4.12), 
though a shorter incubation of 9.5 hours did not (figure 4.9 and figure 4.11). To 
see if application of 100% BCM to cutaneous wounds also reduced Cx43 
expression in the dermis, immunofluorescence staining was conducted on 
sectioned tissue from these wounds. Cx43 expression was examined at both 
day 3 and day 7. The dermis was imaged and single optical sections taken of a 
distal region (up to 1 mm from the wound edge) and at the wound edge, as 
indicated in the inset in figure 6.5. The Cx43 expression in each image was 
quantified (figure 6.6) and expression in control wounds compared to BCM 
treated wounds. In all wounds, both controls and where BCM was applied, 
Cx43 expression reduced at the dermal wound edge compared to the distal 
region. Distal Cx43 expression was compared for control and BCM applied 
wounds at both 3 and 7 days, and there were no significant differences in   
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Figure 6.6. Application of 100% biofilm conditioned medium (BCM) has no effect on 
dermal Cx43 expression at 3 or 7 days. (A-B) Graphs illustrating the Cx43 pixels/µm2 in the 
dermis of skin wounds from controls and wounds where 100% BCM had been applied at 3 days 
(A) and 7 days (B). Images were taken of the dermis in regions as indicated by the inset 
diagram. Distal regions are up to 1 mm from the wound edge. (C) Representative confocal 
images are shown of Cx43 expression (green) in the dermis in a distal region and at the wound 
edge at 7 days after wounding. Nuclei are counterstained with Hoechst (blue). Scale bars 
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indicate 50 µm. Statistical differences were tested using independent Student’s t tests, but were 
not significant. 3 days, n=7: 7 days, n=9. All error bars are SEM.  
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expression. Similarly, dermal wound edge Cx43 expression was compared for 
control and BCM applied wounds at both 3 and 7 days, and there were no 
significant differences in expression. Thus it was concluded that a single topical 
application of 100% BCM did not alter dermal Cx43 at the wound edge or 
distally at 3 or 7 days after wounding.  
 
In addition to BCM, infection with a low concentration of live S.aureus in vitro 
also caused a down-regulation of Cx43 protein expression (figure 5.9), whereas 
infection with HKSA did not (figure 5.8). To see if infection of wounds in vivo 
with live S.aureus or HKSA reduced Cx43 expression in the dermis 
immunofluorescence staining was conducted on sectioned tissue from these 3 
day wounds. As with the wounds where BCM was applied, the dermis was 
imaged in a distal region and at the wound edge. The Cx43 expression in each 
image was quantified (figures 6.7 and 6.8) and expression in control wounds 
compared to HKSA or S.aureus infected wounds. In all wounds, both controls 
and infected wounds, Cx43 expression reduced at the dermal wound edge 
compared to the distal region. Surprisingly though, infection of wounds in vivo 
for 3 days with HKSA caused a significant down-regulation of Cx43 expression 
at the dermal wound edge compared to controls (figure 6.7.A: p<0.001). Distal 
Cx43 expression did not vary significantly between controls and HKSA infected 
wounds. In contrast, infection with live S.aureus did not cause a significant 
difference in Cx43 dermal expression at the wound edge (figure 6.7.A). 
Interestingly though, there was a trend (p=0.09) towards increased distal dermal 
Cx43 expression in S.aureus infected wounds compared to controls (figure 
6.8.A).  
 
6.3.4. A comparison of the effect of BCM, HKSA and S.aureus 
on Cx43 expression in the epidermis 
Cx43 is expressed not only in the dermis of skin but in the epidermis as well. Its 
expression changes dynamically during the healing process, becoming down-
regulated initially at the growth tip of the epithelial tongue, and only returning to 
normal levels once re-epithelialisation is complete (Goliger & Paul 1995; 
Coutinho et al. 2003). Thus changes in Cx43 expression were observed in the 
epidermis in response to the application of BCM, HKSA and S.aureus to   
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Figure 6.7. Infection with heat killed S.aureus (HKSA) reduces dermal Cx43 expression at 
the wound edge at 3 days. (A) Graph showing the Cx43 pixels/µm2 in the dermis of skin 
wounds from controls and wounds infected with 6 x 106 CFU ml-1 of heat killed S.aureus (HKSA). 
Images were taken of the dermis in regions as indicated by the diagram in (B). Distal regions 
are up to 1 mm from the wound edge. (C) Representative confocal images are shown of Cx43 
expression (green) in the dermis in a distal region and at the wound edge. Nuclei are 
counterstained with Hoechst (blue). Scale bars indicate 50 µm. Statistical differences were 
tested using independent Student’s t tests. N=7. All error bars are SEM. ***p<0.001.  
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Figure 6.8. Infection with S.aureus has no significant effect on dermal Cx43 expression at 
3 days. (A) Graph showing the Cx43 pixels/µm2 in the dermis of skin wounds from controls and 
wounds infected with 9 x 104 CFU ml-1 of S.aureus. Images were taken of the dermis in regions 
as indicated by the diagram in (B). Distal regions are up to 1 mm from the wound edge. (C) 
Representative confocal images are shown of Cx43 expression (green) in the dermis in a distal 
region and at the wound edge. Nuclei are counterstained with Hoechst (blue). Scale bars 
indicate 50 µm. Statistical differences were tested using independent Student’s t tests but were 
not significant. N=9. All error bars are SEM. 
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wounds. In all 3 day wounds (BCM, HKSA and S.aureus infected) expression of 
Cx43 was observed at a distal region up to 1 mm from the wound edge, at the 
original wound edge itself, and at the tip of nascent epithelial growth. In the 7 
day wounds Cx43 expression was measured distally and at the original wound 
edge, but not at the growth tip at 7 days as many wounds had completed the 
process of re-epithelialisation. In all 3 day control wounds Cx43 expression 
reduced at the epidermal growth tip compared to distal expression, consistent 
with previous reports (Goliger & Paul 1995; Coutinho et al. 2003). Epidermal 
Cx43 expression was compared at each location between control and BCM 
applied wounds at both 3 (figure 6.9) and 7 (figure 6.10) days; there were no 
statistically significant differences in any epidermal location or at either time 
point. There were also no differences observed in the epidermal layers Cx43 
was normally expressed in. Epidermal Cx43 expression was also compared at 
each location between control and HKSA infected 3 day wounds (figure 6.11). 
Unlike in the dermis, infection with HKSA had no significant effect on epidermal 
Cx43 expression compared to controls at any of the epidermal locations. There 
were also no differences observed in the epidermal layers Cx43 was expressed 
in. In contrast, comparison of epidermal Cx43 expression in wounds infected 
with S.aureus showed significant increases in distal epidermal expression 
(figure 6.12). Cx43 also became expressed throughout all layers except the 
most superficial, the stratum corneum. As with BCM and HKSA, no differences 
were observed in Cx43 expression at the wound edge or in the growth tip.  
 
6.3.5. S.aureus infection increases distal epidermal thickness as 
well as Cx26 and Cx30 expression 
Infection with S.aureus caused a significant increase in Cx43 expression in 
distal regions of the epidermis in infected wounds (figure 6.12). Observing these 
images suggested that the thickness of the epidermis might also be increased. 
Measurements were taken of the epidermis thickness using H&Es, at a distance 
of 0.5-1 mm from the wound edge (figure 6.13.A). These showed that epidermal 
thickness was significantly increased (p<0.0001) from a thickness of 17±1 µm in 
controls to 45±4 µm in infected samples, more than 2.6 fold the thickness. The 
epidermal thickening was present for an average of 2.3 mm (± 0.3 mm) from the 
wound edge. However, the epidermal thickening was apparent throughout the   
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Figure 6.9. Application of 100% biofilm conditioned medium (BCM) has no effect on 
epidermal Cx43 expression at 3 days. (A) Graph showing the Cx43 pixels/µm2 after 3 days in 
the epidermis of skin from controls and wounds where 100% BCM was applied. Images were 
taken of the epidermis in three regions, as indicated by the diagram in (B). Distal regions are up 
to 1 mm from the wound edge. (C) Representative confocal images are shown of Cx43 
expression (green) in the epidermis in a distal region, at the wound edge, and at the growth tip. 
Nuclei are counterstained with Hoechst (blue), and white dotted lines delineate the area 
measured to quantify expression. Scale bars indicate 50 µm. Statistical differences were tested 
using independent Student’s t tests but were not significant. N=7. All error bars are SEM.  
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Figure 6.10. Application of 100% biofilm conditioned medium (BCM) has no effect on 
epidermal Cx43 expression at 7 days. (A) Graph showing the Cx43 pixels/µm2 after 7 days in 
the epidermis of skin from controls and wounds where 100% BCM was applied. Images were 
taken of the epidermis in two regions, as indicated by the diagram in (B). Distal regions are up 
to 1 mm from the wound edge. (C) Representative confocal images are shown of Cx43 
expression (green) in the epidermis in a distal region AND at the wound edge. Nuclei are 
counterstained with Hoechst (blue), and white dotted lines delineate the area measured to 
quantify expression. Scale bars indicate 50 µm. Statistical differences were tested using 
independent Student’s t tests, but were not significant. N=9. All error bars are SEM.  
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Figure 6.11. Infection with heat killed S.aureus (HKSA) has no effect on epidermal Cx43 
expression at 3 days. (A) Graph showing the Cx43 pixels/µm2 in the epidermis of skin from 
controls and wounds infected with 6 x 106 CFU ml-1 of heat killed S.aureus (HKSA). Images 
were taken of the epidermis in three regions, as indicated by the diagram in (B). Distal regions 
are up to 1 mm from the wound edge. (C) Representative confocal images are shown of Cx43 
expression (green) in the epidermis in a distal region, at the wound edge, and at the growth tip. 
Nuclei are counterstained with Hoechst (blue), and white dotted lines delineate the area 
measured to quantify expression. Scale bars indicate 50 µm. Statistical differences were tested 
using independent Student’s t tests, but were not significant. N=7. All error bars are SEM.  
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Figure 6.12. Infection with S.aureus (SA) increases distal epidermal Cx43 expression at 3 
days. (A) Graph showing the Cx43 pixels/µm2 in the epidermis of skin from controls and 
wounds infected with 9 x 104 CFU ml-1 of S.aureus. Images were taken of the epidermis in three 
regions, as indicated by the diagram in (B). Distal regions are up to 1 mm from the wound edge. 
(C) Representative confocal images are shown of Cx43 expression (green) in the epidermis in a 
distal region, at the wound edge, and at the growth tip. Nuclei are counterstained with Hoechst 
(blue), and white dotted lines delineate the area measured to quantify expression. Scale bars 
indicate 50 µm. Statistical differences were tested using independent Student’s t tests. N=9. All 
error bars are SEM. ****p<0.0001. 
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entire length of many of the biopsies, so may in fact extend further than this. 
There were also signs of hyperkeratosis (thickened stratum corneum) in many 
samples, as indicated by the arrow in figure 6.13.C. The number of cells in the 
epidermis within a 30-40 µm distance were counted, and presented as nuclei 
per µm of epidermis (figure 6.13.D). Statistical analysis confirmed that the 
observed hyper-thickening was in conjunction with a significant increase in the 
number of cells within the epidermis. Interestingly, HKSA had no effect on 
epidermal thickness, suggesting that metabolically active S.aureus are required 
for this response to occur.  
 
Hyperproliferative, or hyper-thickened, epidermis is frequently associated with 
high expression of Cx26 and Cx30 by keratinocytes in a number of human skin 
conditions: high levels of Cx26 have been reported in viral warts, psoriasis 
(Lucke et al. 1999; Labarthe et al. 1998) and porokeratosis (Hivnor et al. 2004), 
and high levels of Cx30 in psoriatic and porokeratotic skin (Lemaître et al. 2006). 
As S.aureus infection resulted in a hyper-thickened epidermis up to 2.3 mm 
from the wound, with elevated Cx43 expression, it was investigated whether 
Cx26 and Cx30 expression were similarly increased. Expression of both 
connexins was measured at the original wound edge and in a distal region of 
the epidermis. Expression in these regions in controls was compared to 
expression in wounds treated with BCM, or infected with HKSA or S.aureus. In 
all wounds both connexins became elevated at the wound edge compared to 
distal regions, in agreement with previous reports (Coutinho et al. 2003; Goliger 
& Paul 1995). Application of neither BCM nor HKSA had a significant effect on 
distal or wound edge Cx26 or Cx30 expression at 3 days compared to controls 
(figure 6.14). Similarly infection with live S.aureus had no significant effect on 
either Cx26 or Cx30 expression at the wound edge of day 3 wounds compared 
to controls. In contrast, live S.aureus infection caused a significant increase in 
distal Cx26 (figure 6.15) and Cx30 (figure 6.16) expression in all but the basal 
layer of the epidermis.  
 
Thus is was concluded that infection with live S.aureus results in changes in the 
expression patterns of three connexins that normally change dynamically during 
the healing of cutaneous wounds, and are thought to be important for the 
healing process. In particular infection results in abnormally elevated 
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expression of Cx26, Cx30 and Cx43 in the epidermis for up to 1 mm from the 
wound edge. The mechanism of this change is as yet unknown, and the full 
implications of it require further exploration.   
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Figure 6.13. Infection with S.aureus (SA) causes distal epidermal hyper-thickening. (A) 
Graphs showing the average thickness of the epidermis 3 days after wounding, in a region 0.5-1 
mm from the wound edge. Different animals were used for each experimental condition (BCM, 
HKSA and SA) with matched controls. (B-C) Representative images are shown of the epidermis 
in a region 0.5-1 mm from the wound edge. Images are of mice whose wounds were initially 
infected with 9 x 104 CFU ml-1 of S.aureus. The arrow on C indicates the stratum corneum, 
which appears hyperkeratotic in many infected wounds. (D) Graph illustrating the number of 
nuclei per µm of the epidermis, as measured along the bottom of the epidermis. Scale bars 
indicate 100 µm. Statistical differences were tested using independent Student’s t tests. BCM, 
N=7; HKSA, N=7; SA, N=12. All error bars are SEM. ns = not significant. ***p<0.001, 
****p<0.0001. 
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Figure 6.14. Application of BCM and HKSA has no effect on Cx26 or Cx30 expression. A 
schematic is shown of the regions imaged. Distal regions are up to 1 mm from the wound edge.  
(A-D) Graphs illustrating the Cx26 pixels/µm2 (A and B) or Cx30 pixels/µm2 (C and D) in the 
epidermis of skin from controls and wounds where 100% was applied (A and C) or were 
infected with 6 x 106 CFU ml-1 of heat killed S.aureus (HKSA) (B and D). Statistical differences 
were tested using independent Student’s t tests, but none were significant (ns). A, B and D, 
n=7; C, n=6. All error bars are SEM.  
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Figure 6.15. Infection with S.aureus increases distal Cx26 expression. (A) Graph showing 
the Cx26 pixels/µm2 in the epidermis of skin from controls and wounds infected with 9 x 104 
CFU ml-1 of S.aureus. Images were taken of the epidermis in regions as indicated by the 
diagram in (B). Distal regions are up to 1 mm from the wound edge. (C) Representative 
confocal images are shown of Cx26 expression (green) in the epidermis in a distal region and at 
the wound edge. Nuclei are counterstained with Hoechst (blue), and white dotted lines delineate 
the area measured to quantify expression. Scale bars indicate 50 µm. Statistical differences 
were tested using independent Student’s t tests. N=6. All error bars are SEM. **p<0.01. 
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Figure 6.16. Infection with S.aureus increases distal Cx30 expression. (A) Graph showing 
the Cx30 pixels/µm2 in the epidermis of skin from controls and wounds infected with 9 x 104 
CFU ml-1 of S.aureus. Images were taken of the epidermis in regions as indicated by the 
diagram in (B). Distal regions are up to 1 mm from the wound edge. (C) Representative 
confocal images are shown of Cx30 expression (green) in the epidermis in a distal region and at 
the wound edge. Nuclei are counterstained with Hoechst (blue), and white dotted lines delineate 
the area measured to quantify expression. Scale bars indicate 50 µm. Statistical differences 
were tested using independent Student’s t tests. N=7. All error bars are SEM. **p=0.01. 
  
Chapter 6 
	   207	  
6.4. Discussion 
S.aureus is a pathogenic species and is commonly found in wounds, 
particularly chronic wounds (Davies et al. 2004; Gjødsbøl & Christensen 2006). 
Moreover, in chronic wounds it is usually found within a biofilm (James et al. 
2007). Infection with S.aureus or its products have previously been shown to 
alter the connexin expression in several cell types including keratinocytes 
(Donnelly et al. 2012; Esen et al. 2007; Garg et al. 2005) and experiments in 
previous chapters of this thesis showed an effect on fibroblasts. Connexin 
expression is also abnormal in chronic wounds (Brandner et al. 2004; Mendoza-
Naranjo, Cormie, A. E. Serrano, et al. 2012; Mendoza-Naranjo, Cormie, A. 
Serrano, et al. 2012), but it is not known if S.aureus is responsible for this 
abnormal expression. Mouse wounds were infected with S.aureus, in either an 
alive or heat killed state. Wounds on additional mice were treated with media 
conditioned with the toxins secreted by S.aureus when in a biofilm state (BCM). 
The effect they had on healing and expression of Cx43, Cx26 and Cx30 were 
investigated.  
 
In agreement with previous findings, live S.aureus significantly impaired healing, 
by retarding re-epithelialisation (Schierle et al. 2009; Gurjala et al. 2011; Akhil K. 
Seth et al. 2012; A. Seth et al. 2012; Pastar et al. 2013). Interestingly, S.aureus 
infection decreased the width of the wound compared to controls. This is in 
contrast to findings in both pig and rabbits ear wounds, where S.aureus 
infection significantly increased the granulation gap (Gurjala et al. 2011; Akhil K 
Seth et al. 2012). This could be a reflection of the different time points 
examined, as both Gurajala et al and Seth et al examined the wounds 12 days 
post wounding, whereas I examined the wounds after 3 days. Alternatively, it 
may be a reflection of the differences in healing mechanisms between the 
model species, as unlike rabbits and pigs, mice heal partly through contraction 
of the wound. Nevertheless, it was unexpected that the wound width was 
significantly smaller in infected wounds. It would be interesting to ascertain 
whether there was also an increase in myofibroblasts in the wound, the 
fibroblast derived contractile cells found in granulation tissue. Like live S.aureus, 
application of 100% BCM to wounds similarly impaired re-epithelialisation, 
although to a lesser extent, as a difference in the length of re-epithelialisation 
compared to controls wasn’t apparent at day 3, only day 7. A single application 
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was sufficient to result in a small but significant reduction in re-epithelialisation. 
It would be interesting to see whether repeated application would more closely 
resemble the phenotype of live S.aureus infected wounds, as the lesser effects 
might be due to less exposure of the cells to the toxins. At 7 days after 
wounding there was also a trend towards less granulation tissue in the wounds 
where BCM was applied. This reflects the in vitro experimental data with BCM, 
where there was a reduction in fibroblast migration. However, in that instance 
the cells were incubated continuously in BCM, whereas in vivo BCM was only 
applied once (immediately after wounding). Thus in vivo, delivery of the toxins 
were restricted to the period of time the pluronic gel remained in place, which 
may be the reason why the impairment was not as severe. On the other hand 
heat killed S.aureus did not significantly affect healing compared to controls, 
which is also in agreement with in vitro data, where HKSA had no effect on the 
viability or proliferation of cells (although its effect on migration was not tested). 
As no effect on healing was observed when HKSA was applied, it suggests that 
the coat proteins in S.aureus are not responsible for the impaired healing 
observed in the live S.aureus infection.  
 
In future experiments it would be informative to look at proliferation in the BCM 
and S.aureus challenged wounds, through incorporation of BrdU or using 
proliferative markers such as Ki67. In vitro experiments indicated that live 
S.aureus reduced proliferation, and showed that BCM induced senescence in 
fibroblasts. Visual observations of SA-βGal activity in wounds where BCM was 
applied or were infected with live S.aureus suggested that both might increase 
SA-β-Gal activity. This suggests that there may be an increase in senescence 
in the bacteria challenged wounds, but to determine this for certain several 
senescence markers should be used, such as the cell cycle inhibitor markers 
p53 and p16INK4A (Kuilman et al. 2010). Senescence has been associated with 
poor healing in chronic wounds (Clark 2008). Increased senescence has 
previously been noted in the dermis of pressure sores using the senescent 
marker, terminin (Vande Berg et al. 1998), but has most frequently been 
observed in fibroblasts isolated from chronic wounds (Ågren & Steenfos 1999; 
M. V Mendez et al. 1998; A. C. Stanley et al. 1997; Vande Berg et al. 1998). In 
fact, a correlation was established whereby difficult to heal ulcers were 
associated with more than 15% senescence in the population of in vitro grown 
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fibroblasts isolated from the chronic wound (Stanley & Osler 2001). Senescence 
in cell culture has also been shown in response to challenge by Escherichia coli 
colibactin toxin and Pseudomonas aeruginosa pyocyanin toxin (Muller 2006; 
Secher et al. 2013), although neither has been tested in vivo. Interestingly, like 
S.aureus, both these species are common in chronic wounds (Davies et al. 
2004; Gjødsbøl & Christensen 2006).  
 
Infection of wounds with live S.aureus caused a significant hyper-thickening of 
the epidermis for several millimetres from the wound. This was in conjunction 
with an increased number of nuclei, indicating increased proliferation although 
this was not confirmed with a proliferative marker. Interestingly, epidermal 
hyperplasia is also a feature of chronic wounds: increased epidermal thickness 
is associated with hyper-proliferation of keratinocytes (Brem et al. 2007). 
Moreover, in chronic wounds the epidermis is also frequently hyperkeratotic 
(thickened cornified layer), parakeratotic (nuclei present in the cornified layer), 
and fails to differentiate properly (Stojadinovic et al. 2005; Usui et al. 2008; 
Brem et al. 2007; Stojadinovic et al. 2008). The epidermis surrounding S.aureus 
infected wounds was similarly hyperkeratotic, and so it would be interesting to 
ascertain whether keratinocyte differentiation is also abnormal. Epidermal 
hyperplasia also occurs in a number of skin diseases, including psoriasis and 
atopic dermatitis, both of which have been associated with S.aureus (Balci et al. 
2009; Hong et al. 2014). When α-haemolysin from S.aureus was injected 
subcutaneously in mice it resulted in atopic dermatitis-like symptoms, including 
increased inflammation and epidermal hyperplasia (Hong et al. 2014). S.aureus 
infection, particularly toxic strains, was also found to be correlated with patients 
who had psoriasis, but not with healthy controls (Balci et al. 2009). Interestingly, 
S.aureus peptidoglycan (PGN) was found to have anti-apoptotic effects on 
keratinocytes in vitro, and the authors suggest that it could favour proliferation 
in psoriasis (Vázquez-Sánchez et al. 2014). Moreover, increased proliferation 
was shown in vitro when keratinocytes were exposed to S.aureus α-toxin or 
protein A (SpA), associated with increased epidermal growth factor (EGF) and 
EGF receptor activation respectively (Haugwitz et al. 2006; Soong et al. 2011). 
Increased proliferation was similarly shown in keratinocytes challenged with 
S.aureus epidermal cell differentiation inhibitor (EDIN) (Sugai et al. 1992). As 
well as promoting proliferation EDIN prevented differentiation, and injection into 
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mouse skin resulted in extreme hyperplasia. It is therefore apparent that 
S.aureus infection is capable of causing hyperplasia. Whether this is in direct 
response to the bacteria and its toxins, or predominantly a consequence of 
inflammation elicited by the bacteria, is currently unknown. It has been shown 
though, that inflammation is sufficient to cause hyperplasia. For example, IL-
17C is a pro-inflammatory cytokine found expressed abundantly in psoriasis; its 
ectopic overexpression in keratinocytes in mice resulted in epidermal 
hyperplasia (Johnston et al. 2013). Moreover, both psoriasis and atopic 
dermatitis are chronic inflammatory skin diseases in which the cytokine IL-22 
has been shown to play a critical role (Swindell et al. 2013; Hong et al. 2014; 
Fujita 2013).  
 
Hyperproliferative or hyperplasic epidermis is frequently associated with an 
increase in Cx26, and to a lesser extent Cx30, expression; high levels of Cx26 
and Cx30 are frequently reported in hyperproliferative skin conditions including 
viral warts, psoriasis and porokeratosis (Hivnor et al. 2004; Lemaître et al. 2006; 
Lucke et al. 1999; Labarthe et al. 1998). Skin surrounding chronic wounds is 
also typically hyperplastic (Brem et al. 2007), and recently, the Becker lab has 
identified significantly elevated levels of Cx26 and Cx30 in the epidermis of 
human chronic wounds for up to 4 mm from the wound edge (Sutcliffe et al-
manuscript submitted). Both Cx26 and Cx30 have been proposed as markers of 
hyper-thickened epidermis, and both are expressed at significantly elevated 
levels in the hyper-thickened epidermis of S.aureus infected wounds. The 
relationship between these connexins and proliferation of keratinocytes is 
somewhat confusing, with conflicting results. In vivo Cx26 and Cx30 expressing 
cells are often not associated with proliferation markers (Goliger & Paul 1995; 
Lucke et al. 1999; Coutinho et al. 2003). However, ectopic overexpression of 
Cx26 in keratinocytes caused hyperplasia in transgenic mice, and 
overexpression of mutant Cx30 caused mild hyperkeratosis (Djalilian et al. 
2006; Bosen et al. 2014). Conversely, manipulating Cx26 and Cx30 expression 
in keratinocytes in vitro has been found to have no effect on proliferation in 
some circumstances, but over expression increased proliferation in other 
reports (Man et al. 2007; Wiszniewski et al. 2001; Thomas et al. 2007). Thus it 
is unclear whether increased Cx26 or Cx30 expression is a cause of epidermal 
hyperplasia, or a consequence of it. Interestingly, it has been shown S.aureus 
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can increase the expression of Cx26 and Cx30; exposure of astrocytes and 
keratinocytes to S.aureus derived PGN increased Cx26 expression, though 
PGN decreased Cx30 expression in astrocytes (Esen et al. 2007; Donnelly et al. 
2012). Expression of Cx26 was also recently linked to the invasion of epithelial 
cells and keratinocytes by the pathogen Shigella flexneri (Tran Van Nhieu et al. 
2003; Man et al. 2007). Furthermore, tape stripping (repeated epidermal trauma 
from application and removal of sticky tape) increased Cx26 expression in the 
epidermis of humans (Lucke et al. 1999), and tape stripping was also found to 
increase the colonisation of S.aureus in mice (Wanke et al. 2013). Thus it is 
possible to postulate that S.aureus infection might directly, or perhaps through 
inflammation, be influencing Cx26, and perhaps also Cx30, expression in the 
epidermis. Of note, there was no increase in either connexin at the wound edge 
in the S.aureus infected wounds compared to controls. It is possible that this is 
because both Cx26 and Cx30 are already elevated in this region, as both 
normally become elevated behind the re-epithelising growth tip (Goliger & Paul 
1995; Coutinho et al. 2003).  
 
As well as high levels of Cx26 and Cx30, the Cx43 expression was also 
elevated in the hyper-thickened epidermis of the S.aureus infected wounds. 
Cx43 is also reported to be highly expressed in hyperproliferative psoriatic 
epidermis, and viral warts (Lucke et al. 1999; Labarthe et al. 1998), and in the 
epidermis of non-healing chronic wounds, which usually have epidermal 
hyperplasia (Brandner et al. 2004; Mendoza-Naranjo, Cormie, A. E. Serrano, et 
al. 2012; Mendoza-Naranjo, Cormie, A. Serrano, et al. 2012). High Cx43 
expression in the epidermis is similarly reported in hyperproliferative regions 
during wound healing, where its expression was found to correlate with Ki67, a 
proliferative marker (Goliger & Paul 1995; Coutinho et al. 2003). There are, 
though, conflicting reports about the role of Cx43 in cell proliferation, where it 
has been reported to both stimulate and prevent proliferation (Vinken, Decrock, 
Leybaert, et al. 2012). High Cx43 epidermal is also associated with poor healing, 
as it is highly expressed in the wound edge of streptozotocin (STZ) diabetic rats, 
which have delayed healing (Wang et al. 2007). Reducing Cx43 expression in 
the epidermis also improves healing (Mori et al. 2006; Coutinho et al. 2005). 
Although Cx43 is elevated in distal epidermis, S.aureus derived PGN was found 
not to alter Cx43 expression in the HaCaT keratinocyte cell line (Donnelly et al. 
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2012). There is similarly a trend for increased distal expression in the dermis, 
although S.aureus infection was shown in the previous chapter to decrease 
Cx43 expression in fibroblasts (chapter 4.3.6). However, the effect of other 
S.aureus products on Cx43 expression in keratinocytes and fibroblasts has not 
been explored. Moreover, it is possible that Cx43 may be up-regulated in 
keratinocytes or fibroblasts by inflammation, although TNF-α, a pro-
inflammatory cytokine, was found instead to reduce Cx43 in both corneal 
fibroblasts and HaCaT keratinocytes (Kimura et al. 2013; Tacheau et al. 2008). 
For now, why Cx43 becomes elevated is not known. However, in fibroblasts in 
vitro low Cx43 expression facilitated S.aureus internalisation. If the same is true 
of keratinocytes, then perhaps increased Cx43 expression may be a protective 
mechanism against the bacterium.  
 
In the previous chapter it was shown that S.aureus infection decreased Cx43 
expression in 3T3 fibroblasts (chapter 5.3.4). However, a significant decrease in 
Cx43 at the dermal wound edge was not found in S.aureus infected mice. 
Similarly, in vitro prolonged incubation with BCM decreased fibroblast Cx43 
expression (chapter 4.3.6), but BCM did not decrease dermal wound edge 
Cx43 expression at 3 or 7 days post wounding. Fibroblasts are not the only cell 
type in the dermis though, and it was previously found that Cx43 expression 
increased in endothelial cells when exposed to S.aureus PGN (Donnelly et al. 
2012). Furthermore, it has been demonstrated that Cx43 expression is turned 
on in activated neutrophils, and presumably there was an increased influx of 
neutrophils into infected wounds (Zahler & Hoffmann 2003; Jara et al. 1995).  
Thus any decrease in Cx43 expression in dermal wound edge fibroblasts could 
be masked by the expected increased expression in neutrophils and endothelial 
cells. Interestingly, HKSA caused a significant decrease in dermal Cx43 
expression. HKSA had no effect on fibroblast Cx43 expression in vitro (chapter 
5.3.4) so this was unexpected, and the reason for it is unknown. Perhaps it 
would be worth ascertaining if HKSA reduces angiogenesis or the expression of 
Cx43 in endothelial cells; either could result in lower Cx43 expression at the 
dermal wound edge. For now though, the reason for this cannot be explained.   
 
In this chapter it was shown that infection with S.aureus impaired healing of 
mouse skin wounds, as did BCM, but to a lesser extent. S.aureus infection also 
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resulted in hyper-thickening of the epidermis for several millimetres around the 
wound, which was in conjunction with increased expression of Cx26, Cx30 and 
Cx43. This response was only caused by infection with the live bacteria, and 
was a phenotype very similar to that of chronic wounds, which also have 
elevated Cx26, Cx30 and Cx43 in hyperplasic epidermis surrounding the wound 
(Brandner et al. 2004; Mendoza-Naranjo, Cormie, A. E. Serrano, et al. 2012; 
Mendoza-Naranjo, Cormie, A. Serrano, et al. 2012). Whether the increased 
connexin expression was due to inflammation or in direct response to 
interaction with S.aureus or its secreted toxins remains to be determined, but 
these experiments suggest a new role for S.aureus infection in the aetiology of 
chronic wounds.  
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7.1. Introduction 
Both biofilm conditioned medium (BCM) and infection with live S.aureus 
decreased Cx43 expression in fibroblasts. Although exceptions exist, the 
majority of bacteria, or components derived from them, decrease connexin 
expression and gap junction intercellular communication (GJIC) in non-
professional phagocytic cells in cell culture (Ceelen et al. 2011). In contrast 
though, the expression of three connexins, Cx26, Cx30 and Cx43, is increased 
in chronic wounds (Brandner et al. 2004; Mendoza-Naranjo, Cormie, A. Serrano, 
et al. 2012; Mendoza-Naranjo, Cormie, A. E. Serrano, et al. 2012), wounds 
which typically are infected with bacteria, including S.aureus (Davies et al. 
2004; Gjødsbøl & Christensen 2006). Moreover, it was demonstrated in this 
thesis that infection of skin wounds in mice with live S.aureus resulted in a 
phenotype that closely mimics several aspects of chronic wounds; impaired re-
epithelialisation, hyperplasia of the epidermis surrounding the wound and 
hyperkeratosis (Brem et al. 2007; Herrick et al. 1992). In particular, the 
hyperproliferative epidermis also expressed high levels of Cx26, Cx30 and 
Cx43, suggesting that S.aureus infection is involved in the abnormal connexin 
expression in chronic wounds. This is despite S.aureus causing a decrease in 
Cx43 expression in fibroblasts in vitro, although the effect on connexins in 
keratinocytes wasn’t investigated. High levels of Cx43 expression in the 
epidermis have previously been shown to impair re-epithelialisation (Wang et al. 
2007). Interestingly, the high connexin expression and thickened epithelium 
also resembles buccal mucosa, although this tissue exhibits privileged healing 
rather than impaired healing, potentially due to its ability to rapidly down-
regulate connexin expression at the wound edge. The relationship between 
S.aureus, healing, and connexins are discussed here.  
 
7.2. Parallels between S.aureus biofilms in oral 
inflammatory disease and chronic skin wounds  
Bacterial biofilms have only relatively recently been established as major 
contributors to impaired healing in chronic wounds (James et al. 2007). Oral 
biofilms, though, have been studied for considerably longer. Comparisons have 
been drawn between bacterial biofilms in chronic wounds and oral mucosa 
biofilms, and it has been suggested that our understanding of oral biofilms may 
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aid our understanding of chronic wounds (Mancl et al. 2013). Despite oral 
mucosa normally healing both rapidly and with minimal or no scarring (Enoch & 
Stephens 2009), oral biofilms, in the form of dental plaques, have long been 
established as the cause behind inflammatory periodontal diseases (Mancl et al. 
2013). Parallels can be drawn between chronic inflammation in periodontal 
disease and persistent inflammation in chronic skin wounds. Although not 
generally considered an oral pathogen, S.aureus oral mucosa biofilms 
particularly have been associated with aggressive periodontitis (Fritschi et al. 
2008; Souto & Andrade 2006). S.aureus is also one of the most commonly 
recovered species in chronic wounds, where it was found to be associated with 
approximately 90% of ulcers (Davies et al. 2004; Gjødsbøl & Christensen 2006). 
It has been suggested that pockets of oral S.aureus biofilms may provide a 
reservoir responsible for airway and systemic infections, as well as preventing 
the removal of infection in both chronic wounds and oral disease.  
 
7.3. The relationship between intracellular and biofilm 
S.aureus in inflammatory diseases  
7.3.1. Correlations between biofilms and intracellular S.aureus 
and their roles in pathogenicity and virulence  
It has been shown that, despite being healthy, human buccal epithelial cells 
contain and tolerate intracellular oral bacteria, without apparently causing 
inflammation (Rudney et al. 2001; Rudney & Chen 2006). Although it is not 
considered a normal oral pathogen S.aureus was demonstrated to be 
intracellular in buccal and gingival epithelial cells (Colombo et al. 2013). In this 
study it was reported that S.aureus was present in a significantly higher 
proportion in cells from patients with periodontitis compared to healthy controls, 
suggesting a role for the intracellular pathogen in the disease. Intracellular 
S.aureus have also been identified in vivo in a number of other chronic 
infections and inflammatory diseases caused by S.aureus infections; these 
include chronic rhinosinusitis, bovine chronic mastitis, recurrent tonsillitis and 
cystic fibrosis lung infections (Clement et al. 2005; Plouin-Gaudon et al. 2006; 
Hébert et al. 2000; Jarry & Cheung 2006). The intracellular location is 
considered to be involved in the persistence and reoccurrence of the infections. 
Interestingly though, S.aureus surface biofilm formation has also been linked to 
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persistence and reoccurrence in all these diseases (Cucarella et al. 2004; 
Madeo & Frieri 2014; Torretta et al. 2013; Davies & Bilton 2009). Despite both 
biofilm and intracellular S.aureus being associated with the same diseases 
there has been little examination of the association between the intracellular 
and biofilm state of S.aureus. It was reported, though, that in patients with 
chronic rhinosinusitis all incidences of intracellular S.aureus were associated 
with surface biofilms, and the authors suggested a link between the two (Tan et 
al. 2012). Also, in an in vivo rat model of S.aureus biofilm infection, significantly 
higher levels of intracellular (within leukocytes) than extracellular S.aureus were 
found in the wound fluid (Murillo et al. 2009). S.aureus can survive within 
leukocytes for several days, and the invasion of macrophages, mast cells and 
neutrophils has been suggested to be a virulence mechanism related to the 
pathogenicity and dissemination of the bacteria (Kubica et al. 2008; Gresham et 
al. 2000; Abel et al. 2011). Although the relationship between S.aureus biofilms 
and intracellular persistence is not clear, both have been shown to relate to the 
bacteria’s virulence. Preventing internalisation of S.aureus through either pre-
treatment with mimetic peptides or use of mutant S.aureus lacking certain 
copies of the fibronectin binding protein (FnBP), significantly decreased 
infection and mortality in guinea pig and murine in vivo models respectively 
(Menzies et al. 2002; Edwards et al. 2010). Similarly, disrupting S.aureus biofilm 
formation in a murine in vivo skin wound model using RNAIII inhibiting peptide 
(RIP), which disrupts biofilms but has no effect on S.aureus viability, restored 
normal healing in a mouse model (Schierle et al. 2009). Normal healing was 
also recovered by preventing biofilm formation using bacteria mutants unable to 
form biofilms. Thus for now both biofilm formation and intracellular persistence 
appear to be involved in recurrent infections, and it is highly feasible that both 
strategies are used by S.aureus; this bacterium is highly adaptable and mutable, 
and the predominant strategy used could well depend on the host environment 
and interactions with other bacteria (Goerke & Wolz 2010). 
 
7.3.2. S.aureus biofilm formation and its influence on the 
internalisation of the bacterium 
Interestingly, the ability of some bacteria, such as Salmonella enterica, to 
invade host cells has been shown to be related directly to the particular strain’s 
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ability to form biofilms (Latasa et al. 2005). The biofilm associated protein (Bap) 
A gene was found to be necessary for S.enterica biofilm formation, and its loss 
significantly decreased the ability of the bacteria to invade intestinal epithelial 
cells. In contrast though, S.aureus expression of Bap (a functionally related 
homologue to BapA) increased adhesion to epithelial cells, but inhibited the 
internalisation of the bacterium (Valle et al. 2012). Moreover, using bovine 
mammary cells no direct correlation was found between the ability of different 
S.aureus strains to form a biofilm and their invasiveness into host cells (Oliveira 
et al. 2011).  
 
It is also not known if the presence of biofilm S.aureus influences the 
invasiveness of planktonic S.aureus. Interestingly, migrating fibroblasts 
incubated with S.aureus BCM closely resemble RhoA depleted mutants in both 
morphology and impaired migration (Vega et al. 2011). Clinical isolates of 
S.aureus highly express the virulence factor epidermal cell differentiation 
inhibitor (EDIN), a very selective ADP-ribosyltransferase, which inactivates 
Rho(A/B/C/E) GTPases (Munro et al. 2011). Although not yet determined, it is 
highly possible that EDIN is secreted by S.aureus in biofilms. Rho GTPases are 
part of the integrin signalling pathway, and RhoA is a activated by α5β1 (Danen 
et al. 2002), the same integrin through which S.aureus are internalised (Sinha 
et al. 1999). Internalisation of S.aureus also requires RhoA activation by the 
bacterium’s surface protein, Protein A (Soong et al. 2011), which when 
removed severely impaired the invasion of the null mutants into oral 
keratinocytes (Jung et al. 2001). Thus it would be interesting to determine if 
incubation with S.aureus biofilm toxins alters the internalisation of S.aureus, or 
other bacteria that utilise α5β1 to invade cells.  
 
7.3.3. Intracellular biofilms 
Intriguingly, it was discovered that both Escherichia coli and Klebsiella 
pneumoniae can form largely quiescent biofilm-like communities within the 
cytoplasm of host urinary tract epithelial cells and airway epithelial cells (Justice 
et al. 2006; Rosen et al. 2008; Garcia-medina et al. 2005). This ability has been 
shown using in vivo murine models but similar biofilm aggregates have also 
been observed in human urinary tract epithelial cells (Rosen et al. 2007). It is 
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not yet known whether other bacteria, such as S.aureus, also form intracellular 
biofilms, or what role these bacterial communities perform.   
 
7.3.4. Intracellular S.aureus in chronic wounds 
Thus far, intracellular S.aureus have not been demonstrated in cells isolated 
from chronic wounds, although their identification has not been the particular 
focus of any published research to date. Nevertheless, it was recently 
demonstrated that healthy human skin not only has a surface microbiome but 
also a subcutaneous microflora (Nakatsuji et al. 2013). Multiple species of 
bacteria were found within both the epidermis and dermis in healthy intact skin, 
though it wasn’t determined if they were intra- or extra-cellular. S.aureus is 
known to commonly colonise the surface of human skin, though the study did 
not state if this was one of the species found under the surface. S.aureus 
though is able to invade many of the cell types present in wounded skin, 
including keratinocytes, fibroblasts, endothelial cells and leukocytes (Kubica et 
al. 2008; Gresham et al. 2000; Sinha et al. 1999; Kintarak et al. 2004). 
Moreover, another pathogenic bacteria, Chlamydia pneumonia, an obligate 
intracellular species, has been found in intracellular locations in chronic skin 
ulcers (King et al. 2001). It is therefore plausible that intracellular S.aureus 
could, in the future, be found in chronic wounds. 
 
7.4. The relationship between S.aureus and connexins 
in wounds 
7.4.1. The relationship between α5β1 and Cx43 expression 
S.aureus predominantly enters cells through the host integrin α5β1, bridged by 
fibronectin (Sinha et al. 1999). Α5β1 is a component of focal adhesions, forming 
the attachment between cells and the extracellular matrix component fibronectin. 
Its expression is required for the migration of keratinocytes, fibroblasts and 
endothelial cells (Watson et al. 2009; Xu & Clark 1996; Collo & Pepper 1999). 
In vivo it is expressed at low levels by keratinocytes and becomes up-regulated 
during re-epithelialisation, as the cells migrate over fibronectin in the wound bed 
(Larjava et al. 1993). Similarly, α5β1 expression increases in fibroblasts during 
wound healing, and endothelial cells during angiogenesis (Xu & Clark 1996; 
Boudreau & Varner 2004). Epidermal keratinocytes in chronic wounds do not 
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have increased α5 expression at the wound edge, unlike their acute wound 
counterparts (Ongenae et al. 2000). Currently, the α5β1 expression in chronic 
wound fibroblasts and endothelial cells is not known. However, we hypothesise 
that reduced wound edge α5β1 expression may protect cells in chronic wounds 
from invasion by S.aureus, and other bacteria that use α5β1 for internalisation, 
such as P.aeruginosa and E.coli, both also commonly found in chronic wounds 
(Scibelli et al. 2007; Gjødsbøl & Christensen 2006; Davies et al. 2004).  
 
Moreover, α5β1 can regulate Cx43 expression (Guo et al. 2002; Shanker et al. 
2005; Czyz et al. 2005). Interestingly, loss of the β1 component has been 
shown to result in an increase in Cx43 expression in embryonic stem cell 
derived cardiomyocytes (Czyz et al. 2005), although in contrast, activation of 
α5β1 has also been reported to increase Cx43 in cardiomyocytes and alveolar 
epithelial cells (Guo et al. 2002; Shanker et al. 2005). Cx43 expression is 
elevated in chronic wounds, which fail to increase α5 expression (Brandner et al. 
2004; Mendoza-Naranjo, Cormie, A. Serrano, et al. 2012; Mendoza-Naranjo, 
Cormie, A. E. Serrano, et al. 2012; Ongenae et al. 2000). However, the 
relationship between α5β1 and Cx43 in both acute and chronic wounds remains 
to be determined. In this thesis it was demonstrated that Cx43 expression was 
significantly elevated in the distal epidermis of S.aureus infected wounds, and 
there was a trend for increased distal dermal Cx43 expression. Due to the 
phenotypic similarities between the S.aureus infected in vivo model and chronic 
wounds, we hypothesise that the infected wounds may too have aberrant or 
depleted α5β1 expression or activation.  
 
7.4.2. The causes and consequences of increased epidermal 
connexin expression 
S.aureus infection resulted in a significant increase in the expression of Cx26, 
Cx30 and Cx43 in the epidermis for several millimetres surrounding the wound 
edge (chapter 6). It also caused a trend for increased Cx43 expression in the 
dermis away from the wound edge (chapter 6). However, in vitro S.aureus 
infection, and S.aureus biofilm toxins, decreased Cx43 expression in fibroblasts 
(chapter 5 and 4 respectively). In keratinocyte HaCaT cells, S.aureus derived 
peptidoglycan (PGN) was found to have no effect on Cx43 expression, although 
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it did increase Cx26 expression (Donnelly et al. 2012). It is possible that 
S.aureus might have directly increased Cx26 expression in the epidermis, but it 
seems less plausible that the high Cx43 expression observed was in direct 
response to infection with the bacteria. Instead, increased Cx43 in the distal 
epidermis and dermis could perhaps be mediated through an as yet unknown 
mechanism, which may or may not involve the inflammatory response. 
Alternatively, increased Cx43 expression in the epidermis of infected wounds 
might not be in response to the infection, but be related to the hyperproliferative 
nature of the tissue during the infection, as could Cx26 and Cx30. All three 
connexins have been reported in hyperproliferative epitheliums such as viral 
warts and psoriasis (Hivnor et al. 2004; Lemaître et al. 2006; Lucke et al. 1999; 
Labarthe et al. 1998; Goliger & Paul 1995; Djalilian et al. 2006), and are also 
strongly expressed in the highly proliferative epidermis of buccal mucosa 
(chapter 3). Cx26 and Cx30 in particular have been suggested to be markers of 
proliferative epithelia, although their expression is often reported in vivo not to 
correlate with cells positive for proliferative markers (Goliger & Paul 1995; 
Lucke et al. 1999; Coutinho et al. 2003). However, overexpression of Cx26 in 
keratinocytes in vitro was found to increase proliferation, and ectopic 
overexpression in the skin of transgenic mice resulted in a hyperplasic 
epidermis (Djalilian et al. 2006; Man et al. 2007). So it is possible that increased 
Cx26 in keratinocytes exposed to S.aureus might be involved in the epidermal 
hyperplasia. The effect of infection with live S.aureus on Cx26 expression in 
keratinocytes in culture has yet to be determined, but it will be interesting to 
ascertain if it increases or decreases proliferation.   
 
High levels of Cx43 expression impairs cell migration during wound healing, 
and decreasing the expression improves the rate of healing (Mori et al. 2006; 
Wang et al. 2007; Mendoza-Naranjo, Cormie, A. Serrano, et al. 2012). For 
example, abnormally elevated Cx43 was found in diabetic skin wounds and 
contributed to retarded healing; this was overcome by decreasing Cx43 
expression with Cx43 asODN (Wang et al. 2007). Although Cx43 expression 
was elevated by S.aureus infection, it was elevated distally, not at the wound 
edge where migration primarily occurs. Consequently, the abnormally elevated 
Cx43 expression induced by the infection is unlikely to underlie the impaired 
healing. However, the change in Cx43 expression may have functional 
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consequences for the host’s response to the bacterial infection. Reducing Cx43 
expression in fibroblasts increased internalisation of S.aureus (chapter 5).  
Similarly, reducing Cx43 expression was found to result in increased mortality in 
an infected peritonitis murine model (Anand et al. 2008), where mice were 
infected with E.coli, another bacterium that is internalised into cells through 
integrin α5β1 and commonly found in chronic wounds (Scibelli et al. 2007; 
Davies et al. 2004; Gjødsbøl & Christensen 2006). Thus it is feasible to 
speculate that increased Cx43 expression could reduce internalisation of some 
species of bacteria, and so be protective. However, high Cx43 expression is not 
protective against all infections. Reducing Cx43 expression instead protected 
epithelial cells challenged with Helicobacter pylori VacA toxin (Radin et al. 
2014), and inducing Cx43 expression in HeLa cells increased the invasion of 
Yersinia enterocolitica (L. A. Velasquez Almonacid et al. 2009). However, both 
H.pylori and Y.enterocolitica are primarily gastrointestinal pathogens, and are 
not commonly associated with skin or chronic wounds (Ceelen et al. 2011).  
 
It is not currently known if the increased epidermal connexin expression seen in 
the infected mice is a specific response to S.aureus infection, or whether it is a 
more general response to infection with any bacteria. Determining this might 
shed some light on both the cause of the connexin increase, and its role in 
infected wounds.  
 
7.5. Polymicrobial infections 
Formerly it was thought that the bacterial load in a wound was a determinant for 
the healing outcome, with high bacterial counts indicative of poor healing. 
Increasingly though it is thought that it is actually the number of different 
species that may be more important. Using traditional culture techniques one 
study found that 76% of venous leg ulcers were simultaneously infected with 
multiple bacterial species, up to 5 different species at a time (Gjødsbøl & 
Christensen 2006). However, the number of species in each may actually be 
even higher, as another study, this time using PCR, found 40% more species in 
wounds compared to normal culture techniques (Davies et al. 2004). In vivo 
infected wound models similarly indicate that polymicrobial wounds impair 
healing to a significantly greater extent than single species infections (A. Seth et 
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al. 2012; Pastar et al. 2013). In a porcine model re-epithelialisation was 
significantly delayed in polymicrobial infections over single microbial wounds 
(Pastar et al. 2013). The same was found using different strains in a rabbit ear 
model, alongside an increase in IL-1β and TNF-α expression (A. Seth et al. 
2012). Both studies focused on infections with P.aeruginosa and S.aureus, as 
both have been shown in approximately 90% of chronic wounds (Gjødsbøl & 
Christensen 2006; Davies et al. 2004). Another murine wound model found that 
a polymicrobial biofilm containing four species (P.aeruginosa, S.aureus, 
Enterococcus faecalis and Finegoldia magna) only significantly impaired 
healing at one time point compared to planktonic applied P.aeruginosa (A. Seth 
et al. 2012). The difference might be due to the fact that comparisons were 
made to P.aeruginosa infected wounds; P.aeruginosa was found to impair 
healing significantly more than infections with several other single species in a 
rabbit wound model (Akhil K. Seth et al. 2012), and its presence in is indicative 
of poor healing outcome in chronic wounds (Gjødsbøl & Christensen 2006). 
Alternatively, it might due to interactions between the bacterial species, as 
bacteria in polymicrobial biofilms can influence the behaviour of one another (A. 
Seth et al. 2012; Pastar et al. 2013; Dalton et al. 2011). Over 12 days Seth et al 
found that in vitro and in a rabbit in vivo model P.aeruginosa came to dominate 
S.aureus (A. Seth et al. 2012). Pastar et al further established that in their 
porcine model P.aeruginosa suppressed the growth of S.aureus, and altered 
the expression of several S.aureus virulence factors, reducing some and 
inducing others (Pastar et al. 2013). Likewise, P.aeruginosa outcompeted and 
reduced the virulence of S.aureus in cystic fibrosis polymicrobial biofilms 
(Baldan et al. 2014), and there is evidence that P.aeruginosa may even use 
S.aureus as a source of iron during co-culture (Mashburn et al. 2005). 
Furthermore, distinct ‘pockets’ of homogenous bacteria were observed in a 
polymicrobial wound biofilm containing four different species, with P.aeruginosa 
preferentially locating to the leading edge of the infection (Dalton et al. 2011). 
Biofilms in nature, and specifically in chronic wounds, are typically polymicrobial. 
Interestingly, it appears that intracellular populations may also be polymicrobial, 
at least in oral mucosa, where polymicrobial populations were identified in both 
buccal and gingival epithelial cells (Rudney et al. 2005; Colombo et al. 2013). 
As there may be an association between the presence of biofilms and 
intracellular bacteria in chronic rhinosinusitis (Tan et al. 2013) it would be 
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interesting to see if the same species are found in both locations, and whether 
this extend to other regions and diseases, including chronic wounds. 
 
7.6. Concluding remarks 
Connexins, and Cx43 in particular, are clearly important during the wound 
healing process. The exact roles played by each connexin is as yet uncertain 
though, and it is not known how much the expression patterns and changes in 
expression contribute to the healing ability of different tissues. The abnormal 
connexin expression in chronic wounds seems likely to contribute to their poor 
healing. Although a role for S.aureus in chronic wounds is acknowledged, it is 
evident that our understanding of the parts played by biofilm and intracellular 
bacteria is still rudimentary. Moreover, prior investigations into the relationship 
between S.aureus and connexins are very limited. From the investigations in 
this thesis, it is clear that live S.aureus, and its biofilm-secreted products, can 
reduce Cx43 expression in fibroblasts. Cx43 expression can also determine the 
internalisation of live S.aureus and thus influence the cell’s viability in response 
to the pathogen, though it does not influence the cell’s response to biofilm 
exotoxins. Both biofilm exotoxins and live S.aureus impaired healing in an in 
vivo cutaneous wound model, but only the live bacterium altered connexin 
expression, albeit by increasing the expression of Cx43, Cx26 and Cx30 away 
from the wound edge. However, it is not yet established how S.aureus infection 
results in abnormal connexin expression in vivo, and whether this contributes to 
the infection’s impairment of healing. There is much still to be learnt about 
S.aureus and wound healing, and the relationship between the bacterium and 
connexin expression.  
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Appendix Table 1. Summary of results related to connexin expression changes due to 
exposure to bacteria or bacterial components.    
  BCM HKSA Live SA 
In vitro 
(fibroblasts) 
Cx43 
No effects at 24 
hours, 
decreased at 7 
days 
No effect 
Decreased at 24 
hours 
In vivo 
(dermis) 
Cx43 
No effect at the 
wound edge or 
distally at 3 or 7 
days 
Decreased at 
wound edge at 3 
days, no effect 
distally 
No effect at the 
wound edge or 
distally at 3 days 
In vivo  
(epidermis) 
Cx43 
No effect at the 
growth tip, 
wound edge or 
distally at 3 or 7 
days 
No effect at the 
growth tip, 
wound edge or 
distally at 3 days 
Increased 
distally at 3 days, 
no effect at the 
growth tip or 
wound edge 
Cx26 
No effect at the 
wound edge or 
distally at 3 days 
No effect at the 
wound edge or 
distally at 3 days 
Increased 
distally at 3 days, 
no effect at the 
wound edge 
Cx30 
No effect at the 
wound edge or 
distally at 3 days 
No effect at the 
wound edge or 
distally at 3 days 
Increased 
distally at 3 days, 
no effect at the 
wound edge 
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